The short version

• Your body needs cholesterol. Problems can develop when the particles carrying it get stuck inside artery walls and help form plaque, a fatty buildup.

• A cholesterol test cannot show whether you already have plaque. Blood tests give clues about risk, scans show particular features of the heart or arteries, and tests of heart function show how it performs. A normal result has meaning within what that particular test measures.

• The same cholesterol number can mean different things for different women. Blood pressure, smoking, diabetes, inherited risk, and health history help determine which prevention steps are likely to help most.

Lipids are fats and fat-like substances. A lipid panel, often called a cholesterol test, measures cholesterol and triglycerides, a fat your body uses for energy. It is used to assess risk and track treatment.

Let’s follow the cholesterol first. The reference at the end is optional, for when you want details about a specific test or treatment.

Follow the cholesterol

Your heart is a pump. Electrical signals time its beats, valves keep blood moving forward, and coronary arteries bring oxygen-rich blood to the heart muscle. We’re following atherosclerosis, fatty buildup called plaque inside artery walls. It is one form of cardiovascular disease, the broader term for heart and blood-vessel disease.

Well-established: your body needs cholesterol to build the barriers around its cells and make hormones, vitamin D, and bile acids that help digest fat. The liver, intestine, and other cells make it from small carbon building blocks. You can make what you need without eating cholesterol. Physiology

Cholesterol needs a ride because it does not mix with watery blood. It travels inside tiny carriers called lipoproteins. Think of delivery vans, with cholesterol as the boxes inside. LDL, short for low-density lipoprotein, is one kind of van. Cholesterol is what it carries.

The liver sends out carriers rich in triglycerides. As muscle and fat tissue take up that fuel, some carriers become LDL. LDL receptors, docking sites on liver cells, pull LDL out of blood.

There is a recycling route too. The liver sends cholesterol and bile acids into the gut in bile, a digestive fluid. The intestine absorbs cholesterol from food and bile. Most bile acids return to the liver; some leave in stool. That route will matter when we get to fiber. Transport

Trouble can begin when carriers enter an artery wall and get stuck beneath its lining. Trapped material can change and trigger inflammation, part of the body’s response to damage or irritation. Defense cells called macrophages take in the trapped material. As they fill with cholesterol, they become foam cells. Over time, fat and the remains of dying cells collect in the wall. Other cells build a covering over this buildup, called a fibrous cap. Calcium can collect in plaque too.

Inflammation does not always have to happen first. It can already be present in an artery wall, but trapped carriers can also trigger it. That inflammation can then help plaque grow. Plaque biology, human artery study

Plaque can narrow an artery enough to limit blood supply during activity, or grow outward while leaving room for blood to pass. If its cap breaks or its surface wears away, a clot can abruptly block flow. What you might find shocking is that your arteries don’t need to be nearly blocked beforehand for a heart attack (myocardial infarction) to happen. Atherosclerosis

What are these blood tests actually measuring?

You can have your cholesterol checked for years without ApoB or Lp(a) ever being measured. Here is what those additional tests can tell you. Standard panel, additional tests

First, your result reflects a balance: how much cholesterol your body makes, how much your gut absorbs, and how much your liver removes from the blood. Food matters, but so do inherited genes, thyroid problems, how your body handles blood sugar, medicines, and pregnancy. Eating well cannot guarantee an unchanged result. Sleep and stress matter too, but cannot automatically explain an individual rise. Causes, evaluation, sleep research

LDL-C: how much cholesterol is inside the LDL vans?

The C stands for cholesterol. LDL-C measures how much cholesterol is inside the LDL vans in your blood, not how many vans are carrying it.

ApoB: how many carriers could contribute to plaque?

Imagine the same small amount of blood from two women:

• One has 10 LDL vans carrying 10 boxes each.

• The other has 20 LDL vans carrying 5 boxes each.

Both have 100 boxes. Their LDL-C results could look the same, but the second woman has twice as many vans. More carriers, circulating over more years, means more opportunities for them to enter an artery wall and get stuck.

Apolipoprotein B, or ApoB, is a protein attached to each of these carriers: one per carrier. Measuring it helps estimate their number. It includes LDL and other types that can contribute to plaque, including Lp(a). Particles is another name for these tiny carriers. You may also hear them called atherogenic, which means capable of contributing to plaque. Why the count matters

HDL-C and triglycerides: what else is being carried?

HDL, high-density lipoprotein, helps move cholesterol toward the liver to be reused or removed. These carriers are not included in the ApoB count. HDL-C measures the cholesterol inside those carriers, not how well that return system works.

Triglycerides are energy fuel carried in the blood too. A triglyceride-to-HDL ratio divides one result by the other. Even a favorable ratio cannot show that your arteries are clear or make high ApoB unimportant. Transport, ApoB guidance

Lp(a): how much of this particular carrier do you have?

Lipoprotein(a), or Lp(a), pronounced “L-P-little-a,” resembles LDL with an extra protein attached. Its level is largely determined by genes passed down in your family. A high level can increase risk even when other cholesterol numbers look reassuring.

Lp(a) has ApoB too, so it is part of that overall estimate. But ApoB cannot tell you how much of the total is Lp(a). That takes a separate test.

Check the units: mg/dL measures mass; nmol/L reflects the number of particles in a volume of blood. Common cutoffs that add concern about risk are 50 mg/dL and 125 nmol/L. They are separate thresholds, not a fixed conversion, because particle sizes vary. Risk rises across a range, rather than starting at one exact number. Lp(a) and measurement guidance

Why am I only hearing about these tests now?

The usual panel reports total cholesterol, LDL-C, HDL-C, and triglycerides. ApoB and Lp(a) generally need separate orders. “Cholesterol normal” does not tell you whether either was checked.

These tests are not new, but recommendations about using them have expanded. The 2026 U.S. heart-society guideline recommends Lp(a) at least once in adulthood. ApoB can be useful more selectively, including when diabetes or high triglycerides make the usual numbers less informative. Standard testing, current guidance

ApoB may reveal more plaque-contributing carriers than LDL-C suggests. Lp(a) may reveal inherited risk that was never separately measured. That can influence how much to lower LDL and how closely to manage other risks. Neither test shows whether plaque is already in your arteries or says that a heart attack is inevitable.

What about inflammation?

A high-sensitivity C-reactive protein test, or hs-CRP, measures small amounts of a protein the liver releases in response to inflammation. It adds risk information but cannot locate inflammation or show trapped particles. A lower result is generally favorable; it cannot rule out plaque or cancel high LDL or Lp(a). Infection can raise it, so testing for heart-disease risk is best done when you’re well.

Long-term research in initially healthy women found that hs-CRP, LDL-C, and Lp(a) each add information about risk. So a reassuring result on one of them doesn’t settle the other two. Inflammation guidance, Lp(a) and hs-CRP, women’s study

The same result can mean a different decision

Imagine two women in their 40s with the same mildly elevated LDL-C. One doesn’t smoke, has healthy blood pressure, and has neither diabetes nor kidney disease. The other smokes and has high blood pressure and diabetes.

Those additional conditions also harm artery walls. The second woman has more chance of a heart attack or stroke, so lowering LDL is likely to prevent more problems. Someone who has already had a heart attack has an especially strong reason to prevent another. Artery health

Clinicians combine age, cholesterol, blood pressure, smoking, diabetes, and kidney function to estimate risk. A low ten-year estimate means a lower chance during that window, not proof of plaque-free arteries. At 35, it asks what might happen before 45. It cannot answer what happens by 65 after another thirty years of elevated LDL. Risk estimation

Family history matters too. Inherited conditions can expose arteries to more particles from childhood, before a short-term estimate looks concerning. The reference below explains inherited high cholesterol and screening.

Your reproductive history adds information. Preeclampsia is a pregnancy complication involving high blood pressure and organ problems. Preeclampsia, other high blood pressure in pregnancy, diabetes during pregnancy, and preterm birth are all linked with higher cardiovascular risk later. Study in women

LDL often rises and body-fat distribution changes during menopause, when menstrual cycles end. Hormonal changes overlap with aging, sleep, and activity, so if your LDL climbs around this time without a change in your habits, the transition itself may be part of the reason. Menopause before 45, and especially before 40, adds risk information, so say when yours happened if it was early. Hormone treatment has its own considerations in the reference. Menopause and heart health

Where medication fits

A statin is a prescription medicine that lowers LDL cholesterol, such as atorvastatin or rosuvastatin. It slows a cholesterol-making step in the liver. The liver responds by adding LDL receptors, those docking sites that pull more carriers from blood. Your cells still have cholesterol for essential jobs. Statins do not directly lower Lp(a). Mechanism

Statin trials included women and found fewer major problems such as heart attacks and strokes. Evidence is less complete for younger women and treatment over decades. For the first woman in our example, the likely benefit over the next few years is smaller, so daily medication and possible side effects weigh more heavily in her decision. Trying lifestyle changes and then reassessing may be reasonable for her, and inherited risk or other findings can change that. Pregnancy plans belong in the prescribing conversation too. The question worth asking is how much a statin would lower your own risk, and over what stretch of time. Trials in women, treatment guidance

Statins can cause muscle symptoms and modestly increase diabetes risk. Trials are reassuring about memory. Studies measuring fatigue have had different findings. If muscle pain, exhaustion, or brain fog begins after starting treatment, it deserves assessment. A different dose, statin, or non-statin medicine may help. The reference takes a closer look at fatigue and research funding. Muscle symptoms, diabetes, larger analysis

Can medicine help with inherited Lp(a)?

Inherited does not mean impossible to change. Studies of inherited differences support Lp(a)’s contribution to coronary disease and narrowing of the aortic valve, which blood passes through as it leaves the heart. But lowering a blood result must also help people.

In the Lp(a)HORIZON trial, a drug called pelacarsen lowered Lp(a) substantially. It did not demonstrate fewer cardiovascular deaths, heart attacks, strokes, or urgent coronary procedures considered together over nearly five years. Participants already had cardiovascular disease. Side effects more often led people to stop treatment. Whether treatment earlier in life or treatment to protect the valve could help remains unanswered. Starting “too late” is a possible explanation, not something this trial proved. Coronary evidence, valve evidence, trial

That is disappointing. Heart disease remains the leading cause of death for women in the United States, and we need better options. CDC

The trial tested one drug in people who already had cardiovascular disease. It did not erase the evidence that high Lp(a) adds risk. Knowing your Lp(a) is high still helps guide prevention, even though lowering the number with this drug did not produce a proven benefit in this trial. Blood pressure, LDL, blood sugar, and tobacco exposure remain places to act even when Lp(a) stays high. Guidance

What you can change today

Remember the liver–gut recycling route? Certain soluble fibers form a gel in the gut, reducing how much bile acid gets absorbed again. More bile acids leave in stool, so the liver uses cholesterol to make replacements and can pull more LDL from blood. Oats, barley, beans, lentils, fruit, carrots, and Brussels sprouts help supply fiber. Gut bacteria also process fiber and bile acids, although their exact contribution to LDL lowering remains uncertain. Food sources, human study, mechanisms

Saturated fat and cholesterol are different substances. Replacing some saturated fat with unsaturated fat can lower LDL. Reach for olive or avocado oil more often instead of butter, ghee, tallow, or coconut oil. Those fats can still fit; how much and how often matter. Clearance study, dietary guidance

A Mediterranean-style pattern has evidence for fewer cardiovascular problems: vegetables, fruit, beans, whole grains, nuts, fish, and mostly unsaturated fats. Lean, unprocessed meat can fit. Olive oil has more direct heart-health research than avocado oil, which remains a reasonable choice. Diet trial

Build toward 150 minutes of moderate activity, such as brisk walking, weekly, plus strength training twice. Aim for 7–9 hours of sleep. Avoid tobacco and secondhand smoke; vaping isn’t harmless. Red wine’s reputation rests largely on studies observing people’s habits, which cannot establish that drinking prevents heart disease. Alcohol is not a recommended prevention strategy. Prevention basics, alcohol

A normal heart test answers a particular question

A resting echocardiogram uses ultrasound to show how the pump and valves work. An exercise test records how the heart responds to activity. Neither directly shows coronary plaque. A calcium scan looks for one feature of plaque; a zero score can miss buildup without detectable calcium, especially in younger adults. Reassuring results still have value, within what the test can tell us. Testing guidance, calcium and age

Investigating symptoms and choosing preventive treatment are different jobs. Not everyone needs imaging. The reference separates what six tests show, what they can miss, and coverage questions.

Leave knowing which next step is yours

If your result changed unexpectedly, compare it with the previous report: which value changed, by how much, and over what period? That helps you and your clinician review possible causes and decide whether to repeat it.

If inherited risk is the concern, work on the parts of your overall risk that can change, including LDL and blood pressure. Feeling well does not make preventive care unnecessary, and needing medication does not mean you failed.

If you are starting from scratch, routine primary care can establish your blood pressure and cholesterol picture. Choose one change you can repeat, such as adding beans to dinner or a regular walk.

Symptoms need their own answer. Recurring chest pressure, breathlessness with usual activity, or a decline in what you can comfortably do deserves assessment even after reassuring tests. Women can have microvascular dysfunction, small coronary vessels not working properly, or vasospasm, temporary artery tightening that can happen at rest, without major blockages. Symptoms alone cannot diagnose these conditions. Chest-pain guidance

New chest pressure or sudden unexplained breathlessness can be an emergency. Call 911 rather than waiting for an outpatient scan.

Before another heart test, ask: What will this tell me? What can’t it see? What would we do differently with the result?

Which would be more useful to you next: a closer look at statins, or menopause and your heart? Let me know in the comments.

Congratulations, we’re healthing.

Keep this reference for when you need it

Understanding a heart test

Contrast is a substance given during some scans to make the images clearer.

Coronary artery calcium score (CAC): how much calcified coronary plaque is visible?

A computed tomography (CT) scan, which uses X-rays to make pictures. It can help selected people when the decision about preventive treatment is uncertain. Zero is often reassuring about near-term risk, but means no detectable calcium, not necessarily no plaque. Noncalcified plaque is buildup without detectable calcium. It can grow or rupture, although not all is unstable. Earlier plaque may not register, especially in younger adults. Low-dose radiation; no injected contrast. CAC, age and zero

Coronary CT angiography (CCTA): what plaque and narrowing are present?

Can be an initial test for selected people with symptoms. Seeing a narrowing does not, by itself, tell us whether it is limiting blood flow. Uses radiation and iodine contrast. Kidney function and any previous reaction to contrast matter when choosing this test. CCTA

Exercise electrocardiogram (ECG): what changes with exertion?

Records electrical activity, symptoms, blood pressure, and how much exercise you can do. Changes can suggest that the heart is not getting enough blood; it does not show plaque. The starting ECG must be readable, and you need to be able to exercise enough for the test. No radiation or contrast. Stress testing

Resting echocardiogram: how are the pump and valves working?

Ultrasound that cannot rule out coronary plaque. No radiation; contrast sometimes improves images. Echo

Cardiac magnetic resonance imaging (MRI): how does the muscle look and function?

Can identify scarring or inflammation in the heart muscle. A routine scan does not map coronary plaque. It uses a magnetic field, without X-ray radiation; some exams use a contrast substance called gadolinium. Cardiac MRI

Carotid magnetic resonance angiography (MRA): are the neck arteries supplying the brain narrowed?

Does not examine coronary plaque or replace cardiac MRI. Routine screening without symptoms is not recommended. No X-ray radiation; it can be done with or without contrast. MRA, screening

Stress imaging adds pictures during exercise or after medicine that changes blood flow or makes the heart work harder. Ultrasound shows heart movement; nuclear testing or stress MRI assesses blood supply. Nuclear testing uses radiation. Radiation-free does not automatically mean best. Testing guidance, stress-test medicines

Reports may call plaque noncalcified, calcified, or mixed, rather than “soft” or “hard.” Calcium alone cannot establish danger or safety. How much plaque there is, where it is, and what it contains matter. Studies link statin use with less fatty material in plaque and denser calcium, so a rising calcium score alone cannot tell you whether treatment is working. Plaque study

Follow-up tracks cholesterol, blood pressure, blood-sugar measures when relevant, side effects, and symptoms. Lipids are commonly rechecked 4–12 weeks after starting or increasing treatment, then every 6–12 months. These checks show whether treatment is changing risk factors, not whether plaque is shrinking. Repeat calcium scans are not used to monitor treatment; another scan needs a specific question to answer. Monitoring, follow-up

Coverage varies. Insurers may require advance approval, records, or an appeal. There is no universal requirement to “fail” a stress test before CCTA, and approval does not guarantee payment. Check whether the facility is in your insurance network and what you would owe under your plan. For cash-pay imaging, request a written estimate including the scan, the person reading it, and contrast charges. Coverage example, estimates

If your report includes non-HDL cholesterol

Non-HDL cholesterol is total cholesterol minus HDL-C. It measures cholesterol in the carriers that can contribute to plaque. Transport, ApoB guidance

Inherited cholesterol and screening

Familial hypercholesterolemia (FH) is an inherited difficulty removing LDL, often causing very high levels from childhood. Adult LDL-C of 190 mg/dL or higher before treatment is a clue, not a diagnosis. Assessment includes repeating the blood test, reviewing family history, checking other causes such as an underactive thyroid, and sometimes genetic testing. A negative genetic test does not always exclude FH.

The 2026 U.S. heart-society guideline recommends routine cholesterol screening at 9–11, or as early as 2 when family history suggests FH. Adult screening starts at 19, generally every five years when risk is low. A parent’s unusually early heart attack or high Lp(a) also deserves attention beyond the basic calculation. Screening and FH

Menopause and hormone treatment

Menopause hormone therapy is medicine that replaces estrogen, sometimes alongside progesterone or a related hormone. Some studies of treatment started early suggest heart benefits; others found no improvement in artery measurements. Better cholesterol or artery-wall measurements do not themselves prove fewer heart attacks. Hormone therapy is not currently recommended mainly for cardiovascular prevention. For healthy women treating symptoms, the balance of benefits and risks is generally more favorable before 60 or within ten years of menopause. The hormone, dose, pills versus patches, and your health matter; some forms taken by mouth raise clot and stroke risk. Evidence and guidance

Premature ovarian insufficiency means the ovaries, which release eggs and make hormones, lose normal function before 40. It and early menopause need a different discussion. When safe, hormone therapy is generally recommended at least until the usual menopause age, around 50–52, to replace hormones lost early. That is a reassessment point, not an automatic stop date. Treatment after menopause can also help with symptoms or some bone-health needs, with regular review. Endocrine guideline

A closer look at statin evidence

Many original trials had funding from drug companies. The analysis combining results from multiple trials had public and charitable support. Funding deserves scrutiny alongside how a study was done and what it found. Funding and data access

For fatigue, a small trial found worse energy and tiredness with activity. A larger analysis combining trials found no increase in reported fatigue, using different ways to measure it. These studies alone cannot tell you whether your own tiredness comes from the statin. A symptom that starts after treatment is still worth evaluating, and treatment can be adjusted when needed. Smaller fatigue trial, larger analysis

Lindsay Savage, PA-C, Physician Associate

General education, not individualized diagnosis or treatment. Evidence reviewed through November 11, 2026.

Selected studies and guidance

1. 2026 dyslipidemia guideline.

2. Atherosclerotic plaque biology and ApoB consensus.

3. Women’s Health Study: hs-CRP, LDL-C and Lp(a).

4. Lp(a)HORIZON and companion analyses.

5. Statin trials in women and men and 2026 adverse-event analysis.

6. Menopause Society statement and 2025 endocrine guideline.

7. PREDIMED dietary-pattern trial.

Reading in your inbox? Open the full article for every graphic and source.

Maybe vitamin D came up because you’re exhausted. Maybe it’s already in your prenatal or your multivitamin. Maybe you got a result back and your clinician said it was fine, the lab printed a flag next to it, and someone online said you should be twice as high, with K2.

Clinical observation: in my Michigan practice, many of the unsupplemented adult women I tested came back in the low twenties, and among the 16- to 18-year-olds I tested in winter, 14 to 19 ng/mL was common. Those are observations from one practice, not population estimates, but they’re why I have a point of view on this. I also have a stack of research that has gotten better, and more surprising, since I was in clinic. You’re getting both.

What vitamin D does, and what the test measures

Vitamin D arrives three ways: your skin makes it from summer sun, you eat a little of it (fatty fish, fortified milk), or you swallow it. Whichever door it comes through, your liver converts it into a storage form, 25-hydroxyvitamin D. That storage form is what the standard blood test measures. Think of it as the inventory in a warehouse.

Well-established: your kidneys turn some of that inventory into the active hormone, calcitriol, in the amount your calcium system asks for. The hormone’s main job is helping your intestine absorb calcium and keeping the mineral supply to bone steady; it also takes part in muscle and immune function. Other tissues, including immune cells, skin, and the placenta, can make small amounts of the hormone locally for their own use. NIH vitamin D fact sheet, Vitamin D physiology review

So the test tells you how stocked the warehouse is. It does not measure how much hormone your tissues are making or what it’s doing there, and it isn’t supposed to. Much of the argument about vitamin D is an argument about how full the warehouse should be.

Deficiency, symptoms, and prevention are three different questions

Most of the conflicting advice you’ve heard comes from people answering different questions as if they were one.

Do I have enough for normal function? This is deficiency. Well-established: below 20 ng/mL, and especially below 12, the risk of problems from inadequate supply rises: bone softening (osteomalacia) and a parathyroid gland working overtime to defend your calcium. A result below 20 doesn’t diagnose those by itself; it marks the zone where correcting supply matters, and that stays true even when a trial finds that extra vitamin D did nothing for people who already had enough. NIH vitamin D fact sheet

Could a low level be part of how I feel? Possibly, for some symptoms, in people who are deficient. The trial most of us would want, vitamin D in tired young adults who were actually low, is small: 120 adults, mean age 29, about half women, a single large dose. Four weeks later, fatigue scores had fallen more than with placebo, and 72 percent reported feeling less fatigued versus 50 percent on placebo. That supports taking a real deficiency seriously when a woman is exhausted. It doesn’t make vitamin D an energy supplement. Fatigue trial in deficient adults If your number comes up on treatment and your exhaustion doesn’t, that’s useful information: the deficiency may have been worth fixing, and the fatigue still needs attention. Sleep, iron, thyroid, mood, medications, and the load you’re carrying all belong in that conversation. An improved lab result and an improved life are related goals, not interchangeable ones.

If I already have enough, would more protect my future health? This is where the biggest promises get less certain. VITAL enrolled 25,871 U.S. adults, about half of them women and including 5,106 Black participants; most already had adequate vitamin D. It found no reduction in new invasive cancers or major cardiovascular events, and its fracture study found no reduction over five years. A related study found no benefit for preventing depression. These trials were not designed to test correction of an established deficiency, an important limitation discussed in a 2024 international consensus. That cuts both ways: the trials don’t prove extra vitamin D is useless, and they don’t show a benefit from raising an adequate level either. Evidence in young, deficient women, who are rarely enrolled, remains thin. VITAL fracture results, VITAL main results, VITAL depression results, 2024 consensus on assessment and supplementation

Subscribe free

Why recommendations and targets differ

Three different kinds of number get printed as if they were the same thing.

A reference range is what a laboratory considers within normal for the test it runs. A clinical threshold is a cutoff used to identify possible inadequate supply or guide care. A treatment target is where a clinician is trying to get a particular patient. They don’t have to agree.

Units first: most U.S. labs report ng/mL, some report nmol/L, and 20 ng/mL equals 50 nmol/L.

The National Academies, summarized by NIH, set the thresholds most U.S. guidance uses: below 12 ng/mL, risk of deficiency; 12 to 19, potentially inadequate for some people; 20 and above, adequate for bone health in nearly everyone; above 50, linked to potential adverse effects in observational data, particularly above 60. Those were set to answer a population nutrition question. NIH vitamin D fact sheet

In 2011 the Endocrine Society, writing for clinicians treating deficiency, described 30 to 100 ng/mL as sufficient; Quest’s 30-to-100 reference range follows that historical guideline.

Mayo Clinic Laboratories uses a different source and prints 20 to 50 as optimum, with a flagged category from 51 to 80 for increased risk of high urine calcium, which its note ties to levels sustained above 50 along with prolonged calcium supplementation. Neither lab is wrong; they’re answering different questions, and a reference range is where a lab draws its lines, not a promise that every level inside it is good for you.

In 2024 the Endocrine Society, this time writing about prevention in generally healthy people rather than treatment of established deficiency, stopped endorsing 30 as the definition of sufficiency, because trials never identified a level that reliably predicts benefit from supplementing. A 2024 international consensus says it plainly: optimal levels remain debated, and societies differ because they weigh different clinical and public-health approaches. Endocrine Society 2011 guideline, Quest test 92888, Mayo Clinic Laboratories 25HDN, Endocrine Society 2024 guideline, 2024 consensus

Why integrative and functional clinicians often aim higher. If you’ve seen one of us, you’ve probably heard a target of 40 to 60, 50 to 80, or 50 to 90. The case rests on association studies (people with higher levels have less disease, though they also spend more time outside, weigh less, and are healthier to begin with), on physiology (tissues outside the kidney make their own hormone from the circulating supply), and on the point that the big trials dosed people who already had enough. Each is real. What research has not established is a universal higher target for energy or immune outcomes, or safety for holding a level for years; it also hasn’t ruled one out for the deficient younger women who are rarely studied. Dissenting view, 2024, Extrarenal vitamin D activation

Clinical observation: my own target was above 50 and preferably below 90 ng/mL, generally for energy and immune function, and I rechecked about three months after starting replacement because the dose that gets a woman there varies. My reasoning was to correct low levels promptly and address a possible contributor to her symptoms. In practice I rarely saw levels above 60, let alone 90. That is a practice target and a practice observation, not an outcome-proven range and not proof that higher levels are safe for everyone. Many conventional references treat 20 to 30 as sufficient, so ask what range your clinician is using and what she expects it to do for you.

It helps to separate three things: raising a low blood level, relieving symptoms that were due to deficiency, and holding a level high for years in the hope of preventing disease. Temporary higher-dose replacement for a deficient adult has a clinical rationale and adult research behind it. That doesn’t settle the long-term question, and lack of proven benefit is not proof of harm any more than lack of observed harm is proof of safety.

One Calgary trial studied long-term higher dosing in 311 generally healthy adults aged 55 to 70, who were not recruited for deficiency treatment. They took 400, 4,000, or 10,000 IU daily for three years. The higher-dose groups lost more bone density at the wrist, more so among women in an exploratory analysis, and more of them had high urine calcium. Current evidence suggests that long-term high dosing in replete older adults doesn’t help bone and may cost some. The trial was designed around bone-density outcomes and couldn’t establish an effect on fracture risk; it didn’t test treating deficiency and didn’t randomize blood targets; calcium supplementation and the potency of some preparations also mattered, as the authors have discussed. It’s a caution about long-term “more” in people who have enough, not a verdict on a short replacement course for someone who is low. Calgary trial, Calgary trial, results by sex, Authors’ clarification

Two things move the number without changing your routine: season and estrogen. At Michigan’s latitude, skin makes little vitamin D from about November through February, and levels often run lower in late winter than in late summer; in one cohort of older adults the average swing was about 10 ng/mL, with real variation between people. A February result is real, and it’s usually one of the lower points in your year rather than your average. Estrogen-containing contraception raises the protein that carries vitamin D and can change the total, in a way that varies by formulation. Season and latitude, Seasonal pattern in 3.4 million samples, Seasonal variation in the Cardiovascular Health Study, Contraceptive formulations and vitamin D

Food, supplements, and safety, without making it a second job

Food and sun. Few foods carry much: fatty fish, cod liver oil, UV-exposed mushrooms, fortified milk, egg yolks. The recommended daily intake is 600 IU through age 70 and 800 after, from all sources, assuming minimal sun. In a Michigan winter, food alone rarely gets there, which is why a supplement is a reasonable winter tool. Dermatologists don’t recommend sun or tanning as a vitamin D strategy, and I’m not going to argue with them here. NIH vitamin D fact sheet, American Academy of Dermatology

Three categories of dose that get confused. The tolerable upper intake for adults, from all products combined, is 4,000 IU a day. That is a limit for routine, unsupervised use, and it counts every product you take. A temporary replacement course for a diagnosed deficiency is different: a clinician may use higher doses for a defined period with a recheck, and that has adult research behind it. Maintenance after correction is different again, usually a lower ongoing dose. Know which one you’re on, when it ends, and what comes next. NIH vitamin D fact sheet, 2024 consensus

D3, meals, and a routine. Both D2 and D3 raise blood levels; D3 generally raises them more effectively. If your level barely changes on a prescription, ask about the form, the schedule, and whether absorption or missed doses could be involved. Taking D3 with a meal containing some fat can help absorption. For adults 50 and older who need supplementation or treatment, the 2024 Endocrine Society guideline favors daily lower doses over larger intermittent doses. Follow your prescribed schedule; large intermittent doses in older adults have sometimes increased falls. Clinical observation: I often preferred a liquid D3/K2, including drops with 1,000 IU each, because it’s easy to adjust; that’s a practice preference, not evidence that liquid works better. Whatever the form, check whether the label gives the amount per drop, per dropper, or per serving. That distinction can help prevent dosing mistakes. D2 versus D3, meta-analysis, Dietary fat and absorption, Endocrine Society evidence review, 2024

Rechecking. On a steady daily dose the blood level settles over about three months, which is why that was my checkpoint. Whether and when to recheck after that depends on why you were treated and how you responded. For a healthy adult with no symptoms or risk factors, the U.S. Preventive Services Task Force found the evidence insufficient to recommend for or against screening, and the 2024 Endocrine Society guideline suggests against routine testing. Time to steady state, USPSTF, Endocrine Society 2024 guideline

Does D3 need K2? Vitamin K activates proteins involved in bone and in keeping calcium out of blood-vessel walls, and K2 supplements reliably change those protein markers. The mechanism is real. In a three-year trial, 142 postmenopausal women with osteopenia took calcium and D3 with or without K2. Adding K2 changed a vitamin K-related protein marker but did not improve bone density or microarchitecture compared with placebo after three years. That study does not establish a benefit for younger women or during pregnancy. K2 has not been established as protection against taking too much vitamin D. If you take warfarin or a related blood thinner, do not start or stop a K2 product without your anticoagulation clinician. K2 added to calcium and D3, three-year trial, NIH vitamin K fact sheet

Safety. True vitamin D toxicity, with dangerously high blood calcium, is rare and has come from manufacturing errors or large dosing mistakes. Before that point, calcium can run high in the urine or blood without obvious symptoms, which is one reason higher-dose treatment belongs under a clinician. Reasons to involve a clinician before supplementing at more than routine doses: pregnancy, a history of kidney stones or high blood calcium, kidney or liver disease, sarcoidosis or lymphoma, an overactive parathyroid gland, or a thiazide diuretic plus calcium. Reasons to be seen: new bone pain, muscle weakness, a fracture from a minor fall, or, on supplements, unusual thirst, frequent urination, nausea, constipation, or confusion. Vitamin D toxicity case review, NIH vitamin D fact sheet

What to do next

1. Ask which question you’re answering: correcting a deficiency, investigating a symptom, or trying to prevent something.

2. If you’ve never been tested and feel well, you don’t need a lab result to start. The general recommended intake is 600 IU a day through age 70 and 800 after, from food and supplements combined; the adult upper limit of 4,000 IU a day is a ceiling for routine use, not a daily goal. Treating a diagnosed deficiency is a separate, individualized decision. A test is for a reason (a symptom, a risk factor, a treatment to check), not a ritual. NIH vitamin D fact sheet

3. Keep the result, the units, the month, the lab, and whether you were on estrogen together. That context helps your clinician interpret the result.

4. Add up the vitamin D across every product you take.

5. If you’re treating a low level, know the dose, the duration, the recheck point, and what would change the plan.

6. If a target is recommended to you, ask what it’s expected to do for you and what that rests on. A good answer names the outcome and the evidence, and your clinician should be able to explain how the guidance applies to you.

Has anyone ever explained to you what the month you drew your blood in does to the number?

Leave a comment

Congratulations, we’re healthing.

Share this guide

Sources

1. Vitamin D Fact Sheet for Health Professionals, NIH Office of Dietary Supplements

2. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects, Physiological Reviews, 2016

3. Vitamin D and fatigue in deficient adults, randomized trial, Medicine, 2016

4. Supplemental vitamin D and incident fractures, VITAL, New England Journal of Medicine, 2022

5. Vitamin D supplements and prevention of cancer and cardiovascular disease, VITAL, New England Journal of Medicine, 2019

6. Vitamin D and depression prevention, VITAL-DEP, JAMA, 2020

7. Consensus statement on vitamin D status assessment and supplementation, Endocrine Reviews, 2024

8. Evaluation, treatment, and prevention of vitamin D deficiency, Endocrine Society guideline, 2011

9. Quest Diagnostics test directory, 25-hydroxyvitamin D, test 92888

10. Mayo Clinic Laboratories, 25-hydroxyvitamin D2 and D3, interpretation

11. Vitamin D for the prevention of disease, Endocrine Society guideline, 2024

12. Revisiting the vitamin D guideline, dissenting view, Endocrine Practice, 2024

13. Extrarenal expression of the vitamin D-activating enzyme, Archives of Biochemistry and Biophysics, 2012

14. High-dose vitamin D and bone density and strength, Calgary trial, JAMA, 2019

15. Calgary trial, results by sex, Journal of Bone and Mineral Research, 2020

16. Calgary trial, authors’ clarification, Journal of Bone and Mineral Research, 2021

17. Influence of season and latitude on cutaneous vitamin D synthesis, Journal of Clinical Endocrinology and Metabolism, 1988

18. Vitamin D seasonality in the United States, 3.4 million samples, PLoS One, 2013

19. Effect of oral contraceptive formulations on total and bioavailable 25-hydroxyvitamin D, Journal of Steroid Biochemistry and Molecular Biology, 2021

20. Vitamin D position statement, American Academy of Dermatology

21. Vitamin D2 versus D3 for raising 25-hydroxyvitamin D, meta-analysis, American Journal of Clinical Nutrition, 2012

22. Dietary fat increases vitamin D3 absorption, Journal of the Academy of Nutrition and Dietetics, 2015

23. Endocrine Society systematic review supporting the 2024 guideline, Journal of Clinical Endocrinology and Metabolism, 2024

24. Efficacy and safety of vitamin D3 at 1,000 and 4,000 IU daily, American Journal of Clinical Nutrition, 2001

25. Screening for vitamin D deficiency in adults, U.S. Preventive Services Task Force, 2021

26. Vitamin K2 added to calcium and vitamin D in women with osteopenia, three-year trial, Osteoporosis International, 2021

27. Vitamin K Fact Sheet for Health Professionals, NIH Office of Dietary Supplements

28. Vitamin D toxicity, case review, Nutrients, 2018

29. Seasonal variation in 25-hydroxyvitamin D concentrations in the Cardiovascular Health Study, American Journal of Epidemiology, 2011

About the evidence: reviewed last on November 5, 2026, drawing on the HowToHealth research dossier, clinical guidance, and selected primary studies; a focused editorial review, not a systematic one. Trial findings in older adults are not assumed to apply at every age. The clinical observations are my account of my own practice and are not efficacy evidence. I have no relationship with any laboratory, and no product or dispensary is linked here.

This is general health education, not individualized medical advice. It cannot diagnose a deficiency, interpret your result, or set your dose. Keep any prescribed treatment in place while you discuss changes with your clinician.

You can spend eight hours in bed and wake up exhausted. You can be tired all day, then suddenly available for every thought you have ever had the moment your head hits the pillow. You can fall asleep beautifully and be awake again at 3 a.m., doing math about how much sleep is still possible.

And someone, somewhere, will suggest a bedtime routine.

In my practice, sleep was where every care plan started. Meals, movement, mood, hormones, and blood sugar all got easier when a woman was sleeping and harder when she wasn’t, and no supplement made up the difference. So I wrote the sleep piece I wish I’d been able to hand women in the exam room. It’s long on purpose, it’s built to be skipped around in, and it’s meant to be sent to someone.

The short version:

• A night is four to six cycles of light, deep, and dreaming sleep. “Light” sleep counts, and cutting the morning short takes away a REM-rich part of the night.

• Two things decide when you sleep: a pressure that builds while you’re awake, and a clock set by light. Caffeine hides the first. A bright evening confuses the second.

• Getting by on less is not needing less. In the lab, performance kept falling while people stopped noticing.

• Your night changes with your cycle, pregnancy, a new baby, the menopause transition, and age. The useful question is what changed for you.

• A bad night sorts into three questions: enough chance to sleep? unable to sleep despite the chance? something interrupting? You can answer yes to more than one.

• Coffee, wine, gummies, melatonin, the herbal shelf, and screens each do something specific, and most of it isn’t what the label implies.

• Chronic insomnia has a first-line treatment with a name, CBT-I, and you can start it from your phone. Snoring, breathing pauses, or waking unrefreshed with headaches need an evaluation, not a checklist.

Read the full piece →

This weekend: the clocks go back on Sunday, November 1. If you’re already short on sleep, the American Academy of Sleep Medicine’s advice is the simplest thing in the whole article: don’t shift anything, and take the hour as sleep. Section 10 has the rest, including what to do in March when the harder change comes.

If a woman came to mind while you were reading, send it with that same intention.

Has anyone ever actually taught you about sleep?

1. Never. This is the first time.

2. A little, from a parent or in school.

3. A clinician brought it up once.

4. I figured it out the hard way, on my own.

Leave a comment

Congratulations, we’re healthing.

Lindsay Savage, PA-C

You can spend eight hours in bed and wake up exhausted. You can be tired all day, then suddenly available for every thought you have ever had the moment your head hits the pillow. You can fall asleep beautifully and be awake again at 3 a.m., doing math about how much sleep is still possible.

And someone, somewhere, will suggest a bedtime routine.

We spend about a third of our lives asleep, around 26 years of an 80-year life. If we’re going to spend that much time doing something, we should probably know what we’re doing in there.

In my practice, sleep was where every care plan started. Meals, movement, mood, hormones, and blood sugar all got easier when a woman was sleeping and harder when she wasn’t, and no supplement made up the difference. So the people who care about you and keep telling you to get some sleep have a point, even when it stings. The woman in your group chat who guards her sleep is not the lazy one. And if you’d love to sleep and can’t, you deserve more help than another reminder that sleep matters.

This is a long one on purpose. You don’t have to read it in order; take the section you need tonight and come back for the rest.

The short version

• A night is four to six cycles of light, deep, and dreaming sleep. “Light” sleep counts, and cutting the morning short takes away a REM-rich part of the night.

• Two things decide when you sleep: a pressure that builds while you’re awake, and a clock set by light. Caffeine hides the first. A bright evening confuses the second.

• Getting by on less is not needing less. In the lab, performance kept falling while people stopped noticing.

• Your night changes with your cycle, pregnancy, a new baby, the menopause transition, and age. The useful question is what changed for you.

• A bad night sorts into three questions: enough chance to sleep? unable to sleep despite the chance? something interrupting? You can answer yes to more than one.

• Coffee, wine, gummies, melatonin, the herbal shelf, and screens each do something specific, and most of it isn’t what the label implies.

• Chronic insomnia has a first-line treatment with a name, CBT-I, and you can start it from your phone. Snoring, breathing pauses, or waking unrefreshed with headaches need an evaluation, not a checklist.

Find your section

1. What actually happens after you fall asleep? (the stages)

2. Why can you be exhausted and wide awake? (sleep pressure and your clock)

3. What are you getting from all those hours?

4. Why does your sleep change across your life?

5. Four rules you’ll hear about women’s sleep, graded

6. Which kind of bad night are you having? (3 a.m. waking, apnea, CBT-I, medication)

7. What are coffee, wine, and the sleep aisle doing? (caffeine, alcohol, cannabis, melatonin, herbs)

8. The last hour: phones, TV, and the rest of it

9. The cheat sheet: what’s worth trying first?

10. Daylight saving time and your sleep

The bold labels tell you how firmly to hold a claim: Well-established, Current evidence suggests, Mechanistic plausibility, or Uncertain or contested. Clinical observation means what I saw in my own practice, which is a real kind of knowledge and not a trial.

1. What actually happens after you fall asleep?

Picture tonight. The light goes off. At some point your thoughts stop making quite so much sense, and you lose track of the room.

Well-established: sleep moves through non-REM and REM stages several times a night. REM stands for rapid eye movement. Non-REM has three stages, N1, N2, and N3, named for patterns measured in the sleeping brain. None of the names is a grade. How sleep stages work

N1: drifting off

You’re crossing from awake into asleep. Your muscles relax, your thoughts wander, and you may still feel partly aware of the room. This is where the falling jolt lives, the sudden kick that snaps you awake; it’s common and harmless. N1 is usually a brief part of the night, and if someone wakes you here, you’ll insist you weren’t asleep yet. Sleep physiology

N2: properly asleep, even though we call it “light”

Your heart rate slows, your body cools, and your brain produces distinctive bursts of activity called sleep spindles. Adults spend a large share of the night here, often about half. Sleep physiology

The name makes it sound like the free trial before the real sleep starts. It isn’t. Research connects spindles and other non-REM activity with processing and strengthening memories. A night with plenty of light sleep hasn’t gone wrong. Sleep and memory

N3: deep sleep

Brain activity becomes dominated by large, slow waves, which is why you’ll also hear slow-wave sleep. You’re harder to wake, and if the alarm lands here you get the heavy, confused minutes nobody warns you about. More of this stage happens earlier in the night. Sleep stages

This is also when sleep-related growth-hormone release is most prominent. One caveat: the classic study behind that finding enrolled 149 healthy men and no women, so it describes men’s nights; treat it as a finding in men until it has been measured properly in women. Growth hormone and slow-wave sleep Despite the name, growth hormone still has work to do after you stop growing taller, including supporting tissue maintenance. Sleep physiology

REM: a busy brain in a sleeping body

Your eyes move under your lids. Brain activity looks more like waking, while most of the muscles you use to move your body are temporarily switched off. Vivid dreams are common here, although dreaming happens in other stages too. The first REM period arrives roughly 90 minutes in and is short; the ones near morning run longer, which is why the dream you remember is usually the one the alarm interrupted. Understanding sleep

Current evidence suggests REM contributes to memory and emotional processing. The tidy version, in which deep sleep fixes the body and REM fixes the brain, leaves out too much; the stages share the work. Sleep and memory

The night changes as it goes

An early cycle often moves from N1 through N2 and N3, back toward lighter sleep, and into REM. Later cycles hold less deep sleep and longer REM periods. Understanding sleep

You’ll hear “90-minute cycles.” Treat it as a rhythm rather than a train timetable. Cycle lengths vary, and every cycle doesn’t contain the same amount of every stage, so setting an alarm in neat 90-minute multiples can’t reliably arrange a perfect wake-up. Sleep physiology

Here is why the order matters: the morning part of your sleep still has work to do. Routinely cutting it short removes sleep from the part of the night that’s usually richest in REM. Getting some deep sleep early doesn’t make the remaining hours optional.

Waking briefly is part of a normal night, and you may remember none of it. The concern is persistent difficulty getting back to sleep, distress, or a day that suffers for it, not the fact that you noticed the room once. Nighttime awakenings

Screenshot this: your night, at a glance

• N1: drifting off. A few minutes. Where the falling jolt lives.

• N2: light sleep that counts. About half the night.

• N3: deep, slow-wave sleep. Mostly early in the night. Hardest to wake from, and the stage that shrinks most with age.

• REM: active brain, still body, vivid dreams. Longer periods toward morning, so an early alarm cuts into them.

• The whole night: four to six cycles of roughly 90 minutes, with proportions that shift as the night goes on.

Before you inspect your sleep score

A watch or ring estimates sleep stages from indirect signals. In a study comparing six wrist-worn devices with a laboratory sleep study in 62 adults, mostly men, agreement with the lab ranged from fair to moderate; the devices were good at telling asleep from awake and rougher on the stages. Use trends as a conversation starter. One low “deep sleep” number can’t tell you that your brain missed its repair shift. Wearable validation study

2. Why can you be exhausted and wide awake?

Well-established: two interacting systems decide when you sleep. The two-process model

Sleep pressure is the need for sleep that builds while you’re awake and eases while you sleep. Adenosine, a chemical involved in that process, is part of the reason you get sleepier after a long day. A nap relieves some of the pressure. Caffeine blocks adenosine’s action, which makes you feel more awake without replacing the sleep you need. Your sleep-wake cycle, Caffeine pharmacology

Your circadian rhythm is your roughly 24-hour internal schedule. It times alertness, sleepiness, temperature, and hormone release. Light reaching your eyes is the main signal that keeps this clock lined up with the outside day. Your sleep-wake cycle

Your clock also produces a strong alerting signal in the hours before your usual sleep period. The evening “second wind” is real, even after a tiring day. The two-process model

Usually the two systems cooperate: you’ve been awake long enough to need sleep, and your clock is moving into its biological night. But you can carry plenty of sleep pressure while your clock is still cheering for wakefulness, and stress can add a layer of alertness on top. “I’m exhausted” and “I can fall asleep now” are different experiences.

Three familiar things live inside this timing system:

• Melatonin helps signal biological night. Evening light can delay or suppress its rise. It’s one signal in a much larger system, which is why swallowing more of it doesn’t solve every sleep problem. Room light and melatonin

• Core temperature falls as the body prepares for sleep. Comfortable cooling matters; you don’t need a cold-plunge bedroom. Understanding sleep

• Cortisol follows a daily rhythm too, generally lowest early in the biological night and rising toward morning. That rise is normal. A 3 a.m. awakening, by itself, can’t tell you whether your cortisol is abnormal. Cortisol rhythms

Once you understand the pressure and the clock, the usual advice stops sounding random. A long late nap can make bedtime harder because it drained the pressure. A brightly lit evening can tell the clock that night is arriving later. Neither means you’re bad at sleeping.

Subscribe now

3. What are you getting from all those hours?

You know what a bad night feels like. Everything takes a little more effort. The email feels ruder. Remembering why you walked into the room becomes a group project.

Sleep supports attention, learning, emotional steadiness, metabolism, and immunity. None of this means every tired day is quietly ruining you. What the research does show is that you’re a poor judge of how little sleep you can get away with.

Well-established: in a controlled experiment, people allowed four or six hours in bed each night for two weeks developed accumulating problems with attention and other cognitive tasks. The impairment reached levels seen after one to two nights without sleep, depending on the restriction and the task. Their ratings of sleepiness barely moved after the first few days. “I’m used to it” was an unreliable measure of how they were doing. Chronic sleep restriction experiment

I heard “I’m fine on five hours” in clinic more than I heard almost anything else, usually from the women carrying the most: the job, the household, a baby, a parent, sometimes all of it at once. Some of them had no choice that month, and I’m not going to pretend a bedtime routine fixes a life that doesn’t leave room for one. What I’d want you to know is that the five hours aren’t free. Surviving on less sleep doesn’t make you stronger; it’s a bill, and you’re the one who pays it later. If the hours truly aren’t there right now, that’s a reason to protect every one you can get and to ask for help with the load, not a reason to feel bad about yourself.

Your mood and your ability to handle the day

Current evidence suggests sleep loss makes positive emotions harder to reach and increases anxiety symptoms. That comes from a review of 154 experiments involving more than 5,000 participants. Effects on negative emotions varied with how sleep was disrupted and what was measured, and the studies weren’t exclusively in women. Sleep loss and emotion

That’s a reason to take sleep seriously when life feels harder to manage. It doesn’t make sleep the explanation for every mood symptom. Persistent anxiety, depression, or distress deserves attention in its own right, alongside sleep.

Blood sugar, appetite, and energy

Insulin is the hormone that moves glucose from the blood into cells. Current evidence suggests repeatedly shortening sleep makes that job harder: in a trial of 38 women, about 80 minutes less sleep each night for six weeks increased insulin resistance. These women had risk factors for conditions such as diabetes or heart disease, without established disease, and the trial measured a metabolic change, not new cases of diabetes. Sleep restriction in women

You may also notice that appetite, or the appeal of certain foods, changes after poor sleep. The popular explanation is that sleep loss turns the hunger hormone up and the fullness hormone down; the famous version of that finding came from a study of 12 men. Hunger hormones after short sleep Human results since then, especially on sex differences, are less tidy. A recent review found inconsistent changes across appetite hormones and studies too small to settle many differences between women and men. Sex and appetite-hormone responses

Your immune system

Current evidence suggests sleep supports how the body responds to infection and vaccination. In the often-cited cold study, 164 adults were exposed to a cold virus; those sleeping six hours or less beforehand had about four times the odds of developing a cold compared with those sleeping more than seven. That was a deliberately controlled exposure, not a promise that good sleepers never get sick. Sleep and cold susceptibility

A later meta-analysis linked objectively measured short sleep with a weaker antibody response to vaccination. The women-only estimate was uncertain, so nobody should pretend we know the exact effect in women. Sleep and vaccine responses

Does sleep “wash your brain”?

You’ll see this claim everywhere, usually next to something for sale. Here’s what’s behind it.

Current evidence suggests the brain does something during sleep that it doesn’t do awake. In humans, slow waves of the fluid surrounding the brain have been measured pulsing through it during sleep, and in a small study of 24 adults, one night without sleep slowed the clearance of an injected tracer from the brain. Human fluid waves, Human clearance study

Uncertain or contested: whether that flow actually clears waste, how much, and what it means for preventing disease. The animal studies that started the story now conflict with each other, and the methods are debated. Nobody has shown that a bad night causes lasting damage, or that any product or “deep sleep” habit protects you from Alzheimer’s disease. Conflicting experimental findings

What to take from it: sleep is doing something for your brain that you can’t get another way, which is a reason to protect it. It’s not a reason to buy anything, and not a reason to lie awake worrying about lying awake.

So how much do women need?

For most adults, seven to nine hours is the useful starting range, with individual and age-related variation. The American Academy of Sleep Medicine and the Sleep Research Society put the floor for adults at seven or more hours a night. AASM/SRS consensus on sleep duration A 2026 review did not find grounds for a separate women-only number. Sleep-duration evidence review

Think about three things: whether you have an adequate chance to sleep, how you function during the day, and whether sleep feels restorative. A naturally short sleeper is a different person from someone who’s fighting sleep every day. You don’t need to diagnose your genes to take persistent tiredness seriously.

4. Why does your sleep change across your life?

Here’s the part the sleep research world has been slow to admit. A 2014 expert report from the Society for Women’s Health Research listed the open questions: how common sleep problems really are in women, how women’s sleep is regulated, how to measure its quality, how to diagnose it, and how to treat it. Sex and gender differences in sleep, expert report That was 2014. Reviews published in 2024 and 2026 still describe women as underrepresented in sleep and circadian research, still find sleep apnea being diagnosed with criteria built around male physiology, and still list women’s sleep disorders as underdiagnosed, with symptoms that don’t match the textbook and screening tools that work less well in women. The one clear improvement: most sleep studies now at least report whether they enrolled women, men, or both. Who gets studied in sleep research, 2024, Sex differences review, 2024, Sleep apnea in women, 2026 review, Women’s sleep research directions, 2026

So where I can tell you something solid about women specifically, I will. Where the answer is “nobody has studied that in women yet,” I’ll say that too.

What we do know: women have a higher risk of insomnia than men, about 40% higher in a large meta-analysis. A laboratory study found a slightly shorter internal circadian period in women, by about six minutes on average. Useful biology, and nothing you need to do anything about. Insomnia by sex, Internal clock study

Current evidence suggests women without insomnia show more sleep spindles and stronger slow-wave activity on recordings, on average, than men without insomnia. Yet women are more likely to report insomnia. A favorable-looking brain-wave feature isn’t the same as a restful lived experience. If your sleep looks fine on paper and feels terrible in life, the paper is not the final word. 2026 sleep-activity review

What matters most in your own life is the pattern: what changed, what came with it, and what’s getting between you and sleep. Here’s how that tends to go.

Young adulthood: when your free time starts at bedtime

If you’re reading this at 11:40 p.m. on your phone, hi.

You finally stop being useful to everyone else. You sit down. Someone sends a video. Suddenly tomorrow has started.

Researchers call some of this bedtime procrastination: delaying bed despite intending to sleep, with nothing external requiring you to stay awake. Across studies it’s associated with shorter and poorer sleep. Those studies can’t prove a phone causes every late night; stress, a later body clock, or a shortage of personal time is often part of the story. Bedtime procrastination review

The thing to watch is the moment bedtime disappears. A stopping cue, autoplay off, or the phone charging across the room can help if you keep going after you meant to stop. If nighttime is your only personal time, protecting some earlier time matters too, and that may take help or a change in who does what, not more willpower.

If you have the opportunity, put the phone down, and still can’t sleep, that deserves a different conversation. It’s in section 6.

The menstrual years: notice your pattern without expecting one

Two different cycles share a word here. A sleep cycle is the sequence repeated within a night; a menstrual cycle runs from one period to the next. Hormonal shifts across the menstrual cycle can influence sleep, but the two aren’t interchangeable.

Current evidence suggests the cycle affects temperature more consistently than it affects everyone’s sleep. After ovulation, progesterone rises and core temperature typically runs higher. Some women notice worse sleep before a period, particularly with pain, PMS, or PMDD, a condition involving severe premenstrual mood symptoms. Cycle-related sleep review

In a study of 116 women, temperature changed across the cycle, but measured sleep duration and quality did not show significant phase-related changes. There’s no universal “bad sleep week” to brace for. Menstrual-cycle study

Clinical observation: I always asked women whether the sleep problem showed up at a particular point in their cycle. “This happens before my period, and the pain wakes me” tells us far more than “my hormones are off.” A simple note on your calendar can show you a pattern; you don’t need to track every temperature fluctuation.

Mechanistic plausibility: progesterone’s metabolites act on brain pathways involved in calming and sleep. Trials of prescribed progesterone in selected women are a separate question from what your natural cycle will do. The mechanism can’t tell us that everyone sleeps best after ovulation, or that a bad night means progesterone is low. Progesterone and sleep trials

Pregnancy: common doesn’t mean you have to put up with everything

Sleep changes for very ordinary physical reasons: nausea, reflux, needing to urinate, discomfort, and the search for a position that works. Sleep disorders also occur during pregnancy, including restless legs, insomnia, and obstructive sleep apnea, and sleep complaints affect more than half of pregnancies. Sleep disorders in pregnancy

The useful next step is to name what’s waking you. Reflux, painful legs, and breathing interruptions need different help. Restless legs is common in pregnancy, the risk rises with the number of pregnancies a woman has had, and iron studies are part of that evaluation. New loud snoring, gasping, or witnessed breathing pauses belong in prenatal care, not waved away as one more pregnancy symptom; current pregnancy-specific guidance supports screening, assessment, and treatment for sleep apnea. Restless legs guideline, 2026 pregnancy apnea guideline

Current evidence suggests pregnancy-adapted cognitive behavioral therapy for insomnia, CBT-I, improves insomnia. In a trial of 194 pregnant women, it cut insomnia severity by more than a comparison therapy and brought remission faster. That gives you an option beyond “wait until the baby arrives,” which is a strange thing to say to a tired pregnant woman. Randomized pregnancy trial

Postpartum: being woken and being unable to sleep can coexist

A baby who needs you repeatedly is reducing your opportunity to sleep. No amount of perfect sleep hygiene creates uninterrupted hours that aren’t available.

For that problem, practical support matters: another person taking a feasible share of care, a protected rest window, work taken off your plate. What’s possible depends on feeding, recovery, household support, and the baby. Start from what’s actually available to you. A small change you can keep beats a perfect plan you can’t use.

There can also be insomnia on top of the interruptions: the baby is asleep, someone else is on duty, and you’re wide awake anyway. Current evidence suggests adapted CBT-I helps. In a trial of 114 women four to twelve months postpartum, CBT improved insomnia and fatigue. The study excluded women with very frequent infant-related waking, so it doesn’t solve the problem of being needed all night. Postpartum trial

Sleep trouble that comes with significant anxiety or low mood deserves a postpartum mental-health conversation as well. “Sleep when the baby sleeps” leaves a lot of women out.

Perimenopause and menopause: the old bedtime may stop working

You haven’t changed the room. You haven’t changed the coffee. Suddenly you’re throwing the covers off and mentally attending a meeting at 4 a.m.

Sleep complaints climb through this transition. A 2026 meta-analysis that pooled 102 studies of mood, anxiety, and sleep symptoms in midlife women put insomnia symptoms at about 27% of women in perimenopause and 42% after menopause. Insomnia across the menopause transition

Current evidence suggests hormonal changes and hot flashes contribute, and neither explains every sleep problem in the transition. In a sleep-lab study of 34 perimenopausal women, about 69% of measured hot flashes came with an awakening, and hot-flash waking added up to about 17 minutes a night, roughly a quarter of all time awake. Pain, mood, stress, bladder symptoms, insomnia, and sleep apnea all matter too. Hot flashes and awakenings, Menopause sleep review

If heat or sweating wakes you, treating those symptoms may improve sleep. Hormone therapy is one option for appropriate candidates with bothersome menopausal symptoms; the choice depends on the whole health picture. If you’re awake even when you’re comfortable, insomnia may need its own treatment. Both conversations can happen at the same visit. Hormone therapy and sleep

CBT-I has evidence in midlife women, including trials specifically in women with menopausal symptoms. A recent pilot in 43 perimenopausal and postmenopausal women found greater improvement in insomnia with CBT-I than with menopause education. Midlife CBT-I trial

Later adulthood: lighter sleep is not the same as needing almost none

Sleep often becomes lighter and shifts earlier with age; the deep sleep from section 1 is the part that shrinks most. Pain, nighttime urination, medications, and sleep disorders add disruption. “I’m older now” is a reason to understand the change, not to dismiss persistent exhaustion. Sleep and older adults

A review of what wakes you, your medication timing, and daytime sleepiness is usually more useful than another sleep product. If your schedule has drifted earlier and you feel well, that’s a different situation from being awake early and miserable.

And the phase no hormone chart includes: shifts and caregiving

A rotating schedule, night work, or caring for another person can make ordinary sleep advice impractical. Night work asks you to stay awake during biological night and sleep when your clock is promoting wakefulness. Sleep timing and shift work

The realistic priorities are a protected sleep opportunity, a bedroom that can be dark and quiet during your sleep hours, help where it exists, and a plan for unsafe sleepiness. Timed light and melatonin depend on the actual schedule; generic “morning light” advice can point a night worker in exactly the wrong direction.

If you’re struggling to stay awake while driving, stop and arrange a safe alternative. That’s a today problem; it can’t wait for a sleep plan to work.

5. Four rules you’ll hear about women’s sleep, graded

Women’s fitness and wellness content is full of confident rules about how women’s sleep is different. Some of it is good science, some of it is one small study, and some of it is a guess repeated often enough to sound settled. I’m including the four I hear most, because women are rearranging their evenings, their workouts, and sometimes how they feel about needing sleep at all, on the strength of rules that deserve a closer look.

“Women are more sensitive to evening light.”

• How firm: Current evidence suggests, partly.

• What the evidence says: in a dose-response study of 56 young adults, women’s melatonin was suppressed more than men’s by bright light, 400 lux and up, but not by the dim-to-moderate light of an ordinary evening at home. Light sensitivity by sex

• What to do: dim the room in the last hour and keep the brightest screens out of your face. You don’t need special glasses on the strength of this claim.

“Women enter REM sooner.”

• How firm: Current evidence suggests the opposite.

• What the evidence says: on brain recordings, women take longer to reach REM, both in a meta-analysis of sleep-lab data from 5,273 healthy adults and in a sleep-clinic sample of 2,365 patients. The one study that found the reverse measured 19 teenage endurance athletes with a bedside radar over 61 nights, not brain recordings. Normal sleep-lab values, Sleep-lab sex differences, Junior athlete study

• What to do: nothing. Anyone selling you a women-specific REM timing plan is working from the weaker study.

“Women need about twenty minutes more sleep.”

• How firm: Uncertain or contested.

• What the evidence says: women do sleep a little longer in large datasets and report wanting more; whether that’s biology or whose alarm sets the weekday is an open question, and no guideline sets a different number. Sleep need by sex across the lifespan

• What to do: don’t hold yourself to a number from either direction. If you consistently need more sleep than the people around you and feel better when you get it, that’s information worth trusting.

“Late workouts hurt women’s sleep more.”

• How firm: Current evidence suggests evening exercise is fine for most people, and no trial has compared the sexes.

• What the evidence says: evening exercise is generally compatible with good sleep; a hard session ending within an hour or two of bed is where the cost shows. Evening exercise meta-analysis

• What to do: if you train in the evening and sleep well, keep it. If you don’t, finish the hard session earlier, or make the late one easy.

The point of this list isn’t that the claims are wrong. Know how firm each one is before you build a routine around it. The same test applies to every rule you’ll hear about women and sleep, including mine.

6. Which kind of bad night are you having?

Clinical observation: when a woman told me she wasn’t sleeping, my first job was to figure out which problem she had, because they need different help. I asked whether she actually had enough chance to sleep. I asked about snoring and breathing pauses, and about legs that wouldn’t stay still in the evening, because sleep apnea and restless legs get missed in women constantly. I checked ferritin early, especially in women with restless legs or who were waking at night; the restless legs guideline backs that check, and for insomnia without leg symptoms it was my practice rather than a guideline. I asked where she was in the menopause transition. And when the stress piece didn’t add up, looking at where her cortisol rhythm sat against her day helped me understand her nights. That was a lens I found useful, not a test anyone needs before getting help, and it’s a question about rhythm rather than a worn-out gland (more on that below). Sleep habits came up too. They were rarely the whole story.

So before buying anything, ask three questions: Did I have enough chance to sleep? Was I unable to sleep despite that chance? Or was something repeatedly interrupting me? You can answer yes to more than one.

“I cannot switch off.”

You’re sleepy on the couch. In bed, you start calculating tomorrow, reviewing yesterday, and checking whether sleep has arrived yet.

Current evidence suggests heightened alertness, often called hyperarousal, is one important part of insomnia. The bed can also become associated with frustration and trying to sleep. None of that means you’re causing the problem by thinking incorrectly. It means learned patterns and the body’s alerting systems can keep a problem going after the original trigger has passed. Hyperarousal and insomnia

That’s one reason “try harder to relax” is such unhelpful advice. Sleep is difficult to force. The treatment built for this exact pattern is CBT-I, further down in this section.

One check worth making if the trouble switching off is new and comes with a racing heart, feeling hot when nobody else is, unexplained weight loss, or shaky hands: an overactive thyroid can look like anxiety and sleeplessness, and it’s a blood test. Hyperthyroidism symptoms, NIDDK

“I fall asleep, then I’m back at 3 a.m.”

First, give the time less power. Three o’clock doesn’t identify one hormone, organ, or diagnosis. The useful detail is what happens around the waking:

• Hot, sweaty, or throwing off the covers? Menopausal symptoms may be part of it.

• Snoring, gasping, or being told you stop breathing? Bring up sleep apnea.

• An urge to move your legs, worse at rest in the evening and relieved by movement? That’s the pattern of restless legs syndrome. The guideline recommends checking iron studies, including ferritin, a measure of stored iron, before anyone reaches for an iron supplement.

• Reflux, pain, congestion, or repeated bathroom trips? Those deserve attention alongside sleep.

• A pattern after alcohol or later caffeine? A clue worth investigating, even though it doesn’t prove the cause.

Women’s sleep apnea, Restless legs guideline, Menopause sleep review

What can help in the moment? A brief awakening doesn’t need an intervention. If you’re comfortable and drifting, let that happen. If you’re increasingly alert and frustrated, a standard part of CBT-I is to take a quiet break from trying to sleep, keep the light low, and return to bed when sleepy. It rebuilds the connection between bed and sleep. You don’t need to watch the clock to earn permission to get up. Stimulus control evidence

Choose something undemanding, like a familiar book or calm audio. This is not the moment for your work inbox. Adapt the approach if getting out of bed is unsafe or difficult, including with mobility limitations or caregiving.

“I wake too early, and that’s it.”

Look at the whole day. Are you getting sleepy much earlier too? Has your schedule shifted? Is there new low mood or loss of interest? Early waking can come with insomnia, changes in body-clock timing, and depression. The pattern deserves attention without assuming one explanation. Sleep and aging, Depression symptoms

“I wake up from dreams I’d rather not have.”

Nightmares that keep coming, especially after something frightening happened to you, are a sleep problem with their own name and their own treatments. The one the American Academy of Sleep Medicine recommends first, for both trauma-related nightmares and nightmare disorder, is a structured therapy that rehearses a different ending to the dream while you’re awake. If bad dreams are what’s wrecking your nights, say so at the visit; “I can’t sleep” doesn’t tell anyone that part. AASM nightmare-disorder position paper

“I sleep fine, but only on a schedule the world won’t accept.”

If you reliably sleep well from very late at night until late morning, but can’t sleep on an earlier required schedule, timing may be the central problem. A later preference alone isn’t a disorder. A persistent mismatch that causes impairment can be a circadian sleep-wake disorder.

Treatment may involve carefully timed light and, in selected situations, melatonin. Current evidence suggests strategically timed melatonin helps delayed sleep-wake phase disorder. Timing matters because the aim is to shift the clock; taking a gummy whenever you finally get into bed is a different proposition. Circadian treatment guideline

“I sleep all night and still feel awful.”

Time in bed isn’t a complete measure of sleep. Obstructive sleep apnea repeatedly narrows or blocks the airway during sleep. Women may report fatigue, insomnia, headaches, or mood symptoms as well as the familiar snoring and breathing pauses, and it gets missed when the mental picture is always a loudly snoring man. In the community, apnea is about twice as common in men; in older data from sleep centers, men outnumbered women about eight to one, and the women who were diagnosed were heavier and treated later. Sex and gender differences in sleep, expert report, Sleep apnea in women

Persistent unrefreshing sleep deserves assessment, especially with breathing symptoms or pronounced daytime sleepiness. Mention congestion and mouth breathing too. Taping the mouth shut is not a substitute for finding out why breathing is difficult. Mouth-taping evidence review

Clinical observation: mouth breathing on its own doesn’t mean sleep apnea, but the women I saw who breathed through their mouths at night rarely woke refreshed. The useful question was always why: congestion, allergies, or an airway problem an ear-nose-throat clinician can assess. Tape covers the symptom and hides the question.

If you have PCOS, renamed PMOS, polyendocrine metabolic ovarian syndrome, in May 2026 (the new name will take a few years to catch on), sleep apnea deserves particular attention. The international guideline reports higher prevalence even after accounting for body size and recommends assessment when symptoms are present. That’s why sleep belongs in the hormone conversation too. The 2026 rename, in The Lancet, International guideline, The HowToHealth PCOS/PMOS series

Where does “adrenal fatigue” fit?

The fatigue is real. The proposed diagnosis of exhausted adrenal glands has not held up in research. Real adrenal diseases exist and need proper evaluation; feeling depleted doesn’t diagnose them. Adrenal fatigue systematic review

A cortisol rhythm that’s out of step with your day, the kind that comes with chronic stress, shift work, or sleep loss itself, is a different and real thing: a rhythm problem, not a worn-out gland. Cortisol rhythms

The next question is what explains the symptoms: insufficient sleep, insomnia, a breathing problem, medication effects, mood, or another health condition. A label is only worth having if it leads somewhere.

The treatment that deserves more airtime: CBT-I

Well-established: cognitive behavioral therapy for insomnia is a first-line treatment for chronic insomnia. Sleep hygiene by itself is not an adequate substitute. AASM behavioral treatment guideline

CBT-I is a structured treatment that works on sleep timing, the connection between bed and wakefulness, and the worry and behaviors that keep insomnia going. It may include adjusting time in bed under appropriate guidance. In 20 trials with 1,162 participants, 64% of them women, it cut the time to fall asleep by about 19 minutes and time awake during the night by about 26 minutes, with gains that held after treatment ended. CBT-I research

Chronic insomnia generally means persistent difficulty falling asleep, staying asleep, or waking too early, at least three nights a week for at least three months, despite adequate opportunity, with daytime consequences. That definition is not an instruction to wait three months before asking for help. Insomnia classification

How to actually get it. This is where most articles stop, so here’s the practical part.

• Digital CBT-I works. In a 2020 meta-analysis of 33 randomized trials with more than 9,000 participants, app- and web-delivered CBT-I cut insomnia severity by about five points on the standard 28-point scale, with gains still present a year later. Face-to-face treatment did a little better, by about three points, which the authors judged close enough to call the digital versions non-inferior. An earlier review found effects comparable to in-person CBT-I. Digital CBT-I meta-analysis, 2020, Internet CBT-I meta-analysis, 2016

• There are public versions you can start tonight. The U.S. Department of Veterans Affairs built two, and you don’t have to be a veteran to download them from the app stores. Insomnia Coach is a self-guided weekly program with a built-in sleep diary; it’s the one to start with on your own. CBT-i Coach is designed as a companion to treatment with a clinician, not as a standalone program. Insomnia Coach, VA, CBT-i Coach, VA

• There are clinicians who do only this. Behavioral sleep medicine specialists keep a public directory, browsable by region, with a separate list of those who see patients by telehealth. Society of Behavioral Sleep Medicine directory, SBSM telemedicine list

• Ask for it by name. A generic meditation app is not CBT-I. The sentence to bring to a visit: “Can we assess what’s disrupting my sleep, and is CBT-I appropriate for me?”

Where does medication fit?

Sleep medication exists for a reason, and needing it is not a personal failure. The American Academy of Sleep Medicine’s 2026 guideline on combining treatments puts CBT-I alone ahead of CBT-I plus medication, and CBT-I plus medication ahead of medication alone. Both recommendations are conditional, on low-certainty evidence, and the guideline notes that someone who values more sleep quickly may reasonably choose the combination. Access, preferences, symptoms, and other conditions all matter. 2026 AASM combined-treatment guideline

So you can follow the conversation, here are the names a prescriber might raise. The AASM’s medication guideline suggests, on weak evidence, a handful of options for chronic insomnia: the newer orexin blocker suvorexant, for staying asleep; the sedative-hypnotics zolpidem, eszopiclone, and zaleplon, mostly for falling asleep; low-dose doxepin, an old antidepressant, for staying asleep; ramelteon, which works on melatonin receptors; and two benzodiazepines, temazepam and triazolam. The same guideline suggests against trazodone, diphenhydramine, melatonin, tryptophan, and valerian for chronic insomnia, because the evidence doesn’t support them for that job. Which fits, if any, depends on whether your problem is falling asleep, staying asleep, or both, and on everything else you take. None of this is dosing advice; it’s so the names aren’t a surprise. If you’re already on one and it’s working, that’s a conversation with your prescriber, and nothing in this article should talk you out of it. Insomnia medication guideline

7. What are coffee, wine, and the sleep aisle doing?

Clinical observation: I asked every woman what she was using to try to sleep, including alcohol, cannabis, and melatonin, and what she was using for energy, including energy drinks like Celsius and supplements. Some were buying energy supplements without realizing those could be the reason they couldn’t sleep later. I tried to get women to stop all of it for at least two weeks, to see what changed once it was gone.

Bring the actual names and labels to the conversation. “Just a gummy” tells us very little about what’s in it. And if you want to run your own version of that two-week experiment, two cautions: prescribed medicines stay, and regular heavy drinking is not something to stop abruptly on your own (more on that under alcohol).

Caffeine: the feeling wears off before the caffeine does

Well-established: caffeine blocks adenosine’s action. How quickly you clear it varies, and so does how strongly it affects your sleep. Caffeine pharmacology

The useful word is half-life: the time it takes for the amount in your body to fall by half. Using a five-hour half-life as an illustration, half the caffeine from a 2 p.m. coffee is still around at 7 p.m., and a quarter at midnight.

That’s why “I can fall asleep after coffee” doesn’t settle whether coffee affects the night. Across 24 studies, most of them in men, caffeine reduced total sleep by about 45 minutes on average. The amount and timing differed between studies, so that’s not a prediction for your next cup. Caffeine and sleep meta-analysis

For women, context matters. Estrogen-containing oral contraceptives slow caffeine clearance. In a small, older study, the average half-life was about 7.9 hours in pill users versus 5.4 hours in controls. Clearance also slows during pregnancy. Caffeine and oral contraceptives

Small studies of caffeine across the menstrual cycle have reached different conclusions. In two studies of 10 women each, one found slower clearance before a period; the other found no significant difference across phases. That doesn’t justify assigning every cycling woman a different caffeine cutoff for each phase. Caffeine metabolism review, Cycle study, 1992, Cycle study, 1999

The practical questions are how much, how late, and what else contains it. Look beyond coffee to tea, matcha, energy drinks, pre-workout, and products with guarana or yerba mate. “Natural” caffeine does caffeine’s job, and labels can be imperfect. Caffeine supplement analysis

If sleep is a problem, earlier or less caffeine is a reasonable variable to test. There’s no universal hour at which everyone’s last cup becomes harmless, and decaf still contains small amounts. Decaf analysis

A quick caffeine comparison

These are typical amounts in the same 12-ounce serving, from the FDA’s own table, not recommended intakes. Brands and preparation vary.

Drink (12 oz) · Approximate caffeine

• Brewed coffee: 113–247 mg

• Black tea: 71 mg

• Green tea: 37 mg

• Caffeinated soft drink: 23–83 mg

• Energy drink: 41–246 mg

Check the amount in the whole container you actually drink, because “one drink” can mean very different things: a 12-ounce can of Celsius lists 200 mg, about two cups of coffee, and by the half-life math above a 2 p.m. can is still half there at 7 p.m. The FDA’s general ceiling for healthy adults is about 400 mg a day. FDA caffeine reference

Alcohol: getting sleepy is only the beginning of the night

Well-established: alcohol changes sleep architecture, including delaying and reducing REM. A review of 27 studies, which didn’t separate women from men, found more REM disruption with more alcohol, beginning around two standard drinks; faster sleep onset showed up at higher amounts, not reliably at lower ones. Alcohol and sleep meta-analysis

So “it helps me fall asleep” can be true while the overall night is worse. In one controlled study at similar bedtime alcohol levels, women’s sleep continuity was more disrupted than men’s. Alcohol and sleep by sex

A glass of wine you enjoy is your call. As an insomnia treatment it’s a bad trade: drowsiness now, a more broken night later. If you wake at 3 a.m. on wine nights and not on dry nights, write that down.

If regular heavy drinking or withdrawal symptoms are part of the picture, stopping abruptly without medical help can be dangerous. Alcohol-withdrawal guideline

THC, CBD, and CBN: three names, different evidence

THC is the main intoxicating cannabis compound, and the one in most sleep gummies. Is it helping or hurting? That depends on whether you mean tonight or every night.

Tonight: it can feel like it works. In one two-week trial of 23 people, 20 of them women, an oral THC-containing oil added about 33 minutes of sleep measured by a wrist device. Cannabinoid insomnia trial In the sleep lab the picture is less flattering: a single oral dose of 10 mg THC with 200 mg CBD, in 20 people with insomnia, 16 of them women, cut REM sleep by about 34 minutes and total sleep by about 25 minutes. A 2025 meta-analysis of sleep-lab studies found THC’s effects on sleep stages inconsistent, with REM suppression clearest at higher doses, and noted that people’s sense that they slept better often doesn’t match the recording. Current evidence suggests that much. Oral cannabinoid lab trial, Cannabis and sleep architecture meta-analysis

Every night: the evidence tilts the wrong way. In 177 adults, cannabis within three hours of bed was associated with more time awake after falling asleep and more light sleep, with no measure of better sleep. In 1,449 sleep-clinic patients, most with sleep apnea, daily use for a year or more was associated with more waking and lower sleep efficiency. None of these can prove cause. None of them points toward sleeping better, either. Cannabis near bedtime, Chronic use in a sleep clinic

When you stop: regular users often get a stretch of disrupted sleep and vivid dreams, which is REM catching up. Feeling worse the week you stop is not evidence that the gummies were fixing the underlying problem. A randomized study of access to medical cannabis also found better self-reported insomnia alongside a higher risk of cannabis use disorder. Sleep during abstinence, Medical-cannabis trial

Short trials can’t settle the lasting benefits or harms. What they do show: THC products change the shape of your sleep, dependable long-term benefit hasn’t been established, regular use carries a dependence risk, and stopping can bring a real stretch of worse sleep. If you use it, those are the tradeoffs.

CBD isn’t intoxicating in the same way, but that doesn’t make it an established sleep treatment. A 2024 trial of 30 people found no advantage over placebo for insomnia severity and most sleep outcomes, although one objective sleep measure improved. CBD insomnia trial

CBD can interact with medicines. In a 2025 trial in healthy adults, liver-enzyme elevations occurred in 5.6% receiving the studied CBD regimen and none receiving placebo. That’s a result for that regimen, not a risk estimate for every CBD product; it does establish that being sold over the counter isn’t proof of harmlessness. CBD liver-safety trial, Drug interactions

CBN, another cannabinoid marketed for sleep, sits under Uncertain or contested. An industry-run seven-night trial missed its main sleep-quality outcome, although some secondary outcomes, including awakenings, improved. A limited signal; nobody should be calling it an insomnia treatment yet. CBN trial

Melatonin: what problem are you asking it to solve?

Remember the clock: melatonin is part of the body’s night signal, which makes it useful for certain timing problems and a poor universal answer to a restless night.

Current evidence suggests its average benefit for some sleep problems is modest. A meta-analysis of 19 trials in adults and children found sleep onset about seven minutes earlier and total sleep about eight minutes longer. Those averages don’t apply equally to every diagnosis or age. Melatonin meta-analysis

The AASM suggests against melatonin for chronic insomnia in adults, while a separate guideline supports strategically timed use for selected circadian problems. That’s why “does melatonin work?” needs a second question: for what? Insomnia medication guideline, Circadian guideline

Product quality matters too. An analysis of 31 supplements found contents ranging from 83% below to 478% above the labeled amount. That study doesn’t describe every product today, but it shows why the label isn’t a precise measurement. Supplement-content analysis

Uncertain or contested: broad claims about years of nightly use. A six-month trial of a specific prolonged-release product offers some reassurance for that setting; it can’t establish the safety of every formulation used indefinitely. A longer-term plan deserves an actual reason and a review of whether it’s helping. Six-month trial

You may have seen a headline linking long-term melatonin to heart failure. It came from a conference abstract presented in late 2025 that, as of this writing, still hasn’t been published as a peer-reviewed paper, drawn from a records database where over-the-counter melatonin users are hard to count. A 2026 analysis of a national health survey found no association between recent melatonin use and heart failure, although that was a snapshot, not a study that followed people over time. It’s unresolved, which argues for using melatonin on purpose rather than by habit, without panicking about the bottle you already own. Melatonin and cardiovascular risk

The herbs: chamomile, valerian, lavender, ashwagandha, and the rest of the shelf

If you’ve seen an integrative clinician, a naturopath, or me, you’ve probably been handed at least one of these. I believe in some of them, I used them, and I still want to be straight with you about what they can do. Here’s the tension: some practitioners reach for an herb because they want a woman to walk out with something in her hand, and an herb is easier to hand over than a hard conversation about insomnia. I understand the instinct. It’s still not a treatment for insomnia. Used correctly, the better-studied ones can take the edge off a rough stretch of nights, and “natural” tells you nothing about whether one works or interacts with your medication. Here’s where each stands.

Chamomile. The best-studied of the teas. A 2024 meta-analysis of ten trials, 772 people, found better sleep-quality scores and fewer awakenings, but no change in how long people slept, their sleep efficiency, or how they functioned the next day. The one trial in diagnosed chronic insomnia, 34 people, found no difference from placebo on any sleep-diary measure. Current evidence suggests it improves the experience of sleep more than the measurement of it, which is still worth something at bedtime. Two cautions: allergic reactions, including severe ones, in people allergic to ragweed and its relatives, and reported interactions with warfarin and some liver-metabolized drugs. Chamomile meta-analysis, Chamomile insomnia pilot, Chamomile safety, NCCIH

Lavender. Two different things share the name. Smelling it has many small positive trials, mostly in older adults and hospital patients; a 2025 meta-analysis pooled ten of them in people over 60 and found better sleep scores, with a lot of variation between studies. Swallowing it, as a standardized oral lavender-oil capsule studied in Europe, improves sleep in people with anxiety, and the researchers’ own analysis found that more than 98% of the sleep benefit ran through the anxiety relief. So lavender is an anxiety tool that helps sleep when anxiety is what’s keeping you up. Current evidence suggests, for that situation. Lavender inhalation in older adults, Oral lavender and sleep

Passionflower. One decent trial: 110 adults with insomnia disorder, 54% women, two weeks, measured in a sleep lab. Total sleep time rose by about 23 minutes compared with placebo; the other measures improved but didn’t separate from placebo. Current evidence suggests, on a single trial. Passionflower sleep-lab trial

Valerian, with or without hops. The most-sold and the most disappointing. A 2024 umbrella review of eight systematic reviews concluded it has a good safety record and no demonstrated efficacy for insomnia: people rate their sleep a little better, and the measurements don’t move. The best single trial, a valerian-and-hops combination in 184 adults with mild insomnia, 110 of them women, found modest self-rated gains and nothing on the sleep recording. In the one meta-analysis that counted side effects, valerian had more of them per person than placebo, not fewer. Product quality varies widely, which is part of why trials disagree. Uncertain or contested. Valerian umbrella review, Valerian-hops trial, Herbal medicine for insomnia meta-analysis

Lemon balm. Almost always studied inside a blend, which makes it impossible to credit any single ingredient. A 2024 trial of a lemon balm, valerian, saffron, and L-theanine combination did no better than placebo on measured or rated sleep. Uncertain or contested. Combination trial

Ashwagandha. The one I’d be most careful with, and the one I most want you to understand. A 2021 meta-analysis of five trials, 400 people, found a small-to-moderate benefit on sleep, strongest in people with diagnosed insomnia and with longer use; the authors noted that long-term safety data are limited. The liver is the issue. A case series from Iceland and the US Drug-Induced Liver Injury Network described five people who developed jaundice and itching two to twelve weeks after starting ashwagandha-containing supplements; liver tests returned to normal in four of them over one to five months, and the fifth was lost to follow-up. A 2026 trial enrolled 1,002 adults, 498 on a standardized root extract and 504 on placebo for eight weeks, and found no significant liver-test differences between groups. That’s reassuring for the product and period studied; it can’t tell us how often rare liver injury occurs or establish long-term safety. Stop and get checked if you turn yellow, itch all over, or feel unwell on it. Current evidence suggests benefit; safety is Uncertain or contested. Ashwagandha meta-analysis, Ashwagandha liver-injury case series, Eight-week safety trial

Kava. Trial evidence for anxiety, not for insomnia, and a link to rare but sometimes fatal liver injury. It shouldn’t be combined with alcohol or sedatives. I wouldn’t use it for sleep. Herbal medicine for insomnia meta-analysis, Kava safety, NCCIH

Where that leaves you: chamomile, lavender when anxiety is the problem, and passionflower have a signal that’s worth something on a rough night. Valerian and lemon balm have a safety record and not much else. Ashwagandha has a signal and a liver question, so it’s the one I wouldn’t take casually or indefinitely. None of them does what CBT-I does for a sleep problem that has lasted months; most of the trials are small and short, and they measure how sleep felt more than how it went. Use them as what they are, a short-term nudge through a bad stretch. And if you’re pregnant or breastfeeding, on a blood thinner, an antidepressant, or anything your liver has to process, bring the bottle to the visit.

And magnesium, the PM pill, and everything else?

Uncertain or contested: magnesium as a routine insomnia treatment. The pooled evidence in older adults came from three small trials with low-quality evidence. Correcting a deficiency and treating insomnia are different questions. Magnesium evidence review

Clinical observation: many of my patients told me magnesium bisglycinate helped them settle at night. I take it myself, nightly, for more reasons than sleep, and I find the same. That is experience, theirs and mine, and I’m labeling it that way on purpose. For the record, I have a practitioner dispensary that carries it; nothing in this article links there, and you don’t need to buy anything to use this piece.

Over-the-counter sleep medicines belong in this conversation too. Diphenhydramine, the sedating antihistamine in most “PM” products, is not recommended by the AASM as a routine treatment for chronic insomnia. Bring the label, especially if a PM product has become part of every night. Insomnia medication guideline

A warm drink or a familiar evening ritual can be enjoyable without becoming a proven treatment. Before adding another product, ask what it’s supposed to change, whether human trials support that use, and whether it could interact with anything else you take.

8. The last hour: phones, TV, and the rest of it

There are at least three ways an evening screen can affect your night: the light, what you’re doing, and the time it takes. Changing one doesn’t automatically change the others.

A dim screen can still contain an argument, an alarming headline, or forty minutes of videos you didn’t mean to watch. And someone who already can’t sleep may reach for a phone, which matters when we read studies linking screen use with poor sleep: the relationship can run both ways.

Current evidence suggests evening screen use can interfere with sleep in some settings. A controlled study using prolonged evening e-reader exposure found delayed circadian timing and sleep changes compared with print. A much larger observational study, with mostly women participants, found an association between bedtime screen use and poorer sleep. The lab setup was more intensive than a quick text, and the observational study can’t establish cause. E-reader experiment, Adult screen-use study

Will a warmer or red screen fix it?

Mechanistic plausibility: the clock responds differently to different wavelengths of light, with particular sensitivity to the blue part of the spectrum, so reducing that exposure has a biological rationale. Brightness, duration, and the rest of the room’s lighting still matter. Human light-response study

Uncertain or contested: how reliably consumer filters or blue-blocking glasses improve sleep. In a randomized study of 167 young adults, 71% of them women, overall sleep outcomes didn’t differ significantly between Night Shift on, Night Shift off, and no phone at all. One detail is worth keeping: in an exploratory analysis done after the main comparison, participants averaging more than 6.8 hours a night slept better with no phone than with Night Shift on. A clue worth following; it wasn’t the trial’s main result. That trial didn’t test a full red filter. A Cochrane review found uncertain evidence for blue-light-filtering glasses and sleep. Night Shift trial, Cochrane review

What I do: my iPhone is set to turn the screen red in the evening so I can still read on it with less blue light. That’s a personal habit, and I’d never call it a treatment.

If you want a practical starting point, think about the whole evening: dimmer room lighting, comfortable screen brightness, less activating content, and a stopping point you can actually keep. A color setting can’t give back an hour spent scrolling.

“But I need the TV to fall asleep.”

The familiar voices may be comforting. Keep that part. The goal is to keep the comfort and lose the light and the program that keeps running after you’ve fallen asleep. Audio with the screen off, or a sleep timer, are reasonable things to try.

In a small laboratory study, sleeping in moderate room light increased overnight heart rate and reduced insulin sensitivity the next morning. That doesn’t tell us exactly what one TV does, but it’s a reason to make a darker room the default when you can. Light during sleep experiment

Sex, since nobody puts it on the sleep-hygiene list

If it’s already part of your evening, it counts. In a 14-day diary study of 159 adults, partnered sex with orgasm was tied to falling asleep faster and sleeping better; sex without orgasm was not. A small EEG pilot in seven couples found less waking during the night after sex, solo or partnered. Current evidence suggests, mostly from self-report, in people without insomnia. Take it as an observation. No trial has tested it in women who can’t sleep, and nobody is assigning you anything. Sex and sleep diary study, Couples sleep pilot

9. The cheat sheet: what’s worth trying first?

Choose the item that matches your problem. It’s a reference to come back to, and nobody is assigning you eleven things tonight. Habits can support sleep while medical problems are being assessed; you don’t have to finish this list before getting help.

1. Protect an actual chance to sleep. Count the available hours before optimizing the pillow. If work or care repeatedly takes those hours, the solution has to include the workload or the support. Most adults need substantially more than a five-hour window. Well-established. Sleep-duration review

2. Give your clock some consistency. A reasonably steady sleep-wake schedule is a useful aim where life allows. Large observational studies associate more regular sleep with better health, but they don’t prove an exact wake time prevents disease. Build consistency you can live with, not a new reason to dread Saturday. Current evidence suggests. Sleep regularity study

3. Make daytime look like day and the approach to bed look like night. For a typical daytime schedule, daylight after waking and less bright light before bed give the clock clear cues. Night shifts and persistent clock disorders need a schedule-specific approach. Well-established for light’s role in timing. Body-clock basics, Room light and melatonin

4. Look at the whole caffeine picture. Amount, timing, contraceptives, pregnancy, and individual sensitivity. Earlier or less tells you more than switching from one caffeinated product to another. Well-established that caffeine can disrupt sleep. Caffeine review

5. Let alcohol be an informed choice, not the sleep plan. Getting drowsy isn’t the same outcome as sleeping well across the night. Well-established. Alcohol review

6. Move in a way that fits your life. Evening exercise is generally compatible with good sleep. If a very hard late session repeatedly leaves you wired, play with timing or intensity. Nobody gets to take a woman’s only available workout away from her. Current evidence suggests. Evening exercise meta-analysis

7. Make the room comfortable and address what wakes you. Dark enough, quiet enough, and cool enough for you. A warm shower or bath before bed may help sleep onset, partly through the heat loss that follows. There’s no universal thermostat setting. Current evidence suggests. Warm-water evidence review

8. Let symptoms guide the food conversation. If lying down after eating brings reflux, meal timing may matter. That doesn’t justify a universal rule that women must eat a small dinner or go to bed hungry. Current evidence suggests that avoiding meals close to bedtime helps some people with reflux. Reflux guideline

9. Give winding down a realistic shape. A familiar book, music, a shower, or gentle stretching can mark the transition. You don’t need an elaborate ritual. For persistent insomnia, use the specific principles of CBT-I rather than adding more bedtime tasks. Well-established for CBT-I; no single perfect routine has been established. Insomnia treatment guideline

10. Use naps according to the problem. Naps improve alertness, but they also drain sleep pressure and can leave temporary grogginess. If falling asleep at night is hard, ask whether a long or late nap is contributing. A night worker or a sleep-deprived parent may need a different approach from someone with chronic insomnia. Current evidence suggests; no universal nap rule fits everyone. Napping review

11. Know when you need treatment. Persistent insomnia, repeated breathing symptoms, marked daytime sleepiness, restless legs, recurring nightmares, or sleep trouble with significant mood changes deserve assessment. Bring what you’ve noticed and what you take. Well-established for assessing sleep disorders and treating chronic insomnia. CBT-I guideline, Women’s apnea review

10. Daylight saving time and your sleep: what to do when the clocks change

Twice a year, most of the United States moves its clocks by an hour. Your phone changes instantly; your body clock takes longer, because it’s set by light and routine, not by a setting. Body-clock basics

When the clocks go back in November (this year: Sunday, November 1, 2026), you gain an hour. If the fall change tends to leave you sleepy in the evening and awake too early, sleep specialists suggest gently moving your schedule later in the days beforehand, keeping the room dark until your intended wake time, and getting regular daylight during the day. If you’re already short on sleep, the American Academy of Sleep Medicine’s advice is simpler: don’t shift anything, and take the hour as sleep. Parents, caregivers, and shift workers may not receive an extra hour at all. 2026 clock-change date, Sleep specialist’s fall-change guidance, AASM guidance on the clock change

When the clocks go forward in March, you lose an hour, and this is the harder change for most people: the days after the spring change are associated with more heart attacks, strokes, and car accidents, and both changes have been linked to mood disturbance. Sleep specialists’ standard advice is to shift bedtime a little earlier over the nights beforehand, get outside in morning light on the first days after, and keep the rest of your schedule steady. AASM guidance on the clock change

The American Academy of Sleep Medicine favors permanent standard time, because it lines up better with human circadian biology; its 2023 position statement is endorsed by twenty other organizations. The goal is less disruption for everyone, rather than getting very good at changing the clocks twice a year. AASM position statement, 2023 update

Leave with one next step

You don’t need to become a sleep researcher or a person with a six-step evening routine.

Try finishing this sentence:

Maybe that means checking what’s in the afternoon energy drink. Maybe it means sharing a caregiving task. Maybe it means starting a CBT-I program tonight, or telling your clinician, “I have enough time to sleep, and I still can’t. I want help with that.”

More than once in this piece the answer was “nobody has studied that in women yet.” I’d rather tell you that than fill the gap with a guess.

And if you already sleep well, keep protecting it. You’re doing something worthwhile with those hours.

If someone sent you this, I hope it feels like being cared for. If a woman came to mind while you were reading, send it with that same intention.

What’s the part of your night you wish someone would explain?

Congratulations, we’re healthing.

Lindsay Savage, PA-C

Leave a comment

Share

Sources & evidence notes

1. Sleep stages, NHLBI

2. Sleep physiology, StatPearls

3. Sleep and memory, Physiological Reviews, 2013

4. Growth hormone and slow-wave sleep, JAMA, 2000 (149 healthy men, no women)

5. Understanding sleep, NINDS

6. Nighttime awakenings, Sleep Medicine, 2010

7. Wearable validation study, six devices versus polysomnography, 62 adults, 2025

8. The two-process model of sleep regulation, Journal of Sleep Research, 2016

9. Your sleep-wake cycle and body clock, NHLBI

10. Caffeine pharmacology and metabolism review, Pharmacological Reviews, 2018

11. Room light and melatonin, Journal of Clinical Endocrinology and Metabolism, 2011

12. Cortisol rhythms, Endocrine Reviews, 2016

13. Chronic sleep restriction experiment, Sleep, 2003

14. Sleep loss and emotion, meta-analysis of 154 experiments, Psychological Bulletin, 2024

15. Sleep restriction and insulin sensitivity in 38 women, Diabetes Care, 2024

16. Hunger hormones after short sleep, Annals of Internal Medicine, 2004 (study in 12 men)

17. Sex differences in appetite-hormone responses to sleep loss, review, 2025

18. Sleep and susceptibility to the common cold, Sleep, 2015

19. Sleep and vaccine antibody responses, meta-analysis, Current Biology, 2023

20. Cerebrospinal-fluid waves during human sleep, Science, 2019

21. Sleep deprivation and tracer clearance in humans, Brain, 2021

22. Conflicting experimental findings on brain clearance during sleep, Nature Neuroscience, 2024 (author correction noted)

23. Recommended amount of sleep for a healthy adult, AASM and Sleep Research Society joint consensus statement, Sleep, 2015

24. Sleep-duration recommendations and sex differences, 10-year systematic review, Sleep Health, 2026 (authored by the National Sleep Foundation)

25. Sex and gender differences in sleep health, Society for Women’s Health Research expert report, 2014

26. Reporting of sex and other demographics across 40 years of sleep and chronobiology research, 2024

27. Sex differences in sleep, circadian rhythms, and metabolism, review, Sleep Medicine Reviews, 2024

28. Sex inequities in sleep-disordered breathing, review, Sleep Medicine, 2026

29. Future research directions for women’s sleep health, Sleep Medicine Clinics, 2026

30. Sex differences in insomnia, meta-analysis, Sleep, 2006

31. Sex difference in the intrinsic circadian period, PNAS, 2011

32. Sex differences in sleep EEG activity, review, Journal of Sleep Research, 2026

33. Bedtime procrastination, systematic review and meta-analysis, Sleep Medicine Reviews, 2022

34. Menstrual cycle and sleep, review, Current Opinion in Psychology, 2020

35. Temperature and sleep across the menstrual cycle in 116 women, Journal of Biological Rhythms, 2024

36. Progesterone and sleep, trials review, Journal of Clinical Endocrinology and Metabolism, 2021

37. Sleep disorders in pregnancy, Obstetrics and Gynecology, 2022

38. Restless legs syndrome clinical practice guideline, AASM, Journal of Clinical Sleep Medicine, 2025

39. Obstructive sleep apnea in pregnancy, American College of Chest Physicians clinical practice guideline, CHEST, 2026

40. CBT-I during pregnancy, randomized trial of 194 women, Obstetrics and Gynecology, 2019

41. CBT for postpartum insomnia and fatigue, randomized trial of 114 women, Psychological Medicine, 2022

42. Depressive, anxiety, and insomnia symptoms in perimenopausal and postmenopausal women, meta-analysis of 102 studies, General Hospital Psychiatry, 2026

43. Hot flashes and awakenings in 34 perimenopausal women, sleep-lab study, Fertility and Sterility, 2014

44. Sleep in the menopause transition, review, Current Opinion in Obstetrics and Gynecology, 2025

45. Hormone therapy and sleep, review, Endocrine, 2017

46. CBT-I versus menopause education in 43 midlife women, pilot trial, Menopause, 2026

47. Sleep and older adults, National Institute on Aging

48. Sex differences in melatonin suppression by light, dose-response study of 56 adults, Journal of Pineal Research, 2024

49. Normal polysomnography values in healthy adults, meta-analysis of 169 studies, Lancet Respiratory Medicine, 2019

50. Sex and age differences in polysomnography, 2,365 sleep-lab patients, Brazilian Journal of Medical and Biological Research, 2008

51. Sex differences in radar-measured sleep in junior endurance athletes, PLoS One, 2021

52. Sleep need by sex across the lifespan, Sleep and Breathing, 2025

53. Evening exercise and sleep, meta-analysis, Sports Medicine, 2019

54. Hyperarousal and insomnia, review, Sleep Medicine Reviews, 2010

55. Hyperthyroidism (overactive thyroid), symptoms, NIDDK

56. Obstructive sleep apnea in women, review, CHEST, 2025

57. Stimulus control for insomnia, evidence review, Journal of Sleep Research, 2023

58. Depression, symptoms and treatment, NIMH

59. Treatment of nightmare disorder in adults, AASM position paper, Journal of Clinical Sleep Medicine, 2018

60. Circadian rhythm sleep-wake disorders clinical practice guideline, AASM, Journal of Clinical Sleep Medicine, 2015

61. Mouth taping, evidence review, PLoS One, 2025

62. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome, global consensus, The Lancet, May 2026

63. International evidence-based guideline for the assessment and management of PCOS/PMOS, 2023

64. The HowToHealth PCOS/PMOS series, Part 1

65. Adrenal fatigue does not exist, systematic review, BMC Endocrine Disorders, 2016

66. Behavioral and psychological treatments for chronic insomnia, AASM clinical practice guideline, Journal of Clinical Sleep Medicine, 2021

67. CBT-I for chronic insomnia, meta-analysis of 20 trials, Annals of Internal Medicine, 2015

68. Insomnia classification, CHEST, 2014

69. Digital CBT-I, meta-analysis of 33 randomized trials, Sleep Medicine, 2020

70. Internet-delivered CBT-I, meta-analysis of 11 randomized trials, Sleep Medicine Reviews, 2016

71. Insomnia Coach app, U.S. Department of Veterans Affairs

72. CBT-i Coach app, U.S. Department of Veterans Affairs

73. Society of Behavioral Sleep Medicine, member directory

74. Society of Behavioral Sleep Medicine, telemedicine providers

75. Combination treatment for chronic insomnia disorder in adults, AASM clinical practice guideline, Journal of Clinical Sleep Medicine, 2026

76. Pharmacologic treatment of chronic insomnia in adults, AASM clinical practice guideline, Journal of Clinical Sleep Medicine, 2017

77. Caffeine and sleep, meta-analysis of 24 studies, Sleep Medicine Reviews, 2023

78. Caffeine clearance and oral contraceptives, European Journal of Clinical Pharmacology, 1985

79. Caffeine pharmacokinetics across the menstrual cycle, 10 women, 1992

80. Caffeine pharmacokinetics across the menstrual cycle, 10 women, 1999

81. Caffeine content of supplements versus labels, Foods, 2023

82. Caffeine content of decaffeinated coffee, Journal of Analytical Toxicology, 2006

83. Spilling the beans: how much caffeine is too much? FDA

84. Alcohol and sleep architecture, meta-analysis of 27 studies, Sleep Medicine Reviews, 2024

85. Alcohol and sleep by sex, controlled study, Alcoholism: Clinical and Experimental Research, 2011

86. Alcohol withdrawal management, ASAM clinical practice guideline, 2020

87. Cannabinoid oil for chronic insomnia, two-week crossover trial of 23 adults, Sleep, 2021

88. Oral THC plus CBD in insomnia, sleep-lab pilot trial, 20 patients, Journal of Sleep Research, 2025

89. Cannabis and sleep architecture, systematic review and meta-analysis, Sleep Medicine Reviews, 2025

90. Cannabis use before sleep and sleep architecture, 177 adults, Journal of Clinical Sleep Medicine, 2024

91. Chronic daily cannabis use in a sleep-clinic cohort, 1,449 patients, Sleep, 2025

92. Sleep during cannabis abstinence, Drug and Alcohol Dependence, 2011

93. Medical cannabis card access, randomized trial, JAMA Network Open, 2022

94. CBD for insomnia, randomized trial of 30 adults, Journal of Clinical Sleep Medicine, 2024

95. CBD and liver safety in healthy adults, randomized trial, JAMA Internal Medicine, 2025

96. CBD drug interactions, review, Journal of Clinical Medicine, 2019

97. CBN for sleep, seven-night industry-run trial, Experimental and Clinical Psychopharmacology, 2024

98. Melatonin for primary sleep disorders, meta-analysis of 19 trials, PLoS One, 2013

99. Melatonin supplement content versus label, analysis of 31 products, Journal of Clinical Sleep Medicine, 2017

100. Prolonged-release melatonin, six-month trial, Current Medical Research and Opinion, 2011

101. Melatonin and cardiovascular risk, NHANES cross-sectional analysis, Open Heart, 2026

102. Chamomile and sleep, systematic review and meta-analysis of 10 trials, Complementary Therapies in Medicine, 2024

103. Chamomile extract in chronic primary insomnia, pilot trial of 34 patients, 2011

104. Chamomile, safety summary, NCCIH

105. Lavender inhalation for sleep in older adults, meta-analysis, Experimental Gerontology, 2025

106. Oral lavender oil (silexan) and sleep, review with mediation analysis, 2022

107. Passionflower and polysomnographic sleep in insomnia disorder, 110 adults, 2020

108. Valerian for insomnia, umbrella review, European Neuropsychopharmacology, 2024

109. Valerian-hops combination and diphenhydramine in mild insomnia, 184 adults, Sleep, 2005

110. Herbal medicine for insomnia, systematic review and meta-analysis, Sleep Medicine Reviews, 2015

111. Lemon balm, valerian, saffron, and L-theanine combination, randomized trial, Scientific Reports, 2024

112. Ashwagandha and sleep, systematic review and meta-analysis of 5 trials, PLoS One, 2021

113. Ashwagandha-induced liver injury, case series, Liver International, 2020

114. Ashwagandha eight-week safety trial, 1,002 adults, Phytotherapy Research, 2026

115. Kava, safety summary, NCCIH

116. Magnesium for insomnia in older adults, systematic review, BMC Complementary Medicine and Therapies, 2021

117. Evening e-reader use and sleep, controlled experiment, PNAS, 2015

118. Screen use before bed and sleep, 122,058 adults, JAMA Network Open, 2025

119. Human circadian light sensitivity by wavelength, Journal of Neuroscience, 2001

120. Night Shift and sleep, randomized trial of 167 young adults, Sleep Health, 2021

121. Blue-light-filtering spectacle lenses, Cochrane review, 2023

122. Light during sleep and cardiometabolic function, laboratory study, PNAS, 2022

123. Sexual activity and sleep, 14-day diary study of 159 adults, Journal of Sleep Research, 2023

124. Sexual activity and measured sleep in cohabiting couples, pilot, Sleep Health, 2025

125. Sleep regularity and mortality, UK Biobank, Sleep, 2024

126. Warm bath or shower before bed and sleep, systematic review, Sleep Medicine Reviews, 2019

127. GERD clinical guideline, American College of Gastroenterology, 2022

128. Napping, review, Sleep Medicine, 2017

129. Daylight saving time dates, NIST

130. Sleep specialist’s guidance on the fall clock change, Ohio State University Wexner Medical Center

131. Daylight saving time, AASM Sleep Education

132. Permanent standard time is the optimal choice for health and safety, AASM position statement, updated 2023, Journal of Clinical Sleep Medicine, 2024

Evidence notes: Several experimental studies are small, and many sleep findings come from mixed-sex samples or from men only; the body says so where it applies. The claim that not much has changed since 2014 rests on recent reviews that still name the same gaps; the one clear improvement, that most studies now report participants’ sex, comes from a 2024 survey of a random sample of 6,777 articles. Observational associations do not establish cause. The wearable validation study was 62 adults, mostly men. The light-sensitivity and REM-timing findings are averages from laboratory samples; the sleep-duration gap is observational and cannot separate biological need from opportunity. The 2026 sleep-duration review was written by the National Sleep Foundation about its own recommendations. The 2026 menopause meta-analysis pooled studies of depression, anxiety, and insomnia together; its participant total spans all three outcomes, and it has no premenopausal comparison group. The hot-flash sleep-lab study is 34 women. The postpartum trial does not represent mothers with very frequent infant-related waking. The digital CBT-I meta-analysis judged app and web programs non-inferior to face-to-face treatment on a four-point margin; face-to-face still did better on average. The VA apps are named because they are public and non-commercial; I have no relationship with them. The medication paragraph summarizes a guideline’s list of names and is not a recommendation for any reader. The THC lab trial was a single dose of a THC-plus-CBD product, not a gummy as sold, and the two cannabis cohort studies are cross-sectional associations; the sleep-clinic cohort was mostly patients with sleep apnea. The CBN trial was industry-run. Herbal trials are mostly small, short, and rated at high risk of bias by the reviews that pooled them; the ashwagandha liver-injury evidence is a five-case series, and the 2026 safety trial was eight weeks. The sex-and-sleep evidence is self-reported sleep in a mostly student diary sample plus one 14-person pilot in healthy sleepers; no trial has tested it in women with insomnia. The 2024 mouse-clearance paper has an author correction and published methodological debate; it is included to show why the mechanism remains contested. The melatonin heart-failure signal is an unpublished conference abstract; the 2026 survey analysis is cross-sectional and found no association, which is not the same as a refutation. Screen-filter results apply to the products studied, not every red or amber setting. Celsius is named as a label example, not a recommendation, and I have no relationship with the company. Specific product trials do not establish safety or effectiveness for an entire supplement category. The clinical observations in this piece are my account of my own practice, not efficacy evidence; the ferritin check without leg symptoms and the cortisol-rhythm lens were my practice, not guideline recommendations; the two-week pause I asked patients for is described as what I did, not as an instruction for readers. I take magnesium bisglycinate and have a practitioner dispensary that carries it; nothing in this article links to it.

This article is for education, not individualized medical advice.

Reading in your inbox? Open the full article for every graphic and source.

If you have PMOS, someone has probably said “diet and exercise” to you on the way out of an exam room. No plate, no plan, no follow-up. Two words and the door.

Here is what I saw in clinic instead. Women who were trying hard to eat well and felt like failures after one meal off plan. Women who never missed a workout and were still exhausted. Women who had read everything and could not tell what to do first.

So before I added one more thing, I asked what they had already changed, and then: was that change relieving stress, or adding to it? The answer told us where to work. Sometimes it was dinner. Sometimes the workout, or the fatigue, or a pattern that was hard to change alone. The effort a woman had already made deserved recognition. Her plan also needed to work in her life.

Picture the treatment whiteboard from Part 1 with one line at the top: feel good in your body, and when you don’t, know why. Lab results and cycle patterns help guide care. So do your energy, sleep, mood, and whether the plan fits your day.

In Part 1, we explored how the symptoms of PMOS, formerly PCOS, connect. Here, we turn that understanding into everyday care, with explanations and examples you can use between appointments.

The plan, in three parts

1. Understand weight and medication. We’ll start with why weight can be harder to manage with PMOS, what can help, and where metformin and GLP-1 medications fit.

2. Make everyday care manageable. Then we’ll work through meals, muscle, sleep, and your nervous system, including what to change when a routine leaves you exhausted, overwhelmed, or feeling guilty.

3. Decide what additional support fits. Finally, we’ll look at gut health, supplements, who can help you put the plan into practice, and what to follow over time.

You can read in order or skip to what you are dealing with: if dinner is the problem, go to section 2; if you are on metformin and worried, go to section 1; if you want to know whether a supplement is worth it, go to section 3. By the end, you should be able to choose one sensible next step, explain why it fits, and know when to ask for more help. You do not have to change everything at once.

Diagnosis, prescriptions, uterine-lining protection, fertility treatment, and lab follow-up still need a clinician. You deserve support with the daily parts, too.

One situation should not wait for a new routine: if you are off hormonal treatment and have gone roughly three months without a period, arrange assessment and take a pregnancy test if pregnancy is possible. Long gaps between periods in PMOS can allow the uterine lining to thicken. Your clinician can check the cause and discuss lining protection; do not wait for lifestyle changes to bring your period back. Cycle and lining guidance

1. Understand weight and medication

Why is weight so hard with PMOS?

The answer: because your body is playing by a harder set of rules, not because you are doing it wrong. And the plan counts whether or not the scale moves.

If you have been eating carefully and moving your body and the number has not changed, you are not imagining that. The international guideline recognizes that many women with PMOS have underlying drivers that make weight gain easier and weight loss harder, even though the exact mechanisms are still unclear. It also says something I want you to hold on to: the benefits of daily care happen even when weight does not change. International guideline on weight

One part of the picture is the loop between insulin and androgens. As we covered in Part 1, higher insulin can push androgen production up, and higher androgens can make insulin work less well. Research also finds differences in where the body stores fat and how fat tissue behaves in some women with PMOS, even at similar body weights, and fat tissue itself can affect how the body responds to insulin. None of this is a verdict on your willpower. It is the reason weight and hormones have to be treated together, and the reason the plan cannot be “eat less.” It does not establish one cause of weight gain for every woman, or mean that weight loss is impossible. Research on insulin, androgens, and fat tissue

You are allowed to decide what role weight plays in your care. The guideline tells clinicians to be aware of weight stigma, to ask permission before discussing or measuring weight, and to offer a choice between care that aims at weight loss and care that does not. If a clinician has only ever talked to you about your weight, you can ask for the rest of the whiteboard: your energy, cycles, skin, strength, mood, and lab results are part of the picture too. Guideline on weight stigma and weight-inclusive care

Current evidence suggests daily care improves metabolic health in PMOS, and the guideline recommends it for every woman with the condition, at every size. The studies behind it are limited, and how much these routines change skin, hair, or ovulation without other treatment is less certain. That is why these routines belong in the same care plan as clinical assessment and treatment, and do not replace them. International guideline on lifestyle

Meals supply fuel, muscles help use it, and sleep affects how the body responds to insulin. That is why these routines belong beside the hormone and symptom treatments in Part 1, for every woman with PMOS, not only the ones who have been told to lose weight.

If weight loss is one of your goals, it deserves a real plan, not a lecture. A dietitian can help you eat a little less than your body uses while staying well fed; movement and ongoing support belong alongside it, and medication may be appropriate for some women. The sections below explain those options. If weight loss is not your goal, or not right now, care focused on health without weight loss is a legitimate choice, and the guideline says so. Weight-management guidance

Where do metformin and GLP-1 medications fit?

Metformin reduces the liver’s glucose production and can help the body respond better to insulin. It can address a metabolic contributor to PMOS and sometimes helps ovulation. The international guideline says it should be considered for metabolic outcomes in adults with a BMI of 25 or higher. It may also be considered below that BMI, although evidence is more limited. The guideline describes active lifestyle intervention and metformin as having similar efficacy; the choice still depends on your health needs and treatment goals. Its most common side effects are stomach upset, usually dose-related and easing with time, and it can lower vitamin B12. Metformin guidance, Metformin review

My clinical perspective: in practice I laid out both paths, metformin and the approaches women thought of as more natural, and I told them what the evidence could and could not promise for each. Some women wanted to see what they could accomplish with lifestyle changes and supplements first. When a monitored trial was reasonable, I worked with that preference, said plainly when medication could help and when I would recommend it sooner, and we reassessed symptoms and labs at three months. Berberine was one of the supplements I used that way.

Your preferences deserve to be heard, and the options still need to be weighed against the evidence, your health risks, and your goals. My experience does not establish berberine as equally effective or safer than metformin; current research does not support treating them as interchangeable. Medication can be appropriate before a problem becomes urgent, and you do not have to exhaust every supplement first. Shared decision-making and medication guidance, Berberine evidence review

Needing medication does not mean you have failed. If metformin causes stomach upset, ask your prescriber whether slower dose increases or an extended-release formulation could help. Discuss any medication change with your prescriber; do not stop metformin or replace it with berberine on your own. Metformin guidance

What can’t metformin do on its own?

It can help with glucose handling, but it does not provide the nourishment, muscle-building activity, or sleep your body also needs. It may improve cycles, but persistent missing periods still require a plan to protect the uterine lining. Skin symptoms or fertility may need their own treatment. Taking metformin and building daily routines can be parts of the same plan. Treatment guidance

Where do GLP-1 medications fit?

GLP-1 medications act on signals involved in blood-sugar control and appetite. Some people qualify under diabetes or weight-management indications. These medications can be considered alongside lifestyle care when indicated. The decision depends on your health needs, eligibility, preferences, and pregnancy plans. When appetite drops, the plan needs enough nourishment, strength training adapted to ability, and prescribing follow-up. If pregnancy is possible, discuss effective contraception with your prescriber while using a GLP-1 medication. Planning a pregnancy requires medication-specific guidance about stopping treatment beforehand. Some people benefit from long-term treatment. Nutrition and muscle-health advisory, medication guidance, GLP-1 guidance

Whatever you decide about medication, women also need help living the plan between appointments. That is the rest of this article.

2. Make everyday care manageable

Make eating well easier to repeat

There is no single best diet for PMOS. The international guideline found no evidence that one diet composition beats another; it recommends sustainable, healthy eating that fits your preferences and cautions against restrictive plans. That leaves room to build around the foods, budget, culture, and schedule you actually have. Diet guidance

In clinic, “eat better” was never enough instruction, so here is the picture I gave women to take home. Build a plate around protein, vegetables, carbohydrate, and fat: roughly half non-starchy vegetables, a quarter protein, a quarter carbohydrate, with fat in the meal or added on top, adjusted to your appetite, activity, and needs. Chicken or tofu, rice, broccoli, and olive oil is a complete dinner. Eggs with vegetables, toast, and fruit is a complete breakfast. Ready-cooked protein, microwave rice, and frozen vegetables make the same plate on a busy night, and fresh, frozen, and canned foods all count. CDC meal guidance

And one question I want you to carry into every meal, because it turns the whole conversation from subtraction into addition: what would make this meal more nourishing? Most women with PMOS have spent years being told what to cut. Start with what is missing, usually protein, fiber, or simply enough food.

Then look at where feeding yourself actually falls apart. These are the three places it happens most, and none of them is a willpower problem.

You get busy, miss a meal, and feel ravenous later. Before making another food rule, make the missed meal easier to eat. If mornings disappear into coffee and work, put breakfast where you will see it: overnight oats with Greek yogurt, fruit, and nuts, or eggs and toast made ahead. If lunch disappears between meetings, pack it when you put dinner away and protect a real break to eat it. Then notice whether eating more consistently changes your hunger and energy later in the day. Cravings have several possible causes; they are not proof of poor willpower or a blood-sugar diagnosis. Dietitian guidance on regular meals

You eat a “healthy” lunch and are hungry an hour later. Check whether it was enough food. A bowl of leaves may need beans, tofu, chicken, or fish; rice, potatoes, or bread; and a dressing you enjoy. A sandwich can be a nourishing lunch. If dinner is hours away, fruit with yogurt or crackers with hummus can bridge the gap. The aim is to feel adequately fed; a smaller lunch was never the assignment.

You buy ingredients with good intentions, and the week gets away from you. Plan for the evenings you actually have. Before shopping, check what is already in the house, pick the one meal that repeatedly causes trouble, and write down a realistic option for it plus one backup that needs almost no preparation. Pasta with a lentil sauce on the quieter night; a frozen meal you like, with a side if you need more food, on the late one.

Keep the foods you enjoy, and build around them. Carbohydrates are fuel. Fiber-rich choices such as oats, beans, whole grains, and whole fruit support digestion and glucose management, and pairing carbohydrate with protein, fiber, or fat slows the rise in blood sugar. The amount and type still matter, and normal rises are part of eating. Rice stays in the meal. A banana is a banana. You do not need to remove gluten or dairy because you have PMOS; an allergy, celiac disease, or an intolerance is a separate question. Honey and maple syrup count as added sugar, and a little in oatmeal or yogurt can make a nourishing meal more enjoyable. Individualized nutrition guidance, Added sugars explained

What I told women in the room. Three things, and every one of them came with permission to be imperfect.

1. Keep added sugar under about 20 grams a day, and read the label to find it. The American Heart Association’s limit for women is about 25 grams; I set mine a little lower, because the foods that sneak it in are not the ones you expect: flavored yogurt, granola, pasta sauce, salad dressing, bread, and “healthy” bars are some of the worst offenders. The sugar in whole fruit does not count toward it. The Added Sugars line on the nutrition label does the math for you. AHA on added sugars, Reading the Added Sugars line

2. Make lunch your biggest meal, keep dinner smaller, and finish it about three hours before bed. You need the fuel during the day, when you are using it, and your digestion needs time to work before you lie down. The research here is small but pointed: in a 90-day trial of 60 lean women with PCOS eating the same calories, the group that ate most of them early in the day and had a small dinner cut their insulin response by about half, halved free testosterone, and ovulated more often, while the dinner-heavy group did not change. If you fall asleep within an hour or two of your heaviest meal, that is the pattern I would change first. Meal-timing trial

3. It’s okay to break the rule on purpose once or twice a week. Dinner out with friends, a late family meal, a birthday: go, eat, enjoy it, and do not spend the next day feeling guilty. Consistency most of the time is what moves the needle. Perfection is not required, and it was never the plan.

Try one adjustment and ask whether meals feel more satisfying and less stressful. If you still struggle to eat enough, if food has become a source of distress, or if you want help with glucose management or weight, a registered dietitian can tailor the next step. You do not have to figure this out alone.

Want more explanations like this? Subscribe free for one women’s health article every Thursday.

Subscribe now

Muscle is part of your metabolic care

Well-established: muscle is a major destination for glucose. When it contracts, it can take up glucose through processes that do not depend entirely on insulin’s usual action. Regular activity also helps insulin work more effectively. Muscle glucose physiology

A walk uses muscle while a meal is being absorbed. Strength training builds and maintains tissue that uses fuel. Your muscles belong in the conversation about your ovaries. Benefits can begin before the scale changes.

My starting structure is two or three strength sessions a week, walking, and Pilates or yoga if you enjoy them, with enough food and recovery. Begin with something repeatable: perhaps a five-to-fifteen-minute walk after one meal. Walking research

Bands, dumbbells, or body-weight exercises can work at home. Gradually increase the challenge; a qualified trainer can teach you how. Pain or a physical limitation may call for a physical therapist. No single schedule has been shown to be best for everyone with PMOS, and vigorous exercise can also belong if you enjoy and tolerate it.

If you are consistent but still exhausted, that deserves a closer look. In clinic, I would review sleep, medical history, and whether something such as iron deficiency needed assessment. We would also look at the type and length of the workouts and whether she was eating enough to support them. Sometimes the next step was a shorter, more manageable session.

If this sounds like you, arrange an appointment for persistent or unexplained fatigue, especially if it affects daily life. Bring a short account of how long it has been happening, your sleep, workouts, and eating, and any previous tests. Persistent fatigue deserves assessment even if previous tests were normal; your clinician can decide what further evaluation fits. Fatigue assessment

Sleep is the foundation

My clinical perspective: sleep was the foundation for everything else on the whiteboard. Meals, movement, mood, cravings, and the nervous-system work all got easier when a woman was sleeping and harder when she was not, and no supplement made up the difference. If you only have the energy to protect one thing this month, protect this.

Well-established: short sleep changes how the body handles insulin. In a randomized crossover trial of 38 women, six weeks of about an hour and a half less sleep a night, the kind of short sleep millions of women live with, raised fasting insulin and insulin resistance, and the change did not depend on any change in body fat. For a condition built around insulin, that makes sleep a treatment, not a luxury. Sleep restriction trial

Sleep also shapes appetite and cravings the next day, the energy you have for training, and how well you recover from it. And PMOS can make sleep harder in its own right: sleep apnea is more common with the condition, which is why the guideline tells clinicians to ask about snoring, breathing pauses someone has noticed, and waking unrefreshed. Sleep apnea in the guideline

Here is what I would protect, in this order:

1. A consistent wake time, seven days a week. It anchors everything else, including when you get sleepy at night.

2. Enough hours in bed to get seven or more hours of sleep. That is the floor for adults, not a stretch goal. CDC on sleep

3. Dinner finished about three hours before bed, so digestion is not competing with sleep.

4. A repeatable wind-down: lights lower, screens away, caffeine finished by early afternoon, and alcohol kept away from bedtime, because it helps you fall asleep and then fragments the second half of the night.

5. Recovery between demanding workouts. Muscle is built in the rest, not the session.

When sleep needs assessment: loud snoring, breathing pauses, or waking unrefreshed deserve evaluation for sleep apnea. Lying awake most nights, or waking in the small hours and staying awake, for a month or more deserves a conversation with your clinician; cognitive behavioral therapy for insomnia is the first-line treatment and works without medication. Magnesium bisglycinate helped some of my patients settle at night, and it does not fix apnea or a schedule. CBT-I as first-line treatment

Stress, fear, and your nervous system

Being ambitious or a perfectionist is not an established cause of PMOS, and I am not going to hand you one more thing to blame yourself for. I would be leaving something out if I stopped there, though.

Small studies suggest that stress responses differ in some women with PCOS, but they do not establish stress as its cause. Stress research, research in young women

There is also research on helping women feel better. An eight-week trial combining mindfulness-integrated cognitive behavioral therapy with lifestyle support improved anxiety and depression compared with a control group. A newer review found improved PCOS-specific quality of life, although overall anxiety and depression scores did not significantly improve. The findings are mixed, and these structured programs involve more than a breathing exercise. They support taking psychological care seriously; they do not establish a way to reset your hormones. 2025 trial, 2026 review

Clinical observation: underneath a lot of what I saw in clinic was fear: of failing, of not being pretty enough, of not being liked, of dying. That was true whether or not a woman had PMOS, and it shaped how she slept, ate, trained, and recovered. Calming the nervous system was part of care, not a side quest. That does not mean fear caused her condition. Support changed how she felt living in it. That mattered alongside the symptoms and lab results we were following.

When the plan itself becomes stressful

This is where the question from the beginning becomes useful: is the change helping, or is the routine adding pressure? To answer it, look at what is happening in your day.

Here is an illustrative example of how we might adjust it. A woman wants to cook nourishing dinners, but she works full time, spends ages reading labels, and comes home too tired to make the meals she planned. Then she feels guilty about what she eats instead.

Start with the part that is making dinner difficult. If shopping is the barrier, grocery delivery may help. If cooking is the barrier, a box of ingredients still leaves that job to do. Prepared meals or a meal service could be useful if they fit her needs and budget.

A lower-cost starting point could be one dependable dinner assembled from ready-cooked chicken or tofu, microwave rice, and frozen vegetables. Keep those ingredients available for the busiest evenings. She can try the simpler version and ask: am I feeding myself more reliably, with less work and less guilt? If it still costs too much or takes too much effort, we adjust again.

That is the kind of problem-solving I mean. Convenience can belong in a nourishing routine. You do not have to cook every meal from scratch or buy organic food to begin.

New habits can take effort, and progress can take time. But a routine that repeatedly leaves you overwhelmed or ashamed deserves another look. Give yourself credit for what you have changed. Once one part feels manageable, you can decide whether you have room for another goal.

“Meditate more” is not much of a plan, and I am not going to hand you a morning routine. Pick one moment in your day that repeatedly leaves you tense or overwhelmed, and give that moment one small thing:

• When you need a moment to settle: sit comfortably with your feet supported. Breathe gently in through your nose and out through your mouth, counting slowly if that helps, without forcing a deep breath. Try five minutes. If it makes you dizzy or more anxious, stop and return to your usual breathing. NHS breathing exercise

• When worry keeps sending you back to your phone: notice the trigger, what you do next, and what happens afterward. For example: a symptom video → more searching → more fear and less sleep. Write down the question for your clinician and choose a stopping point for tonight. This example applies psychiatrist Judson Brewer’s work on recognizing anxiety habit loops. Brewer’s practical explanation

If your feed consistently leaves you feeling worse about yourself, mute or unfollow the accounts that contribute to it, or take a break from the app. You can choose how much space comparison gets in your day.

The practice matters less than the pattern it interrupts. Calming your nervous system is not a side quest, and it is not one more thing to do perfectly. Choose one place to begin. Prayer, gentle yoga, or meditation may also suit you. Some of this work is learning to settle; some is changing the patterns and pressures you return to every day. You do not need perfect calm, and a practice that makes you feel worse is not something to push through. Relaxation guidance and cautions

Anxiety and depression are both common with PMOS, and the international guideline recommends screening every adult who has it. If your mood has been low or your worry constant, tell your clinician. Your mental health deserves a place in your care plan. Guideline on mood

3. Decide what additional support fits

Your gut belongs in the picture, too

Gut microbes and their products are being studied for their connections with insulin signaling, inflammation, and hormones in PMOS. That makes gut health relevant; it does not establish one gut imbalance as the cause.

Some trials of probiotics and synbiotics (a combination of probiotics and prebiotics) report improvements in selected metabolic or hormone measurements. Results vary: a July 2026 review found some benefits but no clear improvement in a commonly used measure of insulin resistance, and a September trial analysis found no clear metabolic benefit over placebo. We do not yet have a proven gut protocol for everyone with PMOS. 2026 review, September 2026 trial analysis

Start with the foods already on your plate: oats, fruit, vegetables, beans, or lentils in amounts you tolerate. Add fiber gradually if you are not used to it; more all at once can worsen gas and bloating. Persistent pain, constipation, diarrhea, or bloating deserves its own assessment. Digestive-health guidance

The gut and brain also communicate. For people with IBS, gut-focused cognitive behavioral therapy or hypnotherapy can help digestive symptoms. That is a reason to ask about appropriate care, not evidence that digestive symptoms are imaginary or that the same treatments cure PMOS. NIDDK on IBS care

A commercial microbiome test is not a required first step. Its usefulness for choosing treatment remains limited; that is different from tests your clinician orders to investigate specific digestive symptoms. International microbiome-testing consensus

What about supplements?

The answer: a few earn a place in care, for reasons that have nothing to do with wellness marketing. Every one below is a nutrient or a compound with known biochemistry, studied in randomized trials, and most are used by endocrinologists, OB-GYNs, cardiologists, and dietitians for jobs well beyond PMOS. Clinicians reach for a supplement when it has a job: filling a measured gap, acting on a pathway we understand, or supporting something the body needs whether or not PMOS is in the picture. None is required to begin, and I never wanted a woman buying a stack before she had a plan.

My clinical perspective: I started using these because of the research, and I kept using them because of what I saw. Women told me they felt better. Cycles became more regular. Blood-sugar measures improved while inositol or berberine was part of their care. I take inositol myself, every day. That experience is real, and it is not proof on its own: those women were also eating, moving, sleeping, and being treated differently, so I cannot tell you how much came from the supplement. What I can tell you is why each one comes up in clinics, not just mine, and what I would want you to know before you buy it.

• Inositol: the one I would discuss with most women with PMOS. Myo-inositol and D-chiro-inositol are part of the signals cells use to respond to insulin, and inositol has a role in ovarian function, which is why it is studied for both blood sugar and cycles. A 2023 review of 26 randomized trials found that women taking inositol were about 1.8 times as likely to have regular cycles as women on placebo, with results on that measure not inferior to metformin, and lower glucose, insulin, and testosterone measures than placebo; the placebo comparison for cycles rested on only a few trials. The review that informed the international guideline rated the evidence limited and inconsistent overall, noted that myo-inositol likely causes fewer stomach side effects than metformin, and supports discussing inositol according to your preferences without naming a best form, ratio, or dose. The 40:1 myo-inositol to D-chiro-inositol blend you will see marketed has encouraging results from one small trial. 2023 review of randomized trials, 40:1 trial, guideline review

• Berberine: a conversation about blood sugar. Clinicians consider berberine because its effect on glucose handling is measurable: in a placebo-controlled trial in people with type 2 diabetes, it lowered HbA1c, the three-month blood-sugar average. That is why it comes up for PMOS, where insulin is part of the picture, and some PMOS studies have reported metabolic or cycle improvements. An October 2026 review found all four PMOS trials it assessed unreliable, so the size of the benefit in PMOS is not yet known. I used it with a goal and a three-month checkpoint. It is not a substitute for metformin; do not replace prescribed metformin on your own. Digestive side effects and medication interactions matter, and avoid it during pregnancy and breastfeeding. Diabetes trial, evidence review, NIH safety information

• Omega-3s: the cardiologist’s supplement, with a hormonal side. Concentrated EPA is a prescription treatment for high triglycerides; that is the clearest clinical use, and the reason omega-3s belong in metabolic care. They matter for hormones too: EPA and DHA are built into cell membranes and into the molecules that turn inflammation up and down, and inflammation and insulin resistance feed the androgen excess in PMOS. A 2023 pooled analysis of seven PMOS trials (574 women) found lower triglycerides, total cholesterol, insulin resistance, and testosterone with omega-3 supplementation, with no change in weight or hair scores and marked variation between trials. Fertility improvement is a separate claim. If you rarely eat oily fish, a fish-oil or algae-based product can fill the gap. Prescription doses differ from an everyday supplement, and routine fish oil has not consistently prevented heart attacks or strokes in generally healthy adults. Check the actual EPA and DHA amounts, not the total “fish oil” on the label. Omega-3 physiology and clinical evidence, 2023 PMOS meta-analysis, PMOS trials

• Vitamin D3: the one your clinician may already test. Vitamin D behaves like a hormone: it governs calcium absorption and supports bone, muscle, and immune function whether or not you have PMOS, and low levels are common. In women with PMOS who were low, a small trial found metabolic improvements when levels were corrected. It is not a fertility fix: a large 2026 trial in women with PMOS undergoing IVF found no improvement in live births. My clinical perspective: I aimed for a 25-hydroxyvitamin D level between 50 and 90 ng/mL and rechecked it after three months of supplementing, because the dose that gets a woman there varies. That target is my clinical judgment, not a general recommendation. The NIH notes that 20 ng/mL is sufficient for most people and that levels above 50 ng/mL can be associated with adverse effects. Do not aim for my historical target on your own; agree on a level and monitoring plan with your clinician. The NIH sets 4,000 IU a day as the upper limit for routine use without supervision; higher doses belong under a clinician who is checking your level. Vitamin D is fat-soluble, so take it with a meal that contains fat, or with your fish oil. Vitamin D functions and safety, PMOS metabolic trial, IVF trial

• Vitamin K2: the bone-and-calcium rationale. It comes up because so many products pair it with D3. Vitamin K activates proteins that build bone and limit calcium deposits in soft tissue, which is real physiology. In PMOS specifically there is one small eight-week trial. That is not enough to make K2 routine PMOS care or a required partner for every vitamin D supplement, and trials have not shown that the pairing prevents calcium deposits in blood vessels. Your age, diet, bone health, and medicines decide whether it fits. Vitamin K interacts with warfarin. Vitamin K physiology, K2 trial in PMOS

• N-acetylcysteine (NAC): a hospital medicine with a metabolic signal. NAC has been used in hospitals for decades as the antidote to acetaminophen overdose and as a treatment that thins mucus in lung disease. It works by supplying cysteine, the building block the body needs to make glutathione, the main antioxidant inside our cells and the molecule the liver leans on to neutralize toxins. Oxidative stress uses glutathione up, and oxidative stress is part of the insulin-resistance picture in PMOS, which is why NAC was studied here. Trials suggest a modest benefit for fasting glucose, and a 2024 trial found more pregnancies when NAC was added to ovulation-induction medication. It did not test NAC alone or show a live-birth benefit, so fertility use belongs in a plan with the treating clinician. Metabolic evidence and rationale, fertility trial

• Magnesium: more than sleep. Magnesium is a cofactor in hundreds of enzyme reactions, including the ones insulin uses to move glucose into cells, which is why it is studied in insulin resistance. The PMOS-specific evidence is promising and thin: a small triple-blind trial (40 women, two months of magnesium) found lower insulin and insulin resistance and better cholesterol numbers, with no difference in cycle regularity between groups, and a 2026 pooled analysis of 11 mineral-supplement trials (618 women, magnesium among the minerals) found lower fasting glucose, insulin, and insulin resistance without separating magnesium’s share. One widely cited magnesium combination trial was retracted in 2023, so I would not oversell it. I used magnesium bisglycinate, the form bound to the amino acid glycine, because it is gentle on the stomach and well absorbed, for sleep, recovery, muscle cramps, and as part of metabolic support. Magnesium trial, 2026 mineral meta-analysis, 2025 review

Before adding something, agree on its purpose, how you will assess the response, and when to review it. In my practice, three months was always the checkpoint: long enough for cycles, symptoms, and labs to show a direction, short enough that an unhelpful supplement does not stay on the shelf for a year. For an inositol trial, that meant following cycle dates, a glucose measure chosen with your clinician, tolerability, and how you felt. One returning period does not confirm regular ovulation. A vitamin D plan may instead focus on meeting your needs or correcting a confirmed deficiency. Having PMOS alone does not tell you which supplements you need.

What I take, and how. Women asked, so I put my own regimen on my Fullscript dispensary as a plan you can open without an account. It holds the inositol I take, InosiCare, a 40:1 myo- to D-chiro-inositol blend from Ortho Molecular Products that is only dispensed inside a practitioner’s plan, along with vitamin D3 with K2, fish oil, NAC, magnesium bisglycinate, a blood-sugar support formula, and a few things this article does not cover, including a multivitamin and creatine. It shows the amounts I take. Those are my choices for my body, not a prescription for yours. You do not need all of it, or any of it, to begin; if you have a provider or another source for any ingredient, you do not need to buy through me, because the ingredient is what matters, not the label. InosiCare also contains resistant starch and trace minerals, and the inositol research does not automatically validate every claim for a finished combination. I receive a portion of sales through that link, and that has no bearing on anything written here. If you have a clinician, bring the list to her; the three-month check-in applies to every item on it.

Bring your current products to your clinician or pharmacist so the full ingredients, doses, and interactions can be checked. If side effects develop, ask for advice rather than adding another product to manage them. If the cost crowds out food or other care, revisit the plan. You do not need every supplement on this list, and you do not need any of them to begin.

Who helps you put this into practice?

A PCP or OB-GYN may recommend lifestyle changes while managing diagnosis, bleeding, medications, and pregnancy goals. A standard appointment may not allow time to turn that advice into meals, a beginner lifting routine, and repeated troubleshooting.

• A registered dietitian can help with food and your relationship with it. Nourish is one virtual option; check provider fit, coverage, and cost.

• A qualified trainer can teach you to strength train safely.

• A licensed mental health professional can help with persistent anxiety, body-image distress, disordered eating, and patterns that are difficult to change alone. Ask about experience with PMOS and approaches such as cognitive behavioral therapy.

• A licensed functional or integrative clinician may offer longer visits and coordinated follow-up. Ask what is included, how progress is assessed, and what it costs.

You can ask for support at the beginning. If the plan is still difficult to carry out or you are not feeling better, revisit it with the person helping you rather than adding more goals. Ask your current clinician about covered referrals if private care is out of reach. Bring this sentence: “I understand the recommendation. I need help putting it into practice. Who can help me, and what should we follow to know whether it’s working?”

Can this get better?

The answer: yes, and the check-ups stay, whatever your size. Symptoms can improve substantially, and some women no longer meet the same diagnostic features. That may be called remission. The underlying tendency and the need for follow-up can remain.

Come back to the goal at the top of the whiteboard: feel good in your body, and when you don’t, know why. How you feel deserves its own place in the conversation.

At your review, name two or three changes that matter to your daily life. Are you getting through the afternoon with more energy? Sleeping more restfully? Feeling less distressed around food? Recovering better from movement? Then ask whether the routine is helping or adding pressure. Bring those answers alongside the symptoms and clinical measures you and your clinician are following. Feeling better is meaningful, and persistent symptoms still deserve attention even when a lab result looks reassuring.

Hair changes may take months; one returning period does not establish regular ovulation. Keep the missing-period guidance near the beginning of this article in mind: assessment and lining protection should not wait for lifestyle changes to work.

Even when symptoms improve, keep the blood-sugar, cholesterol, and blood-pressure check-ups, whatever your size. As we covered in Part 1, diabetes risk is higher with PMOS at every body size. Heart and blood-vessel disease follows the same pattern. A 2026 study followed 127,517 women with PCOS in Denmark, Finland, and Sweden for about a decade and found heart attacks, strokes, and blood clots about 30 percent more common than in women without the condition. Among women with a BMI under 25 and no diabetes, the figure was about 40 percent. In absolute terms, the Danish figures were about three women per 1,000 each year compared with about two, as the lead author described them. Most women with PMOS will never have one of these events, and the check-ups exist to keep it that way. The point of that number is not fear. It is that these check-ups belong to every woman with PMOS: the guideline says every woman should have her cardiovascular risk assessed, with a cholesterol panel regardless of age or BMI, blood pressure checked yearly, and blood sugar checked at diagnosis and every one to three years after. “But you’re not overweight” is not a reason to skip them. Nordic cardiovascular study, Follow-up guidance

Work, caregiving, fatigue, and cost are real constraints. You did not choose PMOS. A plan that fits your life can help you influence how you live with it.

Leave with one next step

You do not need a complete new routine tonight. Try finishing this sentence:

“My next step is ____, because ____. I will ask ____ for help if ____.”

For the woman struggling with dinner, that could be: “I will keep one easy meal available for busy evenings, because cooking from scratch after work is where my plan falls apart. If I am still struggling to feed myself regularly, I will ask my clinician about a covered dietitian referral.”

Your next step might be an appointment, a question for your prescriber, or support with persistent worry. Asking for help can be the first step; you do not have to earn it by trying harder on your own.

For a daily habit, you might check in after a week to ask whether it fits your life. That is a check on practicality, not a deadline for symptoms or labs to improve. Agree on medical follow-up with your clinician; the reasons to seek help throughout this article take priority.

Know a woman who was told “diet and exercise” and nothing else? She does not need PMOS to use this. Send her this.

Which would help you more next: a deeper PMOS piece on labs, supplements and fertility, or endometriosis?

Leave a comment

Share

Congratulations, we’re healthing.

Lindsay Savage, PA-C

Sources & evidence notes

1. International evidence-based guideline for the assessment and management of PMOS, 2023 recommendations, ASRM-hosted

2. Endocrine Society — Diagnosis and treatment of PCOS clinical practice guideline, 2013 (PMC5399492)

3. Joint advisory on nutrition and muscle health with GLP-1 medications, 2025 (PMC12125019); NIDDK — prescription medications for weight management

4. CDC — Diabetes meal planning; FDA — Honey, maple syrup and added sugars; British Dietetic Association — PMOS and diet, developed with dietitians Claire Pettitt and Dr Linia Patel (page marked under review)

5. Physiology review of muscle glucose uptake and exercise, 2025 (PubMed 40173020)

6. DiPietro et al. — Post-meal walking and glucose in older adults, 2013 (PubMed 23761134)

7. See 28 (sleep restriction trial)

8. NIH ODS — Vitamin D; omega-3 meta-analysis in PCOS, 2023 (PMC10022207); magnesium systematic review, 2025 (PMC11857371); NCCIH — Berberine

9. Moran et al. — Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in PCOS: systematic review and meta-analysis, Human Reproduction Update, 2010 (DOI)

10. Benson et al. — Disturbed stress responses in women with PCOS, Psychoneuroendocrinology, 2009 (DOI)

11. Mezzullo et al. — Salivary cortisol and cortisone responses to psychological stress in young women with different hyperandrogenic states, Psychoneuroendocrinology, 2018 (DOI)

12. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS, Journal of Endocrinology, 2025 (PubMed)

13. Wang et al. — Mindfulness-integrated CBT plus lifestyle support in PCOS, randomized trial, 2025 (DOI); Li et al. — Mindfulness-based interventions in PCOS, systematic review, 2026 (PubMed)

14. NHS — Breathing exercises for stress; Judson Brewer/Brown University — Recognizing anxiety habit loops; Centre for Clinical Interventions — Perfectionism resources; NCCIH — Relaxation techniques

15. Sun et al. — Probiotic and synbiotic supplementation in PCOS, systematic review, 2026 (DOI); Gorzko et al. — Secondary metabolic analysis of a probiotic trial in PCOS, 2026 (PubMed)

16. NIDDK — IBS diet and treatment; Porcari et al. — International consensus statement on microbiome testing in clinical practice, 2025 (PubMed)

17. Perera et al. — Questionable evidence for berberine in PMOS: an integrity-based reappraisal, October 2026 (Full text); NCCIH — Berberine and weight loss: what you need to know

18. Fitz et al. — Inositol systematic review informing the international guideline, 2024 (Review); Nordio et al. — Small comparison of inositol ratios, 2019 (PubMed)

19. Vitamin D and metabolic measures in PCOS, randomized trial, 2024 (PubMed); vitamin D before IVF in women with PCOS, multicentre randomized trial, BMJ, 2026 (Trial)

20. Tarkesh et al. — Vitamin K2 (MK-7) in PCOS, randomized trial, 2020 (Trial); NIH ODS — Vitamin K and omega-3 fatty acids

21. Liu et al. — NAC and metabolic measures in PCOS, systematic review, 2023 (Review); Fang et al. — NAC added to ovulation-induction treatment, 2024 (Trial)

22. Zhang et al. — Berberine in type 2 diabetes, PREMOTE randomized trial, 2020 (Trial)

23. Greff et al. — Inositol is an effective and safe treatment in PCOS: systematic review and meta-analysis of 26 randomized controlled trials (1,691 women), Reproductive Biology and Endocrinology, 2023 (DOI)

24. Glintborg et al. — Increased prospective cardiovascular disease risk in 127,517 Nordic women with polycystic ovary syndrome: a national cohort study, European Journal of Endocrinology, 2026 (DOI)

25. Huang and Zhang — Meta-analysis of omega-3 polyunsaturated fatty acids in PCOS, 7 studies, 574 women, Medicine, 2023 (DOI)

26. Shahmoradi et al. — Magnesium supplementation, insulin resistance and metabolic profiles in PCOS, triple-blind randomized trial of 40 women, Biological Trace Element Research, 2023 (DOI); Ye et al. — Mineral supplements and insulin resistance in PCOS, meta-analysis of 11 randomized trials, BMC Endocrine Disorders, 2026 (DOI); Maktabi et al. 2018 magnesium-zinc-calcium-vitamin D trial, retracted 2023, not used.

27. Jakubowicz et al. — Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with PCOS, randomized trial of 60 women, Clinical Science, 2013 (DOI); American Heart Association — Added sugars; FDA — Added sugars on the Nutrition Facts label

28. Zuraikat et al. — Chronic insufficient sleep in women impairs insulin sensitivity independent of adiposity changes, randomized crossover trial of 38 women, Diabetes Care, 2024 (DOI); CDC — About sleep; Qaseem et al. — Management of chronic insomnia disorder in adults, American College of Physicians guideline, 2016 (DOI)

Evidence notes: guideline recommendations on lifestyle, metformin and inositol rest on low-certainty evidence and expert consensus, labeled where discussed. The stress studies are small and show altered stress reactivity, not cause. Psychological-intervention findings are mixed; the brief examples here are starting practices, not the full programs tested in trials. Gut-intervention studies do not establish a universal cause or a treatment that works for everyone; changes in laboratory measurements do not establish long-term clinical benefit. The post-meal walking study was in older adults, not women with PMOS. The links between insulin, androgens, and fat tissue do not establish a single cause of weight gain for every woman. The Nordic cardiovascular study is observational and registry-based; it adjusted for obesity and education, but body-mass data were available only for women who had been pregnant and lifestyle factors such as smoking were not recorded, so the figures describe association, not a measured cause, and they are not a prediction for any one woman. My clinical observations and preferences are my account, not efficacy evidence. Improvement during a combined plan cannot establish which part caused it; my recollections are not a measured treatment-success rate. The omega-3 meta-analysis showed marked variation between trials; the magnesium trial was small and short, and the 2026 mineral analysis pooled several minerals. The meal-timing trial was small, 90 days, in lean women, and front-loaded breakfast rather than lunch; my 20-gram sugar target, lunch-as-largest-meal pattern and three-hour dinner window are my clinical practice, not guideline recommendations. My vitamin D target range and three-month recheck are my clinical practice, not a guideline; the NIH upper limit is cited for safety. Commercial note: the Fullscript link goes to a plan on my practitioner dispensary from which I receive a portion of sales; it lists what I personally take and is not individualized advice; the education in this article is complete without any purchase, and every ingredient can be obtained from any provider or source.

This article is for education, not individualized medical advice. Your clinician can recommend care for your circumstances.

Reading in your inbox? Open the full article for every graphic and source.

“You’ll never guess what the doctor I had before you told me.”

I heard some version of that sentence often in clinic. When the woman saying it had PCOS, a story about being brushed off usually followed.

Then came the rest. They did not know whether they could still get pregnant. They despised their chin hairs. They were working out and not losing weight. They had tried every diet and no longer knew what was worth buying or investing in. They told me how exhausting all of it was. And many of them did not want to go on the pill, because they wanted to do things as naturally as possible.

Their stories match what researchers have found. In one survey of nearly 1,400 women recruited through PCOS support groups, about a third waited more than two years for a diagnosis, almost half saw three or more health professionals first, and fewer than one in six were satisfied with the information they were given. Diagnosis survey

I don’t think that happens because clinicians don’t care. Most of the clinicians I know are doing their best inside a visit that is too short for a condition that takes time to explain.

About 1 in 8 women has it. If it is not you, it is very likely someone you know, and she may never have mentioned it. I wrote this for both of you. Prevalence

You can bring your acne to one appointment, your missing periods to another, and your blood-sugar results to a third, and still leave without understanding how they connect. “Your hormones are imbalanced” names a problem without explaining it.

Why would a hormone that handles your breakfast have a say in your cycle? How can a lab come back normal when something is clearly wrong? And if birth control makes your bleeding predictable, what has actually changed?

Once you understand the connections, the treatment choices start to make sense.

At the end of Birth Control Part 1, I said I would go deeper into what hormonal birth control can help with in this condition, what it cannot do by itself, and what else I would want on the whiteboard. This is that article.

This is Part 1 of 2. Here we cover what is happening in your body, why I didn’t start with the pill, and what birth control does and does not change. Part 2, next Thursday, is the plan that is in your hands: weight, meals, muscle, sleep, supplements, medication, and who helps you do it.

THE SHORT VERSION

• PMOS is the new name for PCOS. It is the same condition. The old name pointed attention at ovarian cysts, which you do not need to have for diagnosis.

• Your symptoms can be connected. Insulin, the hormone that helps manage blood sugar, also acts on the ovaries. That is one way periods, skin, hair, and blood sugar end up in the same condition.

• The whiteboard has one line at the top and four jobs under it. The line: feel good in your body, and when you don’t, know why. The jobs: help symptoms, support ovulation when you want to get pregnant, protect the uterine lining, and look after blood sugar, cholesterol, and blood pressure.

• The pill cannot do all of those jobs. A scheduled bleed on the pill does not show that your own ovulation is regular or that your metabolic health has changed.

• Normal labs do not cancel a real symptom. Insulin is not the only thing that turns androgen production up, and chin hair and acne count as evidence.

• You did not cause this, and more of the treatment is in your hands than most women are told. Understanding it is the first step; the plan is Part 2.

Why did PCOS get a new name?

The answer: the old name pointed attention at ovarian cysts, and cysts were never required for the diagnosis.

For decades the condition was called polycystic ovary syndrome. In May 2026, after a 14-year international effort that gathered more than 22,000 survey responses, it was renamed polyendocrine metabolic ovarian syndrome, or PMOS. Endocrine Society announcement, ASRM explainer

The new name works as a summary:

• Polyendocrine: more than one hormone system is involved.

• Metabolic: how your body handles fuel is part of the condition.

• Ovarian: ovulation and the hormones your ovaries make are part of it too.

• Syndrome: a recognizable pattern of features. You can have the pattern without every feature, and two women with the same diagnosis can have different needs.

How it is diagnosed: in adults, clinicians generally look for two of three features after excluding other causes: irregular ovulation, clinical signs or blood-test evidence of excess androgens, and a characteristic pattern of multiple small ovarian follicles on ultrasound. Some women have all three features, and some only have two. The first two can establish the diagnosis without any ultrasound at all, so a normal ultrasound by itself does not rule PMOS out.

You will still see PCOS on charts and in most research, but I’ll use PMOS from here.

Of note: Adolescents need a different assessment, and thyroid conditions, under-fueling, and other problems can also interrupt periods, so a missing period alone does not tell us the cause. Severe period pain, pain with sex, or bowel symptoms that follow the cycle deserve their own assessment; endometriosis can coexist with PMOS, and one diagnosis should not close the conversation. Diagnostic guidance

What does metabolism have to do with my period?

The answer: more than most of us were told. The same hormones that manage your fuel hand out jobs in your cycle, which is where the next section goes.

Metabolism is the work your body does to turn food into usable energy and building materials, then use or store those resources.

Think of food as a delivery of fuel to your body. Some of that fuel powers what you’re currently doing and some of that fuel is stored for later. It keeps your brain working, your heart beating, and your body functioning, even while you sleep. Your metabolism keeps you alive. Metabolism explained, Using and storing fuel

Metabolic health is about how well your body manages the jobs of creating, using, and storing energy. Hormones sent out by different organs are the managers of metabolism and are dishing out jobs. Think of them as messages between different parts of your body. For example: Your organ, the pancreas, sends the hormone, insulin, to help balance blood sugar. So one hormone (insulin), produced by one organ (pancreas), gives other organs (muscle) a job.

So how are multiple symptoms connected?

How can acne, chin hair, thinning hair, and missing periods be one condition?

The answer: the same hormone message lands differently in different tissues.

In PMOS, the body may need extra insulin from the pancreas to manage blood sugar. Insulin also has a job at the ovaries, and the same insulin that is helping balance your blood sugar can encourage the ovaries to make more testosterone, affecting skin, hair, and egg release. A hormone involved in handling your breakfast can also influence the hormones involved in your cycle. That is one reason chin hair, missing periods, and blood-sugar concerns can belong to the same syndrome. Insulin and ovarian pathways

We need androgens as women. The trouble is that insulin is one signal sent to every tissue at once. Think of a house with one thermostat. One bedroom has bad insulation and never warms up, so you turn the heat up for the whole house, and the rooms that were already comfortable get too hot. In PMOS, muscle is the room that stopped responding well, the pancreas is the hand on the thermostat, and the ovaries are a room that never stopped responding. They get the extra insulin and answer the only way they know how: by making more androgens, the group of hormones that includes testosterone. Androgens can also make insulin work less effectively, so these changes can keep one another going, and women can enter this pattern at different points. Connected symptoms give us several places to help. Research on these connections

Skin and hair: the same message can have different effects. Androgens, including testosterone, can increase skin oil, contributing to acne, and encourage thicker, darker facial hair. On a scalp that is sensitive to these hormones, hairs can instead become thinner. More chin hair and less scalp hair can therefore be connected.

Ovaries: starting the process does not guarantee egg release. A follicle is a small sac containing an egg. It needs to mature and respond to coordinated hormone messages before releasing that egg. Excess androgens and changes in the messages between brain (pituitary gland) and ovaries can interrupt the sequence. Ovarian research, hormone-feedback study

An ultrasound may show many small follicles, with more starting the process than completing it. These differ from large ovarian cysts, and PMOS does not require this ultrasound appearance.

Uterus: no ovulation, no progesterone rise. After ovulation, the ovary makes progesterone, the hormone that tells the lining to stop growing and get ready for a pregnancy. Without ovulation, estrogen keeps telling the lining to grow and nothing tells it to stop. Over months, the lining can become too thick and shed unpredictably, which helps explain long stretches without bleeding followed by a heavy bleed. Over years, a lining that keeps growing without that signal raises the risk of precancerous change and endometrial cancer. The overall chance is low, which is why protecting the lining is a job on the whiteboard rather than a reason to panic. Lining risk in the guideline

One common pathway looks like this:

More insulin needed to manage blood sugar → more ovarian androgen production → less reliable egg release → fewer progesterone rises → less predictable bleeding.

Want more explanations like this? Subscribe free for one women’s health article every Thursday.

Subscribe now

How can my blood sugar be normal if insulin plays such a large role?

The answer: a blood-sugar test measures glucose, not how much insulin it took to keep glucose in range, and in PMOS that insulin also acts on the ovaries.

Well-established: glucose is sugar in the blood that the body uses for energy. Insulin, made by the pancreas, helps manage that fuel, including helping muscle take up glucose.

With insulin resistance, some tissues respond less effectively. The pancreas compensates by releasing more insulin, and that extra effort can keep blood sugar in range for a time.

And the ovaries, as you saw above, keep listening to that extra effort. The same hormone can be less effective at one job and keep stimulating another. That is how a problem with fuel handling becomes a problem with skin, hair, and ovulation.

This is a common pathway, not the starting point for every woman. How common? In the most rigorous studies, which measure insulin action directly rather than estimating it from a blood draw, women with PCOS responded to insulin about 27% less effectively than women without it, at the same weight. Extra weight lowered the response further, but the difference was there without it. Insulin and ovarian pathways, human ovarian-cell research, clamp-study meta-analysis

What if my insulin came back normal too?

The answer: a normal fasting insulin does not rule insulin out, and insulin is not the only thing that turns androgen production up.

Three reasons chin hair and acne can sit next to a normal lab report:

1. The test is a snapshot from the quietest moment of the day. A fasting insulin is drawn after hours without food, when insulin is at its lowest. In this pattern the extra insulin shows up after meals, and a fasting draw does not always see it.

2. Insulin is one volume knob of several. Picture androgen production as a speaker with several knobs. Insulin is one. LH, a hormone message from the brain, is another, and in PMOS that message can come more often. The ovary’s androgen-making cells can also carry a built-in tendency to make more: in laboratory studies, cells taken from women with PCOS kept producing extra androgens outside the body. The adrenal glands make androgens too. Your insulin knob can sit at normal while another is turned up. Hormone-feedback study, ovarian-cell research, adrenal androgens in the guideline

3. The symptom is made at the follicle, not in the test tube. Skin and hair follicles have their own sensitivity and convert testosterone into a stronger form locally, so two women with the same blood level can have different chins. The testosterone test has a blind spot of its own: some testosterone travels attached to a carrier protein, SHBG, which keeps it from acting, and fewer carriers mean more unattached, or “free,” testosterone even when the total testosterone looks normal. Hirsutism guideline

What this tells you: a symptom you can see counts as evidence. The international guideline says unwanted coarse hair on its own should be treated as a sign of excess androgen activity in adults, even without a blood test to confirm it.

Why isn’t insulin tested routinely, then? A reference-standard research test for insulin resistance, called a clamp, involves hours on an IV while a team drips in insulin and glucose and measures how your body responds. It is not practical for routine visits, so simpler estimates are sometimes used: a fasting insulin, or a score calculated from fasting insulin and fasting glucose. When researchers ran the real test and the shortcuts on the same 59 women with PCOS, the two did not line up. A woman could look fine on the shortcut and be insulin resistant on the real test, or the reverse. That is why the international guideline calls the clinic tests “of limited clinical relevance” and leaves them out of routine care; it already treats insulin resistance as part of how PMOS works and recommends daily care for every woman with it, whatever the number says. Guideline on insulin and glucose testing, HOMA and QUICKI against the clamp in PCOS

My clinical perspective: I still checked fasting insulin, and I found it useful for following a woman’s own trend, measured the same way over time, alongside how she felt. I understand the reasoning behind the guideline, and I still think those numbers tell us something. What a single value cannot do is diagnose PMOS or rule insulin out.

So how do we treat it?

PMOS involves both hormone signaling and metabolic health, and the mix differs from woman to woman. For one woman the loudest part is metabolic: her body needs extra insulin, and over time her blood sugar or cholesterol can start to drift. For another it is the ovulation and testosterone side, with irregular cycles, acne, or chin hair, while her standard blood-sugar results look normal. Many women have both.

Still being worked out: which part comes first. Unfortunately, researchers have not settled it, and it may not be the same for every woman. That is why two women with the same diagnosis can need different treatment plans, and why a plan aimed at only one feature can leave the rest unattended. Research on these connections

So here is my treatment whiteboard for PMOS.

At the top, before any job: the point of all of this is for you to feel good in your body, and when you don’t, to know why. The point is to live a full life, not just survive it.

Under it, four jobs:

1. Symptom control: Help the symptoms you can see and feel: the acne, the hair, the fatigue, the bleeding you can’t predict.

2. Ovulation: Support ovulation, especially if you want to get pregnant.

3. Reduce cancer risk: Protect the uterine lining.

4. Lower the long-term risks: Look after blood sugar, cholesterol, and blood pressure, the job that is easiest to forget because you cannot always feel it.

Why does ovulation matter if I’m not trying to get pregnant?

The answer: two of the four jobs depend on it. Releasing an egg is also what starts your body’s usual progesterone rise, and your uterine lining depends on that rise.

Well-established: your ovaries contain eggs and make hormones. Your uterus grows the inner lining that sheds during a period.

In a typical cycle, hormones from the brain help small egg-containing structures called follicles develop. One usually becomes ready to release an egg. That release is ovulation.

Before ovulation, estrogen helps the uterine lining grow. Afterward, the part of the follicle left behind becomes a temporary source of progesterone, which changes the lining from growing to preparing for a possible pregnancy. If pregnancy does not occur, hormone levels fall and a period follows. Your period is the lining letting go when progesterone falls. No rise, no fall, no true period.

Ovulation does two jobs: it releases an egg and starts the usual progesterone rise. When egg release does not happen, that rise is missing, and bleeding may be absent, delayed, or unpredictable. You can still bleed without ovulating, but that bleeding is the lining giving way, not a true period, and the difference matters when we get to the birth control pill.

Cycle and bleeding explanation. For the anatomy refresher, see Your body, explained.

Reading the graphic: Start with the progesterone row: no ovulation means no usual progesterone rise. The other rows add detail. These are illustrative patterns, not measured lab results, and PMOS can include cycles with ovulation too. Cycle physiology, hormone-pattern research

Why do some clinicians start with the pill?

The answer: because for two of the four jobs it is a sensible first move. The international guideline says the combined pill could be recommended for irregular cycles and unwanted hair in adults, and could be used over metformin for those symptoms. It has decades of use behind it, even though the research specifically in PMOS is thinner than you would expect, and skin and bleeding usually respond within a few months; hair takes longer. That is a reasonable choice, not a lazy one. It was not designed for job 4, and it cannot tell you whether your own ovulation has recovered. Guideline on the combined pill

Well-established: the combined pill contains estrogen and a progestin, a medication with progesterone-like effects. It suppresses the brain’s stimulation of the ovaries, prevents ovulation, and reduces ovarian androgen production. Its estrogen also increases the carrier protein SHBG, leaving less androgen free to act. That explains its usefulness for acne and excess hair. The patch and ring work on similar principles, although most PMOS research concerns pills. Mechanism

The progestin helps prevent excessive growth of the uterine lining. Bleeding during a hormone break is withdrawal bleeding: a response to reduced medication hormones.

So, if ovulation matters, why deliberately stop it with the pill?

Without ovulation, the lining gets estrogen’s grow signal without progesterone’s stop signal. With a combined pill, ovulation is paused on purpose while the medication supplies that stop signal. Those are different hormonal situations, and the pill is not a reset button: an “ovarian rest” that cures PMOS has not been demonstrated.

You can relieve symptoms now and work on longer-term health at the same time.

A hormonal IUD is doing a different job

A 52-mg levonorgestrel IUD, such as Mirena, acts mainly in the uterus, thinning the lining and thickening cervical mucus. Some hormone reaches the bloodstream, but ovulation often continues if you were already regularly ovulating. It can improve bleeding and protect the lining; but it does not provide the combined pill’s established treatment for androgen symptoms. With this IUD there may be very little lining to shed, which is different from no bleeding after months without ovulation. The calendar can look the same while the uterus is experiencing something different. Other methods have other jobs; Birth Control Part 2 compares them. Mirena label

The graphic below is meant to help you visualize how two of the most common hormonal birth control methods affect you if you have PMOS.

Reading the comparison: Your own progesterone production and a medication’s progestin effects are different. A change in bleeding alone does not show whether ovulation or metabolic health improved. This compares a combined pill with a 52-mg levonorgestrel hormonal IUD; other methods differ. Pill prescribing information, Mirena prescribing information

Why didn’t I start with the pill?

The answer: because of what the pill does and does not do on that whiteboard.

• Job 1, symptoms: the combined pill can help acne, unwanted hair, and unpredictable bleeding. Skin and hair can also be treated directly.

• Job 2, ovulation when you want to get pregnant: the pill pauses ovulation while you take it. Fertility care exists for this job.

• Job 3, the uterine lining: the pill’s progestin helps protect it. A hormonal IUD or periodic progesterone can do this job too.

• Job 4, blood sugar, cholesterol, and blood pressure: the pill does not help with these, and over the years this is the job that matters most. A large Danish study found about four times the rate of type 2 diabetes in women with PCOS overall, compared with women without it. Individual risk varies, and screening matters at every body size. Most women with PMOS do not also have diabetes at the time of diagnosis. However, because of the increased risk, it’s important to keep checking your blood sugar: the guideline says every one to three years, and I lean toward yearly. Diabetes risk meta-analysis, Danish registry study, screening guidance

• The line at the top, how you feel: for some women the pill does make them feel better, and for some it does not. Either answer belongs in the plan.

My clinical approach: I did not start patients on birth control as my treatment approach when I diagnosed PMOS. I wanted care to address both the hormone symptoms and how the body was handling fuel. A more predictable bleed could help a woman’s daily life while her response to insulin still needed attention. So I started with the jobs the pill was not designed to do: in clinic, I connected symptoms and labs with meals, movement, sleep, recovery, deficiencies, and daily circumstances, then reassessed the response. That time and follow-through are what I value in functional and integrative care.

Clinical observation: I saw symptoms improve, periods return, and pregnancies happen. Several things changed at once in those plans, so I can’t hand the credit to any one of them.

If a patient chose the pill for contraception or symptom relief, I supported that decision and the rest of her plan continued alongside it. What I wanted was a plan that fit the woman in front of me and that she could carry out confidently.

Many of my patients wanted to do this as naturally as possible. That is a legitimate preference, and there is a real plan for it; Part 2 is that plan. It still involves a clinician for a few things: confirming the diagnosis, protecting the uterine lining if periods stay away, and following blood sugar, cholesterol, and blood pressure over time.

You can treat acne and unwanted hair directly, too

If you decline the pill, you still have options for symptom relief alongside metabolic care. A clinician can help choose acne treatments applied to the skin, such as azelaic acid, based on your skin and pregnancy plans. For unwanted facial hair, laser hair reduction may help when a qualified provider selects the device and settings for your skin tone and hair color; PMOS may require more sessions. Anti-androgen medication such as spironolactone is another option a clinician may raise; it requires reliable contraception because it can affect a male fetus. None of these require you to wait until your labs or cycles improve. AAD acne guidance, hair-reduction and anti-androgen guidance

The same guideline tells clinicians to treat unwanted hair as important however minor it looks to them. If it bothers you, it counts.

If you want to come off birth control

Plan it with your clinician: contraception if pregnancy is not wanted, and follow-up of your own cycles, since ovulation can return before the first period. Stopping removes the device or pill’s effects; ovulation problems or androgen symptoms may still need treatment afterward, and continuing an appropriate method is also a valid choice. Contraception guidance

Off hormonal treatment and roughly three months without a period? Take a pregnancy test if pregnancy is possible and arrange assessment. Lining protection should not wait for nutrition changes or supplements to work. Care guidance

Can I still get pregnant?

The answer: often, yes, naturally or with help.

If you have been afraid you cannot, here is what the international guideline tells clinicians to say: women with PMOS should be reassured that pregnancy can often be achieved, naturally or with assistance. If you want to get pregnant and ovulation is irregular, seek help while you work on the rest of the whiteboard. You do not have to perfect your lifestyle first. Fertility care may include oral medication such as letrozole; it does not automatically mean IVF. Fertility guidance, letrozole trial

Two practical notes. Irregular cycles do not reliably prevent pregnancy, so if you do not want to be pregnant you still need a plan. And when you do, the guideline recommends a blood-pressure check and a glucose tolerance test before trying, because PMOS raises the risk of blood-pressure and blood-sugar problems in pregnancy; knowing early is what lets you and your clinician plan for it.

Subscribe now

Did I cause this?

The answer: no.

There is no single proven starting cause for every woman. An inherited tendency can affect both ovarian hormones and how the body handles fuel. Symptoms often come into view around puberty; diagnosis may happen much later. Stopping birth control can reveal symptoms that were less visible while taking it. Genetics, onset and possible causes

Sleep, activity, other conditions, and body fat can affect how strongly the pattern shows up. PMOS can also make weight management harder, and women in smaller bodies can have it. Part 2 takes on weight directly.

Being ambitious or a perfectionist is not an established cause of PMOS, and I am not going to hand you one more thing to blame yourself for. Stress and fear do shape how a woman sleeps, eats, trains, and recovers, which is why the nervous system gets its own place in Part 2.

We can ask: What is contributing now, and what can we change? We do not need to go back in time to help you.

If this is not your diagnosis

You almost certainly know someone living with it. Now you know what she is managing: a condition that can reach her cycle, her skin and hair, her mood, and her long-term health, that she did not cause, and that may have taken years to get named.

A few things that help:

• Believe her. Many of the women I saw had been brushed off before they reached me.

• Skip the weight advice. Weight management can be harder with PMOS, and many women with it report weight stigma, including in healthcare.

• Don’t assume anything about her fertility. Pregnancy is often possible, and the subject is hers to raise.

• Let her choose her plan. The pill, metformin, daily routines, or a combination can all be reasonable choices.

Know a woman who was handed the pill without the explanation? Send her this.

Next Thursday, Part 2: the plan that is in your hands. We’ll cover why weight is harder with PMOS and what actually helps, where metformin helps, what it cannot do alone, and why the daily foundations still matter. Then we’ll get practical about the plate, the muscle, the sleep, the few supplements with a purpose, and who helps you do it.

Which connection was new to you: insulin and the ovaries, a scheduled bleed not proving ovulation, or a normal lab next to a real symptom?

Leave a comment

Share

Congratulations, we’re healthing.

Lindsay Savage, PA-C

Sources & evidence notes

1. Endocrine Society — Polyendocrine Metabolic Ovarian Syndrome: new name announcement, May 12, 2026

2. ASRM — PCOS is now PMOS: understanding the name change, May 27, 2026

3. Gibson-Helm et al. — Delayed diagnosis and a lack of information associated with dissatisfaction in women with PCOS, Journal of Clinical Endocrinology & Metabolism, 2017 (DOI)

4. International evidence-based guideline for the assessment and management of PMOS, 2023 recommendations, ASRM-hosted

5. WHO — Endometriosis fact sheet

6. MedlinePlus — Metabolism; Metabolic disorders

7. Reappraising insulin resistance and hyperinsulinemia in PCOS, 2025 review (PMC11906131)

8. Cassar et al. — Insulin resistance in PCOS: meta-analysis of euglycaemic-hyperinsulinaemic clamp studies, Human Reproduction, 2016 (DOI)

9. Diamanti-Kandarakis et al. — Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with PCOS, Journal of Clinical Endocrinology & Metabolism, 2004 (DOI)

10. Human ovarian theca-cell research on insulin and androgen production (PubMed 9626131)

11. Clinical review of cycle and bleeding patterns, 2024 (PMC10833093)

12. Endotext — Physiology of the normal menstrual cycle (NBK279054)

13. Jarrett et al. — Ultrasound characterization of disordered antral follicle development in women with PCOS, Journal of Clinical Endocrinology & Metabolism, 2020 (PMC7473602; DOI)

14. Endocrine Society — Evaluation and treatment of hirsutism in premenopausal women, 2018 (DOI)

15. Ovarian theca-cell research (PubMed 15514033); hormonal-feedback study (PubMed 11095431)

16. Multi-ancestry genetic study of PCOS, 2025 (PubMed 41188533); NICHD — PCOS causes

17. Moran et al. — Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in PCOS: systematic review and meta-analysis, Human Reproduction Update, 2010 (DOI)

18. Rubin et al. — Development and risk factors of type 2 diabetes in a nationwide population of women with PCOS, Journal of Clinical Endocrinology & Metabolism, 2017 (DOI)

19. AAD — Acne guideline

20. DailyMed — combined pill prescribing information; Mirena prescribing information

21. FSRH — Combined hormonal contraception guideline, amended October 2023

22. Legro et al. — Letrozole versus clomiphene for infertility in PCOS, New England Journal of Medicine, 2014

Evidence notes: cycle and insulin physiology are well-established. The “four times” figure describes the overall rate in an 11-year Danish registry study, where diabetes was diagnosed in about 8 of every 1,000 women with PCOS per year versus 2 of every 1,000 without it. It is not a lifetime risk or a fixed multiplier for every weight group. The clamp figure is an average difference in insulin sensitivity. The diagnosis survey was recruited through support groups and describes experience, not prevalence. My clinical observations and preferences are my account, not efficacy evidence.

This article is for education, not individualized medical advice. Your clinician can recommend care for your circumstances.

Part 1 was about what the different methods are actually doing. Part 2 is about the questions women ask after that.

Will it make me gain weight? Change my mood? Lower my sex drive? Raise my cancer risk? Make it harder to get pregnant later? And what am I supposed to do with the posts saying the pill drains your nutrients, affects your thyroid or damages your gut, or that the copper IUD is “inflammatory”?

For this one, I finally had the time to go much deeper into the research than I ever could during a clinic day. I did not come away thinking birth control is secretly terrible for every woman, and I did not come away thinking women’s concerns should be dismissed because a study average looked reassuring.

The useful answer is more specific.

If I were still in clinic, this is the article I would want to hand you before asking you to choose, so that you understand what you are actually choosing.

Two terms first: a combined method contains estrogen plus a progestin (most pills, the patch and the ring). A progestin-only method has no estrogen (the mini-pill, hormonal IUD, implant and shot).

THE SHORT VERSION

• Weight: most combined pills and patches have not shown a large average effect. The shot is different.

• Mood: the research conflicts. Some women do notice a change, and the most concerning signals show up in teenagers and in the first months.

• Sex drive: combined pills measurably change sex-hormone levels, but that does not reliably predict what happens to desire.

• Clots and stroke: this is mainly an estrogen question. Your health history can matter more than the fact that a method is called “birth control.”

• Cancer: it goes in both directions. Hormonal methods in general, not only the pill, are linked to a slightly higher chance of a breast cancer diagnosis while you use them and for some years after. The combined pill is also linked to a lower risk of ovarian and endometrial cancer.

• Fertility: reversible methods have not been shown to cause lasting infertility. The shot can delay the return of fertility longer than the others.

• Online claims: many contain a real piece of biology or a real study.

Will birth control make me gain weight?

The answer: not all birth control has the same weight story.

Current evidence suggests combined pills and patches do not cause a large average weight gain. A major review of trials did not find one. That is an average, so it cannot predict your exact body.

The shot, also called DMPA, is the method I would separate from that reassurance. Well-established: in a large randomized trial, women given the shot gained about 4.5 pounds more over 12 to 18 months than women given the copper IUD.

What changes the decision: if weight is a major concern for you, ask about the specific method, because “Does birth control cause weight gain?” is too broad to answer. And if your body changes in a way that matters to you after starting something, you are allowed to bring that back into the decision.

Can birth control affect my mood?

The answer: possibly, and the research cannot yet tell us who will notice it.

This is one of the least tidy areas of the research. Short clinical trials, mostly of pills in adult women, have not shown an average worsening of depression scores. The researchers rated that evidence as very uncertain, and the trials were short and left out several methods.

Large real-world studies are more mixed. Some find more depression diagnoses or antidepressant use among pill users, and others do not. The most concerning signals show up in younger users.

Because the outcome is serious, you should also know that researchers have looked at self-harm and suicide attempts. A Danish study found more suicide attempts after starting hormonal birth control, most of all in teenagers and in the first months. A Swedish study found more medically treated self-harm or suicide attempts among teenagers using hormonal birth control. In adults, a smaller association appeared in the grouped non-oral progestin-only category, which included hormonal IUDs and implants. A Finnish study found no increase.

These events were uncommon in every group, and this kind of study cannot prove that birth control caused them.

What changes the decision: under CDC guidance, a history of depression does not rule out any method. It is a reason to tell your prescriber and to watch the first few months after starting or switching most closely, in yourself or in your daughter. If your mood clearly changes, treat that as real information and go back to whoever prescribed your birth control. You do not have to push through it.

If you are having thoughts of suicide, call or text 988 in the U.S., any time.

What about sex drive?

The answer: the hormone change is real. The effect on desire is much less predictable.

Well-established: combined pills raise SHBG, a protein that binds sex hormones in your blood, and lower free testosterone, the unbound portion. What is not established is that every woman will have lower desire because of it.

In a placebo-controlled trial, overall sexual function was similar on the pill and on placebo, but desire, arousal and pleasure scores were somewhat lower on the pill. Other studies find lower desire, no change or improvement. That makes sense, because sex drive is not controlled by one hormone. Pregnancy worry, pain, mood, your relationship, sleep and whether the method is helping your symptoms all matter too.

What changes the decision: if sex drive is important to your quality of life and you notice a meaningful change after starting a method, that counts. You do not need a study to prove that your experience happened.

Want one clear women’s health explanation like this every Thursday?

Subscribe now

The risks that can actually change the decision

Estrogen, blood clots and stroke

The answer: estrogen-containing birth control raises clot risk, and for most healthy young women the absolute risk is still low.

This applies to the combined pill, patch and ring, because all three contain estrogen. One useful number: pill labeling estimates roughly 1 to 5 blood clots per 10,000 women per year among women not using a combined pill and roughly 3 to 9 per 10,000 among women using one. That is a real increase and still an uncommon event. It is also lower than the clot risk during pregnancy and the weeks after birth.

What matters most is whether something in your health history raises that risk further. If you have migraine with aura, meaning neurologic symptoms such as flashing lights, blind spots, numbness or speech changes around a migraine, estrogen-containing methods should not be used because of stroke risk.

High blood pressure (even when treated), smoking at age 35 or older, a previous blood clot or known clotting disorder, and the first weeks after giving birth can change the decision too. So can a BMI of 30 or higher if you are considering the patch (Xulane and Twirla labels).

What changes the decision: “Is the pill safe?” is less useful than “Is estrogen a good fit for my health history?” If it is not, there are estrogen-free options.

Cancer is not a one-direction story

The answer: hormonal birth control does not simply “cause cancer” or “prevent cancer.”

Current evidence suggests hormonal birth control is linked to a small increase in breast cancer diagnoses while you are using it or have recently stopped. In most studies the extra risk fades in the years after stopping. How small the increase is depends on your age, because breast cancer is uncommon in younger women. In a large UK analysis, five years of pill use in the late teens was estimated to mean about 1 extra breast cancer per 10,000 women over the 15 years after starting. For use in the late 30s, the estimate was about 27 per 10,000.

The link is not limited to the combined pill. It has also been seen with progestin-only methods, including the hormonal IUD in large studies from Denmark and Sweden, though an older study did not find it. None of these studies can prove the method caused the cancers.

Now the other direction. Well-established: long-term use of the combined pill is linked to a lower risk of ovarian and endometrial cancer, and that protection lasts for decades after stopping.

Longer pill use is also linked to a modest increase in cervical cancer risk that fades after stopping. HPV is the main cause of cervical cancer, which is why routine cervical-cancer screening remains important.

What changes the decision: cancer risk is one of the clearest reasons not to talk about “birth control” as if it had one universal effect. Which cancer, which method, your age, your history and why you are using the method all matter.

Will this make it harder for me to get pregnant later?

The answer: reversible birth-control methods have not been shown to cause lasting infertility.

In a review of studies, most women became pregnant within a year of stopping contraception. What can differ is how quickly fertility returns. For the pill, ring, patch, implant and IUDs, any delay is generally short, and how many years a woman had used birth control made no difference.

The shot stands out again. Its label reports that among women who became pregnant after stopping, half had conceived by about 10 months after their last injection. That timing matters if you know you want pregnancy soon, and the delay has not been shown to be permanent.

Two more things I want women to understand:

• AMH (a blood test) and antral follicle count (small follicles counted on ultrasound) are used as markers of ovarian reserve. They are not a direct egg count or a prediction of your exact chance of conceiving naturally. Both can read lower during long-term hormonal birth control use and rise again after stopping. A low AMH on birth control does not mean the medication “used up your eggs.”

• No period on a hormonal IUD does not mean your ovaries have shut down. Many users still ovulate.

What changes the decision: if pregnancy in the near future matters to you, ask about return-to-fertility timing before you choose a method. A temporary hormone or bleeding change is not permanent infertility.

Before we get into the claims you keep seeing online

I trained in conventional medicine and went on to practice integrative medicine, and I do not see those as opposing teams. Medicine keeps evolving and new data comes out all the time. I think patients do best when their clinicians keep questioning what we were taught, in any kind of practice, even when that is the harder way to work.

So when clinicians and educators I respect raise concerns about birth control, I want to understand what they are seeing. I want the same from the OB-GYNs and primary care clinicians who prescribe it every day and watch it help their patients. Both perspectives can be informed by real clinical experience and research.

What reaches you online is usually a 60-second podcast clip, an Instagram post or one woman’s personal story. That can raise a very legitimate question. It rarely has room to answer it, and a short office visit often does not either.

That is the gap I want HowToHealth to fill. I read across those perspectives and the research behind them to shape my own view, which is the same thing you are trying to do. All of us can only form an opinion from the information we have.

So bring me the concern, and we can look at what it is based on, what is actually supported, what is still uncertain and, most importantly: does this change the decision for you?

“The pill raises hypothyroidism almost 4x.”

What is real: there is a study behind this claim. A 2021 analysis of U.S. health-survey data found a strong association between reporting more than ten years of pill use and hypothyroidism. It is also well-established that estrogen-containing pills raise thyroid-binding globulin, a protein that carries thyroid hormone in the blood, which can change how some thyroid blood tests look.

Where it goes too far: the survey captured one point in time, so it could not show that the pill came first or caused the thyroid condition. It did not record which pills women had used, and its estimate was very imprecise.

Does it change the decision? I would not use that one study to tell a woman the pill causes hypothyroidism. I would tell someone being treated for a thyroid condition to make sure the person managing it knows when she starts or stops an estrogen-containing pill.

A related claim links MTHFR gene variants, pill-related nutrient depletion and thyroid disease. The gene variants are common, and the extensive research behind this article did not find a study testing that full chain.

“The pill depletes your nutrients.”

What is real: some nutrient blood markers do differ in pill users. Vitamin B6 has the most consistent signal. B12 can read lower without a true deficiency, although a low result still deserves follow-up. The evidence for folate, magnesium, zinc, selenium and CoQ10 is older, smaller or less consistent (one, two, three).

Where it goes too far: a lower blood marker is not automatically a meaningful deficiency. We do not have good evidence for one universal “birth-control depletion syndrome,” or that every woman on the pill needs the same supplement protocol.

Clinical observation: in practice, I cared about nutritional adequacy and sometimes used a multivitamin I had vetted for formulation and quality as a basic safety net when it made sense. I was not telling patients to grab a random multivitamin off the shelf. That is my clinical judgment, not a guideline for every woman on birth control.

Does it change the decision? For me, this is a reason to care about nutrition and to check a suspected deficiency properly. I would not use it alone to tell a woman to avoid the pill.

(Separately, anyone who could become pregnant should get 400 mcg of folic acid a day to reduce the risk of neural-tube defects, whether or not she uses birth control. The prevention evidence is specifically established for folic acid; methylfolate is a separate question that deserves its own article.)

“The pill damages your gut.”

What is real: gut bacteria help process estrogen, so the question is a fair one. Observational studies have also linked pill use with Crohn’s disease, a type of inflammatory bowel disease (one U.S. study, a pooled analysis).

Where it goes too far: direct studies of the gut microbiome, the community of bacteria living in your gut, are limited and mostly reassuring so far. A study of Danish women found no clear difference in gut bacteria between women on the combined pill, women with a hormonal IUD and women using neither. The Crohn’s association deserves more study, but a 2022 review graded that evidence as weak, and it does not prove the pill caused the disease.

Does it change the decision? If you have inflammatory bowel disease or significant gut concerns, bring that history into the conversation. The evidence does not support telling the average woman that the pill damages her gut.

“The copper IUD is inflammatory.”

What is real: this one starts with true biology. Every IUD causes a local inflammatory reaction inside the uterus, copper strengthens it, and that is part of how the copper IUD prevents pregnancy. A randomized study also found changes in vaginal bacteria and local inflammatory markers after copper-IUD placement.

Where it goes too far: local inflammation inside the uterus is not the same as inflammation throughout the body, and whole-body harm has not been shown. Neither has copper toxicity in typical users (one study).

Does it change the decision? The tradeoff I would focus on first is more practical. Copper IUDs can make periods heavier and crampier, especially at first. If your periods are already very heavy or your iron runs low, that may matter far more to your decision than the word “inflammation.”

If this kind of evidence translation is useful, subscribe free for one women’s health article every Thursday.

Subscribe now

Three things I would not want buried in the fine print

1. Your medication list can change the answer

Most common antibiotics do not make birth control fail. Some other medicines do matter, according to CDC guidance and drug labels:

• Rifampin and rifabutin (tuberculosis medicines) and several seizure medicines, including carbamazepine, phenytoin, topiramate and oxcarbazepine, can make pills, the patch and the ring less reliable and may affect the implant. IUDs are not affected.

• St. John’s wort can make some hormonal methods less reliable too.

• Lamotrigine, used for epilepsy and bipolar disorder, runs the other direction. Estrogen-containing pills can lower its levels enough to affect seizure or mood control, and stopping the pill lets them rise again.

• Tirzepatide (Mounjaro, Zepbound) has a label warning for birth control pills: switch to a non-oral method or add a barrier method, such as condoms, for four weeks after starting it and after each dose increase.

What changes the decision: bring your real medication and supplement list into the contraception conversation, and tell each prescriber before you start or stop a method.

2. IUDs and implants have practical tradeoffs too

An IUD insertion can hurt. Pain should be discussed and a pain-management plan made around your preferences, so ask about your options before the day of the procedure.

An IUD can also come partly or fully out of place (expulsion). That happened to about 1 in 20 women over five years in a large U.S. study, more often right after delivery and in women with heavy periods. Much more rarely, it can push into or through the wall of the uterus (perforation).

Pregnancy with an IUD is unlikely, but if it happens you need prompt evaluation for an ectopic pregnancy, meaning a pregnancy growing outside the uterus.

With the arm implant, the biggest practical tradeoff is unpredictable bleeding, the most common reason women have it removed.

These things may not sound as dramatic as a viral hormone claim, but they often decide whether a woman is actually happy with her method.

3. The shot deserves its own conversation

My clinical judgment: after reviewing these methods side by side, the shot is the reversible method I would generally be least likely to suggest unless something about a woman’s situation made its advantages the best fit. That is my interpretation of the evidence, not a guideline saying the shot is a bad method.

It is the method where several tradeoffs collect in one place:

• The clearest weight-gain signal.

• Loss of bone density during use, serious enough to carry an FDA boxed warning. The label advises against more than two years of use unless other options are inadequate, and says the effect on peak bone mass in teens and young adults is unknown. In most studies bone density recovers after stopping, though full recovery after long-term use is less certain.

• The longest delay in return to fertility.

• A blood-clot signal that the CDC flags separately from other progestin-only methods.

• A newer FDA warning about meningioma, a usually noncancerous tumor of the tissue covering the brain and spinal cord, seen mainly with long-term use.

The shot has real advantages too. It contains no estrogen. There is no daily pill to remember, and nothing stays inserted in your uterus or arm. It is private. Some medicines that interfere with the pill are less of a problem with the shot. Periods stop for many users, and one version is FDA-approved for endometriosis pain.

What changes the decision: the useful question is whether the shot’s advantages are worth its particular tradeoffs for you.

So how do you actually choose?

I would not start with “Which birth control is healthiest?” I would start with four questions.

What job do I need this method to do? Prevent pregnancy, make my periods lighter, help pain or acne, or more than one?

Which tradeoffs matter most to me? Avoiding estrogen, avoiding a procedure, predictable bleeding, protecting bone health, wanting pregnancy soon, or not having to remember something every day?

What in my health history changes the answer? Migraine with aura, blood pressure, past blood clots, smoking, heavy periods or low iron, a recent birth, my mental-health history, and every medication and supplement I take.

What would make me reconsider? A meaningful mood change, a change in sex drive, bleeding I cannot live with, weight gain, pain, or simply realizing the method no longer fits what I want.

Every method asks you to accept something, and no method is perfect. The goal is to understand the tradeoffs well enough to choose them on purpose.

If anything here makes you want to stop or switch, line up your next method first. Fertility can return quickly, and pregnancies have occurred within one to two weeks of implant removal.

When to get help

Part 1 has the fuller warning-sign list. Call 911 for sudden trouble breathing, severe chest pain, new weakness on one side, trouble speaking, sudden vision loss or a sudden severe headache unlike your normal headaches. New swelling or pain in one leg needs prompt medical attention.

Call a clinician promptly if you might be pregnant with an IUD in place, have severe pelvic pain after placement or can no longer feel the IUD strings.

If your mood changes seriously, tell someone and contact the person who prescribed your birth control. For thoughts of suicide, call or text 988 in the U.S.

And if a method simply makes you feel worse in a way that matters to you, you are allowed to revisit the decision even when nothing dangerous is happening.

Birth control has a job. I want you to understand exactly what that job is, what it isn’t doing, what the tradeoffs are, and what else deserves attention in your health.

If a podcast clip, a friend or a clinician raises a concern for you, bring that question here. We can take it seriously without automatically being scared of it.

What birth-control question do you still want me to look into next?

Leave a comment

Know a woman choosing a method right now, or a mom helping her daughter choose? Send her this.

Share

Congratulations, we’re healthing.

Lindsay Savage, PA-C

The numbers, for anyone who wants them

Most figures are kept out of the article so they do not compete with the answers. Here they are, with their sources.

• Weight: in a randomized trial of about 7,800 women in four African countries, the shot group gained about 4.5 pounds more than the copper-IUD group over 12 to 18 months, and the group given a levonorgestrel implant (not the one used in the U.S.) about 2 pounds more. The shot’s label reports average gains of 5.4 pounds at one year and 8.1 at two among women who stayed on it, with no comparison group. Of the 49 pill and patch trials in the review, four used a placebo or no-treatment group, so smaller effects are harder to rule out.

• Mood and sex drive: in a placebo-controlled trial of 340 women, those on a combined pill reported lower general well-being than those on placebo, with no significant difference in depression scores, and lower desire, arousal and pleasure scores with similar overall sexual function. Free testosterone fell by about 61% on average across 42 studies of combined pills.

• Breast cancer: the UK estimates are 8 extra cases per 100,000 women when the pill was used for five years at ages 16 to 20, and 265 per 100,000 at ages 35 to 39, counted over 15 years (the five years of use plus the ten after).

• Ovarian, endometrial and cervical cancer: in pooled analyses from high-income countries, ten years of pill use meant about 80 ovarian cancers per 10,000 women by age 75 instead of 120, and about 130 endometrial cancers instead of 230. With ten years of pill use, cervical cancer by age 50 rose from about 38 to 45 per 10,000 and returned to baseline about ten years after stopping. Ovarian protection has not been clearly shown for progestin-only methods, where data are limited.

• Fertility: across 22 studies, about 83% of women were pregnant within 12 months of stopping, with no never-user comparison group. In a study of nearly 18,000 women, the delay was roughly two cycles after an IUD or implant, three after the pill or ring, four after the patch and five to eight after the shot. The shot’s label gives a range of 4 to 31 months to conception. In a study of women 30 to 44 with no history of infertility, low AMH did not predict a lower chance of conceiving.

• The “almost 4x” thyroid figure: an odds ratio of 3.8, with a 95% confidence interval running from 1.4 to 10.5.

• IUDs: in the U.S. study of more than 300,000 placements, perforation occurred in about 6 per 1,000 women over five years (about 3 per 1,000 among women who had not given birth in the previous year) and expulsion in about 5 per 100.

• Implant: about 1 in 9 women in the trials behind its label stopped because of bleeding changes.

• The shot and meningioma: in a large U.S. study, the association was concentrated among women with more than four years of use or who started after age 31.

Sources & evidence notes

Sources last checked October 7, 2026.

1. Gallo et al. — Combination contraceptives: effects on weight. Cochrane Database of Systematic Reviews, 2014

2. Beksinska et al. — Weight change with the shot, copper IUD or levonorgestrel implant: randomized ECHO trial. EClinicalMedicine, 2021

3. de Wit et al. — Hormonal contraceptive use and depressive symptoms: network meta-analysis of randomized trials. BJPsych Open, 2021

4. Kellock et al. — Oral contraceptives and depression symptoms, diagnosis and treatment: meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2026

5. Toffol et al. — Systemic hormonal contraception and risk of depression: Finnish registry study. European Journal of Epidemiology, 2025

6. Aleknaviciute et al. — Hormonal contraception and suicidal behaviour: Swedish nationwide register study. BMJ Open, 2025

7. Skovlund et al. — Hormonal contraception, suicide attempts and suicides: Danish cohort. American Journal of Psychiatry, 2018

8. Toffol et al. — Systemic hormonal contraception and attempted suicide: Finnish nested case-control study. European Journal of Epidemiology, 2024

9. CDC — Summary chart of U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

10. 988 Suicide & Crisis Lifeline

11. Zimmerman et al. — Combined oral contraception and testosterone levels: systematic review and meta-analysis. Human Reproduction Update, 2014

12. Zethraeus et al. — Combined oral contraceptives and sexual function: randomized placebo-controlled trial. Journal of Clinical Endocrinology & Metabolism, 2016

13. Yaz — prescribing information (blood-clot rates)

14. CDC — U.S. Medical Eligibility Criteria for Contraceptive Use, 2024: combined hormonal contraceptives

15. Xulane patch — prescribing information

16. Twirla patch — prescribing information

17. Fitzpatrick et al. — Combined and progestagen-only hormonal contraceptives and breast cancer risk. PLOS Medicine, 2023

18. Mørch et al. — Breast cancer in users of levonorgestrel-releasing intrauterine systems. JAMA, 2024

19. Hadizadeh et al. — Hormonal contraceptive formulations and breast cancer risk. JAMA Oncology, 2025

20. Dinger et al. — Levonorgestrel-releasing and copper IUDs and the risk of breast cancer. Contraception, 2011

21. Collaborative Group on Epidemiological Studies of Ovarian Cancer — Ovarian cancer and oral contraceptives. Lancet, 2008

22. Collaborative Group on Epidemiological Studies on Endometrial Cancer — Endometrial cancer and oral contraceptives. Lancet Oncology, 2015

23. International Collaboration of Epidemiological Studies of Cervical Cancer — Cervical cancer and hormonal contraceptives. Lancet, 2007

24. Girum and Wasie — Return of fertility after discontinuation of contraception: systematic review and meta-analysis. Contraception and Reproductive Medicine, 2018

25. Yland et al. — Pregravid contraceptive use and fecundability: prospective cohort. BMJ, 2020

26. Depo-Provera CI — prescribing information, revised December 2025

27. Amer et al. — Anti-Müllerian hormone in women using hormonal contraception: systematic review. Journal of Women’s Health, 2020

28. Landersoe et al. — Ovarian reserve markers after discontinuing long-term combined pill use. Reproductive BioMedicine Online, 2020

29. Mirena — prescribing information

30. Qiu et al. — Birth control pills and risk of hypothyroidism: cross-sectional NHANES study. BMJ Open, 2021

31. Torre et al. — Effects of oral contraceptives on thyroid function and vice versa. Journal of Endocrinological Investigation, 2020

32. Synthroid (levothyroxine) — prescribing information

33. CDC — MTHFR gene variant and folic acid facts

34. Wilson et al. — Oral contraceptive use: impact on folate, vitamin B6 and vitamin B12 status. Nutrition Reviews, 2011

35. NICE guideline NG239 — Vitamin B12 deficiency in over 16s, recommendation 1.3.8

36. Akinloye et al. — Effects of contraceptives on serum trace elements, calcium and phosphorus. West Indian Medical Journal, 2011

37. Fallah et al. — Effect of contraceptive pill on selenium and zinc status. Contraception, 2009

38. Palan et al. — Hormonal contraception and serum coenzyme Q10, vitamin E and antioxidant activity. Obstetrics and Gynecology International, 2010

39. CDC — Folic acid: sources and recommended intake

40. Khalili et al. — Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut, 2013

41. Ortizo et al. — Oral contraceptives and inflammatory bowel disease: meta-analysis. European Journal of Gastroenterology & Hepatology, 2017

42. Krog et al. — The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle. Human Reproduction, 2022

43. Brabaharan et al. — Hormonal contraceptive use and adverse health outcomes: umbrella review. JAMA Network Open, 2022

44. Ortiz and Croxatto — Copper-T IUD and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception, 2007

45. Brown et al. — Copper IUD, vaginal bacteria and inflammation in a randomized trial. Nature Communications, 2023

46. Imani et al. — Copper and zinc serum levels in women with a copper TCu-380A IUD. European Journal of Contraception & Reproductive Health Care, 2014

47. Paragard — FDA prescribing information

48. Lamictal (lamotrigine) — prescribing information, revised October 2025

49. Mounjaro (tirzepatide) — prescribing information, revised August 2026

50. Zepbound (tirzepatide) — prescribing information, revised August 2026

51. CDC — U.S. Selected Practice Recommendations, 2024: intrauterine contraception

52. Fassett et al. — Risks of uterine perforation and expulsion associated with IUDs (APEX-IUD). Obstetrics & Gynecology, 2023

53. Nexplanon — FDA prescribing information, revised May 2026

54. CDC — U.S. Medical Eligibility Criteria, 2024: progestin-only contraceptives

55. Xiao et al. — Depot medroxyprogesterone acetate and risk of meningioma in the US. JAMA Neurology, 2025

56. depo-subQ provera 104 — prescribing information

57. Zethraeus et al. — A combined oral contraceptive and general well-being: randomized placebo-controlled trial. Fertility and Sterility, 2017

58. Iversen et al. — Contemporary hormonal contraception and ovarian cancer: Danish cohort. BMJ, 2018

59. Steiner et al. — Biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA, 2017

Evidence notes: Label statements and CDC eligibility categories are well-established. Mood, self-harm, breast cancer, Crohn’s disease and hypothyroidism findings come from observational studies, which show associations and cannot prove cause. Cancer figures are estimates from pooled analyses. Blood-marker changes are kept separate from clinical deficiency. A copper IUD should not be used by anyone with Wilson disease, a rare inherited condition in which copper builds up in the body (label). Lindsay’s clinical observations and her judgment about the shot are her account, not efficacy evidence.

This article is for education, not individualized medical advice. Your clinician can recommend care for your circumstances.

Updated October 8, 2026: Revised for clarity, expanded the method explanations, and linked to Part 2.

If your birth control came with a folded paper insert roughly the size of a road map, consider this the version I wish someone had actually sat down and explained.

I started birth control at 14 and came off it at 27. In between I used three different methods: the pill for seven years, the NuvaRing for one and an intrauterine device (IUD) for five. I eventually decided the tradeoffs weren’t worth it for me. That does not mean your answer should be mine. But it is one reason I care so much that women understand what they’re putting in their bodies and what a medication or device is actually being asked to do.

That matters whether you use it to prevent pregnancy, control painful or heavy periods, manage symptoms of PCOS/PMOS (polycystic ovary syndrome, now also called polyendocrine metabolic ovarian syndrome), help with endometriosis-associated pain, improve acne, or some combination of those.

So let’s make this make sense.

THE SHORT VERSION

• “Birth control” is not one medication. The hormones, how a method works and what else it can help with depend on the method.

• The scheduled bleed on a combined pill is a withdrawal bleed. It reflects the pill’s hormone schedule, not proof that your own ovulation is regular.

• Birth control can have real jobs beyond preventing pregnancy. That does not mean every method is approved or equally useful for every one of them.

• Symptom improvement does not prove the condition is gone. Feeling better matters, and other parts of your health may still need attention.

• Know what you are taking and why. The method, your goal and your health history belong in the same conversation.

This is Part 1 of 2. Here, we’re covering what birth control does and why you may have been offered it. Part 2 covers the tradeoffs: weight, mood, sex drive, blood clots, cancer, fertility later and the claims you keep seeing online.

What is the pill actually doing to my hormones?

The answer: the combined pill, the one most people mean by “the pill,” mainly works by stopping ovulation, the release of an egg.

Well-established: combined pills contain estrogen plus a progestin, a manufactured hormone that acts like progesterone. Your cycle normally runs on a feedback loop between your brain and your ovaries. Your brain sends two hormone signals, FSH and LH, that help an egg develop inside a small fluid-filled sac called a follicle, then trigger its release.

The pill turns those signals down, so taken as directed it usually prevents ovulation. It also thickens cervical mucus, the mucus at the opening of the uterus, making it harder for sperm to pass through, and thins the uterine lining. Your ovaries make less of their own estrogen and progesterone while you take it.

The pill’s hormones travel through your bloodstream. Tissues with receptors for them can respond, including the breasts, brain, bones, blood vessels and liver. That reach is how one pill can do more than one job. It is also why side effects can show up in places that seem to have nothing to do with your ovaries.

If the phases of the cycle are fuzzy, Your Body Explained covers them.

Is the bleed on the pill a regular period?

The answer: on a combined pill, the scheduled bleed is a withdrawal bleed, caused by the drop in medication hormones during the hormone-free pills or break, if your schedule includes one. It is not a natural period after your own ovulation.

Some combined pills can be prescribed on extended or continuous schedules, with fewer or no scheduled withdrawal bleeds. The schedule needs to fit your specific pill, so check with your prescriber before changing how you take it.

That applies to bleeding on a prescribed hormonal schedule. Before menopause, going three months without a period when you are not using hormonal birth control, and are not pregnant or breastfeeding, is different and worth a call to your clinician.

What this tells you: if the pill turned unpredictable bleeding into a predictable bleed every month, that can be useful. It does not prove that your own ovulation has become regular. It tells you the medication is controlling the bleeding pattern, and that distinction matters in PCOS/PMOS.

Are the IUD, implant, shot, patch and ring doing the same thing?

The answer: methods that share the name “birth control” can have very different biology.

• Combined pills and vaginal rings contain estrogen plus a progestin and mainly work by stopping ovulation. Formulations, doses and schedules vary.

• The patch delivers estrogen and a progestin through your skin into your bloodstream and mainly works by stopping ovulation. Its usual labeled schedule is a new patch each week for three weeks, followed by one patch-free week.

• Progestin-only pills contain no estrogen. They work through cervical mucus and, depending on the formulation, by suppressing ovulation.

• A hormonal IUD releases a progestin mainly inside the uterus, where it thickens cervical mucus and thins the lining. It does not rely mainly on stopping ovulation. Many users continue to ovulate; this varies by device and time since placement. Some hormone still reaches the bloodstream, so side effects elsewhere are possible.

• The arm implant, Nexplanon, works mainly by suppressing ovulation and thickening cervical mucus. The 2026 FDA label approves it for pregnancy prevention for up to 5 years.

• The shot, DMPA, contains a progestin and prevents pregnancy mainly by suppressing ovulation, with effects on cervical mucus too.

• The copper IUD contains no hormone and does not suppress ovulation. Copper interferes with sperm movement and fertilization.

Synthetic and bioidentical: what do those words actually mean?

The answer: “bioidentical” describes a molecule with the same chemical structure as a hormone your body makes. It does not automatically mean safer.

Well-established: the hormones in birth-control pills are manufactured, and a hormone can be manufactured and bioidentical. Many combined pills contain ethinyl estradiol, an estrogen chemically different from the estradiol your ovaries make. Some use a different estrogen (Natazia, Nextstellis). None of the contraceptive progestins are identical to your own progesterone.

The exact formulation and your medical history still matter. Those combined pills still carry blood-clot warnings.

Want more explanations like this? Subscribe free for one women’s health article every Thursday.

Subscribe now

Why was I offered birth control if I wasn’t asking for contraception?

The answer: hormonal birth control can have real jobs beyond preventing pregnancy.

Depending on the method, those can include lighter or more predictable bleeding, fewer cramps, improving acne or unwanted hair growth, treating heavy menstrual bleeding, managing premenstrual dysphoric disorder (PMDD), a severe form of premenstrual symptoms, and reducing endometriosis-associated pain.

FDA-approved for it, or used off-label?

The contraceptive medicines and devices discussed here are FDA-approved to prevent pregnancy. When one is offered for something else, there is a distinction worth understanding.

FDA-approved for that use: the FDA reviewed that exact product for that exact purpose. For example, certain combined pills are approved for PMDD or moderate acne in people who also want the pill for contraception. Natazia is approved for heavy menstrual bleeding with no underlying disease or structural cause, in women who choose an oral contraceptive.

Off-label: the use is not listed on the product’s label. Professional guidelines may still recommend it. Combined hormonal birth control for endometriosis-associated pain is one example.

Off-label does not automatically mean unsupported, and it does not automatically mean well supported. The useful question is what evidence supports this method for this goal.

PCOS/PMOS: what can the pill help with?

The answer: the pill can have a valid job in PCOS/PMOS, and there are jobs it was not designed to do.

Current evidence suggests the international guideline for PCOS/PMOS leans toward the combined pill over metformin, a medicine that helps regulate blood sugar, when the main goals are irregular cycles or unwanted coarse hair growth.

It leans toward metformin over the pill when the main goal is metabolic health, such as blood sugar or insulin resistance, when the body responds less well to insulin. Both are conditional recommendations based on very-low-certainty evidence, meaning the evidence is limited and the choice should fit the person’s goals and health history.

When PCOS/PMOS leads to long gaps without ovulation, the uterine lining can keep building without the progesterone that normally follows ovulation. Over time that can raise the risk of overgrowth, so protecting the uterine lining can be another reason a clinician uses hormonal treatment.

My clinical approach: I did not start patients on birth control as my treatment approach when I diagnosed PCOS/PMOS. My focus was the broader picture and the things the pill was not designed to address.

If a patient chose hormonal contraception for symptom management or pregnancy prevention, I could support that decision while still paying attention to metabolic health, nutrition, movement, sleep, nutrient status, gut health and the rest of her clinical picture.

Hormonal symptom treatment and care for metabolic health can happen at the same time. Using the pill does not mean the rest of your care should stop.

What changes the decision: which goal is the pill being offered for, and what is the plan for the parts of the condition it does not address?

Endometriosis: does hormonal treatment fix it?

The answer: hormonal treatment can reduce endometriosis pain. That does not mean the disease is gone.

My role with suspected endometriosis was different. I did not diagnose endometriosis. If I was clinically suspicious, I referred the patient to OB-GYN for specialist evaluation.

Current evidence suggests hormone treatment is one option for reducing endometriosis-associated pain. The ESHRE guideline, from the European Society of Human Reproduction and Embryology, includes combined hormonal methods, progestin treatments, hormonal IUDs and the arm implant.

If a patient and her OB-GYN chose a hormonal method, I could then work on the broader health picture with her.

What changes the decision: if a hormonal method is controlling your pain, that is a real result. Symptoms can recur after treatment stops, so the plan should include what happens if pain persists or returns.

What about painful or heavy periods?

The answer: combined hormonal methods can reduce cramps and bleeding, and two hormonal IUDs are also approved for heavy bleeding.

Painful or heavy periods were my reason for starting a combined pill as a teenager.

Well-established: Mirena and Liletta are FDA-approved for heavy menstrual bleeding for up to 5 years in people who choose an IUD for contraception. For contraception itself, they are approved for up to 8 years. Those are different uses with different time limits, and not every hormonal IUD has the heavy-bleeding approval.

If heavy bleeding is why you are taking birth control, the plan should also consider the cause and check for anemia, a shortage of healthy red blood cells or hemoglobin, which carries oxygen. Treatment to reduce bleeding and that assessment can happen at the same time.

Two practical basics before you compare methods

Effectiveness: with typical use, about 7 in 100 combined-pill, patch or ring users become pregnant in the first year, compared with fewer than 1 in 100 with an IUD or implant. Typical use includes the missed doses and timing mistakes that happen in real life.

STIs: none of these methods prevent sexually transmitted infections. Correct, consistent condom use can reduce that risk, but does not eliminate it.

Why does estrogen change the safety conversation?

The answer: estrogen-containing methods raise the risk of a blood clot in a vein, although clots remain uncommon in most healthy women of reproductive age.

Well-established: estrogen affects the liver’s production of proteins involved in clotting. For combined pills, the risk is highest in the first year and after restarting following a break of four weeks or more.

One restriction deserves a clear sentence here: if you have migraine with aura, which can include flashing lights, blind spots, numbness or speech changes around a migraine, estrogen-containing birth control should not be used because of stroke risk.

Estrogen-free methods also differ. Current evidence suggests the shot has a vein-clot risk signal, while findings for hormonal IUDs are generally reassuring for this particular risk.

Part 2 explains the risk numbers, the health-history factors that change the answer, and the shot’s particular tradeoffs.

When should you get help?

Get emergency help for sudden trouble breathing, severe chest pain, sudden vision loss, new trouble speaking, weakness on one side, or a sudden severe headache unlike your usual headaches. Call 911 or your local emergency number.

New unexplained leg swelling or pain, especially on one side, needs prompt medical assessment.

These warning signs matter whether or not you use estrogen. Do not assume new, sudden neurologic symptoms are simply migraine aura.

Start with the method you are actually using

Find its exact name and hormones, then finish this sentence:

“I’m using (method name) to help with (my goal).”

If the answer is several things, list them. If you do not know why it was prescribed, that is a useful place to start.

Now you have the foundation for Part 2: The tradeoffs that actually matter. It covers side effects, longer-term concerns, medication interactions and how to use the information when choosing a method. If you want to stop or switch, make a pregnancy-prevention plan first if you do not want to become pregnant.

After this two-part series, I’m going deeper into PCOS/PMOS and then endometriosis: what hormonal birth control can help with, what it cannot do by itself, and what else I would want on the whiteboard.

Which part do you wish someone had explained before you started birth control: how it works, why it was prescribed, or what the bleeding means?

I’ll use the questions to shape what we explain next.

Leave a comment

Know a woman who was offered birth control and still has questions about what it is doing? Send her this.

Share

Congratulations, we’re healthing.

Lindsay Savage, PA-C

Sources & evidence notes

1. CDC — U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

2. CDC — U.S. Selected Practice Recommendations: Combined Hormonal Contraceptives

3. CDC — Progestin-Only Pills

4. CDC — U.S. Selected Practice Recommendations: Intrauterine Contraception

5. CDC — U.S. Selected Practice Recommendations: Implants

6. ACOG — Combined Hormonal Birth Control: Pill, Patch, and Ring

7. ACOG — Progestin-Only Hormonal Birth Control: Pill and Injection

8. ACOG — Long-Acting Reversible Contraception: IUD and Implant

9. International Evidence-based Guideline for PMOS (formerly PCOS): 2023 recommendations, reissued in 2026 under the new name

10. ESHRE — Endometriosis Guideline

11. FDA — Nexplanon prescribing information, revised May 2026

12. Mirena — full prescribing information

13. Liletta — full prescribing information

14. FDA — Paragard prescribing information

15. Yaz — full prescribing information: contraception, PMDD, acne

16. Natazia — full prescribing information: contraception and heavy menstrual bleeding

17. FDA — Understanding off-label use

18. CDC — Combined hormonal contraceptives: medical eligibility and vascular risks

19. CDC — Progestin-only contraceptives: medical eligibility, including the shot and clot risk

20. Nextstellis — current manufacturer-hosted prescribing information

21. NCBI Bookshelf (StatPearls) — Oral Contraceptive Pills: how the pill lowers FSH and LH and suppresses ovulation

22. NCBI Bookshelf (StatPearls) — Physiology, Menstrual Cycle: the brain–ovary feedback loop

23. Deroo and Korach — Estrogen receptors and human disease, Journal of Clinical Investigation, 2006

24. CDC — Stroke signs and symptoms

25. CDC — Venous thromboembolism (blood clots): signs and symptoms

26. Tepper et al. — Progestin-only contraception and thrombosis: an updated systematic review, published online 2025

27. Yonis et al. — Contemporary hormonal contraception and risk of venous thromboembolism, JAMA, 2025

28. Teede et al. — Recommendations from the 2023 international evidence-based guideline for polycystic ovary syndrome, Human Reproduction, 2023

29. Office on Women’s Health, U.S. Department of Health and Human Services — Period problems

30. Faculty of Sexual and Reproductive Healthcare (UK) — Combined hormonal contraception guideline, amended October 2023

31. Stanczyk et al. — Impact of estrogens on hemostasis, Frontiers in Endocrinology, 2025

32. CDC — Summary chart of U.S. Medical Eligibility Criteria

33. NICE — Heavy menstrual bleeding: assessment and management

34. Depo-Provera CI — prescribing information and mechanism of action

35. Xulane — prescribing information: patch mechanism and schedule

Evidence notes: Basic contraceptive actions and product-label indications are well-established. Clinical guidelines and uncertainty are identified where discussed. My clinical approach and personal choices are my account, not efficacy evidence. The synthetic/bioidentical distinction describes manufacturing and chemical identity, not a safety ranking.

This article is for education, not individualized medical advice. Your clinician can recommend care for your circumstances.

Your body can do something similar with iron. Your stores can run low while your blood count still looks normal. On September 16, the American Society of Hematology (ASH) announced new guidance on when those stores should be considered low.

Here’s what changed, which test to look for, and what to ask next.

The 30-second version

• Ferritin estimates your stored iron. It isn’t included in a CBC, the routine blood count.

• ASH suggests a ferritin level of 30 ng/mL or lower to diagnose iron deficiency in most adults. A cutoff of 50 ng/mL or lower may be appropriate in higher-risk situations, including heavy periods.

• A result needs context. Symptoms, inflammation, pregnancy and ongoing blood loss can change its interpretation.

• Find your result and bring it to your clinician. Don’t start iron supplements on your own.

“My blood work was normal.” Which tests?

Well-established: These tests answer different questions.

• CBC (complete blood count): Measures hemoglobin, the iron-containing protein in red blood cells that carries oxygen. A low hemoglobin level means anemia.

• Iron panel: A group of tests that looks at iron circulating in your blood and how it’s being transported.

• Ferritin: Estimates how much iron you have stored. It isn’t included in a CBC, and not every iron panel includes it, so check which tests were ordered.

Your iron stores can become low while your hemoglobin level remains normal. That’s iron deficiency without anemia. Think of ferritin as a battery check, not a literal percentage. A normal blood count doesn’t tell you whether your iron reserve is low.

Why I care about this

I thought my low energy was just not enough sleep. My mom got me a sweatshirt that said “Nap Queen” because I was always looking for an opportunity to sleep. My friends in high school knew I was sleeping if I wasn’t responding in the group chat.

We thought I was just super busy, but it turned out I had iron-deficiency anemia. My heavy periods, overtraining and nutrition were all part of it.

I went digging through my old medical records because I wanted to show you what this looked like in my own labs, before I started taking iron.

My hemoglobin was marked “normal.” My ferritin was 11 ng/mL, flagged low.

From my records before I started iron. My hemoglobin, 11.8, sat just inside that lab’s range, so it was flagged green. A lab’s reference range isn’t the only cutoff clinicians use, and that flag alone doesn’t rule out anemia. My ferritin, 11, was already flagged low.

I’m grateful my provider ordered ferritin when I told them about my very heavy periods. They looked beyond the blood count, and that mattered.

Clinical observation: I carried that experience into practice, especially when caring for adolescent patients and tired moms. I wanted to understand their fatigue, ask about their periods, and consider whether we needed to check their iron stores.

I wish my own stores had been checked after my periods started. Maybe we would have caught the deficiency before I spent so long assuming I was just busy and needed more sleep.

That’s why earlier screening is personal to me.

Should we check before someone feels exhausted?

Screening means checking for a problem before symptoms prompt testing.

Current evidence suggests: The American Academy of Pediatrics’ 2026 guidance recommends screening adolescents who menstruate for iron deficiency and iron-deficiency anemia:

• What to check: A CBC and ferritin.

• When: At least one year after the first period, but no later than age 14.

Your clinician may add an iron panel if they need more information, especially when inflammation makes ferritin harder to interpret.

Symptoms or heavy bleeding deserve assessment sooner; routine screening isn’t a reason to wait.

If you’re an adult and don’t know whether your ferritin has been checked, ask your primary care clinician or gynecologist whether testing makes sense for you, especially with heavy periods, persistent fatigue or other risk factors.

What actually changed?

ASH, the professional society for blood specialists, suggests a higher diagnostic cutoff than the long-used World Health Organization cutoff of 15 ng/mL for otherwise healthy adults.

Current evidence suggests:

• Most adults: ferritin of 30 ng/mL or lower. This includes women who get periods and women who are pregnant.

• Higher-risk situations: 50 ng/mL or lower may be appropriate. Examples include heavy periods, symptoms consistent with iron deficiency, ongoing blood loss, planning pregnancy, or pregnancy with anemia.

The units, ng/mL, mean nanograms per milliliter.

These numbers help identify iron deficiency. They aren’t instructions to get your ferritin to exactly 30 or 50 and then stop treatment. Your clinician should explain what improvement they’re looking for and how you’ll decide whether to continue, change or stop it.

ASH calls its suggested thresholds conditional because the supporting evidence is limited. It makes a strong recommendation against using the old 15 cutoff in pregnancy. Some earlier specialty guidelines already used higher cutoffs; this guidance aims to make diagnosis more consistent.

Inflammation can raise ferritin and hide low iron stores. When inflammation contributes to anemia, ASH suggests checking ferritin alongside transferrin saturation, another blood test that helps assess iron availability.

Lab methods and reference ranges vary. A result marked “normal” can still deserve a closer look alongside your symptoms and history.

Want more explanations like this? Subscribe free for one women’s health article every Thursday.

Subscribe now

What can drain your iron?

Well-established risks include:

• Blood loss: Heavy periods, childbirth, frequent blood donation or bleeding elsewhere.

• Higher needs: Pregnancy and intense endurance training.

• Not getting or absorbing enough: Too little iron in your diet, conditions that affect absorption, weight-loss surgery, or long-term acid-reducing medicines.

Finding the cause matters whether or not you get periods. After menopause, low iron should not simply be assumed to be a dietary problem.

Is my period heavy?

It’s hard to judge “heavy” when the only period you’ve ever had is your own.

Well-established: The CDC lists these signs:

• Changing a pad or tampon in under two hours, or soaking through one every hour for several hours.

• Doubling up on protection or changing it overnight.

• Bleeding for more than seven days.

• Passing clots the size of a quarter or larger.

• Bleeding that gets in the way of your normal plans.

If these sound familiar, bring them up. Heavy bleeding since your first period can be a clue to a bleeding disorder. Periods can change around menopause; a change still deserves attention.

Get emergency care if you’re soaking through a pad or tampon every hour for more than two hours and have chest pain, trouble breathing, or feel dizzy or lightheaded.

If your iron is low, what comes next?

Well-established: Treatment should address both the deficiency and its cause. If heavy periods are draining your iron, treating the bleeding matters, too.

Food contributes iron:

• Meat, poultry and fish provide heme iron, a form your body generally absorbs more easily.

• Beans, lentils, leafy greens and fortified cereal provide nonheme iron. Pairing these with vitamin C foods, such as peppers or citrus, helps absorption.

Food alone may not correct an established deficiency. If iron is prescribed, ask about constipation or nausea before side effects become the reason you stop. Some women need longer-term or repeated treatment because blood loss or an absorption problem continues.

Current evidence suggests: Iron treatment can modestly improve fatigue in some iron-deficient adults without anemia. Fatigue has other causes, too. If the deficiency is corrected and you still feel exhausted, keep looking with your clinician.

Your appointment checklist

Save this for your next visit. Find your last labs in your patient portal, or ask the office for a copy. If you don’t see ferritin, ask whether it was checked. An old result tells you where you were, not necessarily where you are now.

1. “Was ferritin checked, or only a blood count?”

2. “What does my result mean with my symptoms and health history?”

3. “If my iron is low, what could be causing it?”

4. “If my periods are heavy, can we treat the bleeding, too?”

5. “If treatment is recommended, what’s the side-effect and follow-up plan?”

Bring the result and date, your symptoms, medications, and a record of your bleeding if you get periods.

Before testing: If an iron panel is ordered, ask about fasting and when to take any supplements you already use. CBC and ferritin alone generally don’t require fasting.

If treatment starts: Ask when to repeat labs and review symptoms and side effects. Leave with a follow-up plan.

Don’t start iron supplements on your own. Too much can be harmful, and some people have conditions that cause iron overload. Accidental overdose is dangerous, especially for children. Store supplements out of their reach.

You don’t need to memorize every cutoff. You need to know which test was checked, what your result means in context, and what happens next.

Send this to the friend who’s always tired. She knows who she is.

Tell me in the comments: what were you told when you said you were tired? Pick one, or tell me what I missed:

1. “It’s just stress.”

2. “You’re not getting enough sleep.”

3. “It’s just your period.”

4. “Your labs look normal.”

Then read a few of the other comments. You may recognize your own experience. Please don’t post your own lab numbers here. Unfortunately, I can’t interpret individual results in the comments, but your clinician can.

Coming next: The birth control pill, PCOS (now also called PMOS, polyendocrine metabolic ovarian syndrome), and endometriosis. What the pill can and can’t do for these conditions, and what nobody explained along the way.

Subscribe free so the series lands in your inbox.

Subscribe now

Congratulations, we’re healthing.

— Lindsay

Sources & evidence notes

Personal experience and clinical observations are labeled separately from research findings.

1. ASH 2026 guideline for diagnosing iron deficiency. Published online August 24; announced September 16, 2026. Adult thresholds, risks and inflammation. Diagnostic cutoffs are not universal treatment targets. Implementation tool.

2. WHO ferritin guideline and 2024 hemoglobin criteria. Laboratory reference ranges and clinical decision thresholds can differ; a normal flag does not establish absence of anemia.

3. AAP 2026 clinical report and the lead author’s screening summary. Adolescent screening with CBC and ferritin, separate from ASH’s diagnostic guideline.

4. Houston et al., 2018 systematic review. Modest average fatigue improvement; objective exercise measures did not consistently improve.

5. NIH Office of Dietary Supplements: Iron. Food, absorption, side effects and risks.

6. CDC: Heavy menstrual bleeding and ACOG: Abnormal uterine bleeding. Bleeding patterns and emergency-care guidance.

7. British Society of Gastroenterology guideline. Investigating causes, treatment and follow-up.

8. Mayo Clinic: CBC preparation, ferritin preparation, and iron-panel preparation. Follow the ordering clinician’s and laboratory’s instructions.

9. FDA iron warning guidance. Accidental overdose and child safety.

10. Endocrine Society: PCOS name-change announcement. PMOS terminology.

This article is for education, not individualized medical advice. Your clinician can interpret your results and recommend care for your circumstances.

Let's get on the same page about our bodies.

You should know this. Every woman should. But most of us were never taught — smart, capable women don't know where their ovaries are, and it's not because they weren't paying attention. Half of us learned the word "estrogen" from a skincare ad. Our bodies are amazing and a little chaotic at the same time, and nobody sat us down and walked us through them. Health class covered how not to get pregnant and then stopped.

So here's the version I wish someone had handed us at fifteen. No scary diagrams, no quiz at the end. Let's get into it.

The parts

Your ovaries. Two of them, one on each side, about the size of an almond, sitting low in your belly a little below your hip bones. They do two jobs: they hold your eggs, and they make most of your hormones. That second job is the one everyone forgets, and it’s why so much of how you feel — energy, mood, skin, sleep — traces back to them.

Your uterus. The muscular organ in the middle, about the size of your fist. Its inside lining thickens every month to get ready for a possible pregnancy. When there isn’t one, the lining sheds. That’s your period.

Your period is not just “blood.” It’s the lining leaving.

Your follicles. Inside each ovary, eggs sit in tiny sacs called follicles. Every month a group of them starts growing, one wins, and that one releases its egg. When you hear “cysts” in the context of PCOS, this is what they’re talking about — follicles that started and stalled. Not the scary kind.

Ovulation. The moment the winning follicle releases its egg. This is the actual main event of your cycle, not your period. Your period is what happens because ovulation happened and no pregnancy followed. If you’re not ovulating, you can still bleed — but it isn’t the same thing, and it doesn’t mean the same thing. This one distinction explains half of what confuses women about their own bodies.

The cycle, in four moves

Your cycle starts on the first day of your period. Not the last. The first day of real bleeding is day one.

Move one: the bleed. The old lining leaves. Hormones are at their lowest. This is why the first day or two can feel flat and tired — it isn’t in your head.

Move two: the build. A follicle grows and starts pumping out estrogen. Estrogen rebuilds the lining, and it’s also the hormone behind the week where you feel clear, social, and like yourself. This is usually the best-feeling stretch of the month.

Move three: ovulation. Estrogen peaks, your brain sends a signal, and the egg is released. Somewhere around the middle of the cycle, though “middle” varies a lot from woman to woman.

Move four: the wait. The empty follicle turns into a little temporary gland that makes progesterone. Progesterone holds the lining in place and turns up your body temperature slightly. If no pregnancy happens, it drops off, the lining lets go, and you’re back to move one. That drop is where PMS lives — the days before your period when mood, sleep, cravings, and bloating go sideways.

A “regular” cycle is roughly 21 to 35 days from one day one to the next day one, with a bleed of about two to seven days. Some variation month to month is normal. Consistently outside that range, or so unpredictable you can’t answer “when was your last period” — that’s information, and it’s worth bringing to someone.

The hormones

You have more than these, but these four run the show.

Estrogen. Made mostly by your ovaries. Builds the lining, keeps your bones dense, your skin elastic, your brain sharp, your mood steadier, your vagina comfortable. It rises through the first half of your cycle and peaks at ovulation. Too little and you feel dry, flat, and foggy. Too much relative to progesterone and you get heavy periods, sore breasts, and bloating.

Progesterone. Only made in meaningful amounts after ovulation. That’s the key fact. If you didn’t ovulate, you didn’t make much progesterone that month. It’s calming — it helps with sleep and steadies mood — and its drop at the end of the cycle is what triggers your period. Many of the women who tell me “my second half of the month is a disaster” are describing a progesterone problem, which is often an ovulation problem underneath.

Testosterone and the androgens. Yes, you make testosterone. Every woman does, in smaller amounts than a man — and you need it. It’s part of why you have energy, muscle, sex drive, and motivation. But when it runs high, as it does in PCOS/PMOS, it shows up as acne, hair where you don’t want it, thinning where you do, and irregular ovulation. “Androgens” is just the family name for testosterone and its relatives.

Insulin. Not a “female hormone,” but I’m including it because it’s the one that quietly runs everything else. Insulin moves sugar out of your blood and into your cells. When your body stops responding to it well — insulin resistance — the ovaries respond by making more androgens, ovulation gets erratic, and the whole cycle above starts misfiring. This is why a hormone condition can be, underneath, a blood sugar condition. It’s the single most useful thing to understand about PCOS/PMOS, and almost nobody explains it.

A hormone condition can be, underneath, a blood sugar condition.

How this differs from a man

Same hormones, different amounts and a completely different rhythm.

A man’s testosterone follows a daily pattern — highest in the morning, lower at night, roughly the same every day. His hormones run on a 24-hour clock.

Yours run on a roughly monthly clock. Estrogen and progesterone rise and fall across weeks, and how you feel, sleep, recover from workouts, crave food, and handle stress shifts along with them. That’s not weakness. It’s a different operating system, and most health advice — including a lot of fitness and nutrition research — was written for the 24-hour one.

Knowing where you are in your own cycle is the first step to stop measuring yourself against a body that doesn’t work like yours.

Why tracking is the whole game

Everything in this article becomes useful the moment you start writing down day one.

Track it in an app — most are free and take ten seconds a day. Note the first day of bleeding, how heavy, how long, and the days you felt terrible or great. Three months of that tells a provider more than anything you’ll remember to say in the room. It’s how you’ll know if a cycle is actually irregular or just felt that way. And later, when you change something — food, sleep, a medication, a supplement — your cycle is the free monthly report card on whether it’s working.

One note on apps: they estimate ovulation from your past cycles. If your cycles are irregular, that estimate is a guess, not a measurement. Use the app for the record, not for the prediction.

The cheat sheet

Screenshot this.

Ovaries — hold your eggs, make your hormones.

Ovulation — the egg is released. The real main event.

Period — the lining leaving because no pregnancy followed. Day one of bleeding = day one of your cycle.

Estrogen — builds. First half of the cycle. Your “feel like myself” hormone.

Progesterone — holds and calms. Only after ovulation. Its drop = PMS and your period.

Testosterone — you make it, you need it, too much shows up on your skin and hair.

Insulin — the one underneath all of it.

Regular cycle — 21 to 35 days, bleeding 2 to 7 days.

What to do this week

Open your phone, download a cycle tracker, and enter the first day of your last period — or the honest answer, which might be “I don’t know.” Either one is a starting point.

Then come back and read the rest of what I write, because now you have the vocabulary for it.

You’re not behind. You just weren’t taught. Now you have been.

Congratulations, you’re healthing.

Comment

In the comments: tell the women here something in this article you genuinely didn’t know. I promise you’re not the only one — and that’s the whole point of this place.

Coming next: You were handed the pill for your symptoms. Here’s what nobody explained.

If you feel good right now, I want you here. You deserve to understand the body you live in while you’re going about your life, making decisions, and figuring out which health advice is worth your attention.

You hear about hormones constantly. But what do they actually do? What happens during a menstrual cycle? Which everyday habits deserve your energy? How do you tell whether a confident claim online has anything solid behind it?

Those are useful questions long before a symptom sends you searching. And if you already have symptoms, a diagnosis, or years of unanswered questions, you belong here too.

Who I am

I’m Lindsay, a board-certified Physician Associate (PA-C). My clinical work has included integrative and longevity medicine. Before I was a clinician, I was a teenager, and later a D1 volleyball player, going back to appointments with questions about my energy levels, periods and skin.

I always left appointments with questions that stayed with me. There was no time to ask all of the questions I had. That curiosity became part of why I went into medicine.

In my first job out of school, I cared for patients from newborns to older adults. They reminded me how much sitting down and explaining something thoroughly can positively influence the trajectory of someone’s health and well-being.

I went home after clinic to read the research, books, and guidelines so I could come back with even better answers and explanations each time they came back to see me. I’m bringing that same care and curiosity here, with more room to explain.

You can start before something is wrong

Maybe you’re in your twenties and want a better foundation. Maybe you’re navigating a change in your forties or fifties, or finally have time to ask questions you’ve carried for years.

Your health deserves attention in all of those versions of your life.

I want this education to help you build habits that make sense, understand appropriate preventive care, and recognize when a change is worth discussing with a clinician. Learning earlier gives you more opportunities to use what you know.

It cannot guarantee that you’ll avoid illness. Getting sick does not mean you failed to learn enough or do enough. You deserve useful information and good care wherever you’re starting.

Health literacy and health wisdom

Health literacy means being able to find, understand, and use health information: what your body does, what a claim means, and what questions might help you make a decision. Making that information clear and usable is part of my job here.

When I talk about health wisdom, I mean applying that understanding to your actual life. Knowing when to ask for help. Weighing evidence instead of following the loudest advice. Choosing a next step that fits your needs, resources, and priorities.

You can understand a topic without needing every test or product connected to it. You can care about your health without making it your entire personality.

That’s the kind of confidence I want you to build here.

Subscribe now

One clear explanation each Thursday, delivered to your inbox.

What you’ll get from HowToHealth

Each Thursday, I’ll take a women’s health question and make it easier to understand. We’ll cover the foundations as well as specific concerns: cycles and hormones, energy, nutrition, and changes across life.

You can expect:

• Explanations you can follow without a medical background. I’ll define the terms and show how the pieces fit together.

• Evidence with context. I’ll distinguish what’s well established, what current research suggests, what’s only a plausible explanation, what remains uncertain, and what comes from my own clinical observations.

• Questions you can bring to an appointment. Including what a test or treatment can tell you, its limits, and how it might affect your choices.

• Practical perspective. What deserves your attention, what we still need to learn, and what advice leaves out about ordinary life.

There’s more to understand than any one appointment can cover. I want this to help you take part in those conversations with a clearer foundation and more efficient appointments. It’s the education between your visits; your own medical decisions belong in care that knows your history.

Let’s make this a conversation

The comments are a place to share what you’re learning, ask general questions, and help another reader feel comfortable asking hers. I’ll join those conversations.

Start with one: what would you most like to understand better: your cycle, your sleep, everyday health habits, or how to judge health advice? Keep personal medical details out of public comments.

You can also suggest a future topic here.

I hope you leave each article feeling more capable and a little more at home in your own body. I’m glad you’re here.

Congratulations, we’re healthing.

Lindsay

Subscribe free

Join me for next Thursday’s explanation.